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Abstract 
 
Upper airway stenosis has a significant impact on the quality of life and sometimes on 
life itself. The incidence of this condition is likely to be increasing as survival rates 
following periods of ventilation on Intensive Care Units (ICUs) improve (1, 2). 
Paediatric laryngotracheal stenosis is a well researched discipline and treatment includes 
airway augmentation with rib grafts and tracheal or cricotracheal resection with end-to-
end anastomosis. At the start of my research, in 2005, adult laryngotracheal stenosis 
was poorly researched and the treatment options were tracheostomy, tracheal resection 
or cricotracheal resection, each with associated morbidity and mortality. 
This thesis investigates the aetiology, incidence, screening and alternative treatment 
options, which include endoscopic techniques, for the management of acquired adult 
benign laryngotracheal stenosis. The commonest causes for this condition are 
ventilation on intensive care units and inflammatory disorders such as Wegener‟s 
granulomatosis, idiopathic subglottic stenosis and sarcoidosis. 
In January 2004 a prospective database was set up in the busiest airway reconstruction 
unit in the United Kingdom. Data was collected on all new adult patients with upper 
airways stenosis. At the completion of this research in January 2010, 400 patients had 
been entered on this database.  Due to the rarity of this condition, it was not possible to 
design randomised trials to compare different treatment options. 
This thesis is an integrated series of prospective cohort studies, with the aim of 
developing a greater understanding of adult airway stenosis, with a particular emphasis 
on minimally invasive endoscopic techniques.  
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This research has shown that 72% of patients with post-intubation airway stenosis can 
be treated with these minimally invasive endoscopic techniques. Effective new 
treatments have been devised for the management of inflammatory stenoses when the 
results of previous treatments had not been effective. New tools for assessing the airway 
and outcome measures have also been proposed. 
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Chapter 1 
 
1.1  Backround & Aims of Thesis 
The larynx, trachea and bronchi form the conduit between the external environment and 
the lungs through which respiratory gases are transported and pulmonary secretions are 
expectorated.  The principle function of the larynx is to protect the airway from 
aspiration during swallowing, but the larynx is also involved with phonation and 
Valsalva.  The narrowest sites of the adult airway are the larynx and trachea (illustration 
1.1).   
                 
Illustration 1.1 The narrowest site in the adult airway is the glottis followed by the trachea 
 
Upper airway stenosis can have a significant impact on the quality of life and 
sometimes on life itself (illustration 1.4).  Abnormal narrowing of the laryngotracheal 
complex causes breathlessness, especially during physical activity.  Retention of 
pulmonary secretions may lead to lung infection or collapse.  Laryngeal stenosis can 
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interfere with phonation and a dysfunctional larynx can affect swallowing safety.  Due 
to medical advances, more patients are surviving periods of ventilation on intensive care 
units (1, 2).  The incidence of laryngotracheal injury is probably increasing but remains 
unknown. 
To appreciate the impact of airway stenosis one must have a basic understanding of the 
rules governing fluid dynamics (3): 
The Venturi effect states that the velocity of a fluid flowing through a pipe increases as 
the cross sectional area decreases. The velocity must increase to satisfy the law 
governing conservation of mass and to satisfy the law governing conservation of energy 
the static pressure in this fluid must decrease. [The Venturi effect is named after the 
Italian Physicist, Giovanni Venturi (1746–1822)]. 
                                
Illustration 1.2 Experiment to demonstrate the „Venturi Effect‟. The velocity increases as 
the gas flows through the constriction but at the expense of the static pressure, as shown 
by the difference in height of the two columns of water (3). 
 
The Bernoulli's principle states that for an inviscid fluid (no viscosity), an increase in 
the speed of the fluid occurs simultaneously with a decrease in the pressure, or a 
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decrease in the fluid’s potential energy. [Named after the Dutch-Swiss mathematician, 
Daniel Bernoulli (1700-1782)]. 
Poiseuille's law 
 
 R = resistance 
 n = viscosity 
 l = length 
 r = radius 
In laminar airflow, airway resistance is dictated by the diameter of the airway and by 
the density of the inspired gas (Poiseuille’s law). Because of the fourth power in the 
denominator, resistance increases rapidly as diameter decreases. However, an area of 
airway stenosis also produces turbulence, which adds to resistance, but cannot easily be 
calculated. 
 
During inspiration, the intrathoracic airways expand along with the expanding lungs. 
However, the extrathoracic trachea will have a reduced lumen during inspiration 
because the intraluminal pressure is lower than atmospheric. The reverse happens 
during expiration. A variable obstruction of the airway also changes size with breathing. 
Hence an extrathoracic variable tracheal stenosis will limit inspiration whereas an 
intrathoracic variable lesion will limit expiration. A fixed obstruction, whether 
intrathoracic or extrathoracic, will limit peak airflow on inspiration and expiration in 
equal proportions and produce a characteristic flow volume loop (illustration 1.3). The 
exact physiological causes of dyspnoea are not known, however, the extra work of 
breathing, altered afferent input from the respiratory tract and the tendency towards 
carbon dioxide retention must play a part. 
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Illustration 1.3 Patterns of flow volume loops - these graphically depict the rate of 
airflow on the Y-axis and the total volume expired (above) inspired (below) on the X-
axis. The patient is asked to take the deepest breathe, apply the mouth to the device, 
and breathe out as hard as possible and for as long as possible. This is followed by a 
maximum and rapid inspiration. (COPD= chronic obstructive pulmonary disease) 
 
Paediatric laryngotracheal stenosis is a well-researched area of medicine and treatments 
include airway augmentation with rib grafts as well as tracheal and cricotracheal 
resections.  At the start of this investigation in January 2004, adult laryngotracheal 
stenosis was poorly researched and the surgical options included tracheostomy, tracheal 
resection or cricotracheal resection (4).  In the United Kingdom the majority of adult 
airway stenoses were being managed by paediatric airway surgeons.  Most were using 
primary rib grafts for augmentation, even though there is no published series on the 
successful application of this technique in adult patients.  There was no appreciation of 
the fact that there is a high incidence of ischaemic necrosis of primary rib graft in adult 
patients (5).  Furthermore, the quality and quantity of rib cartilage that can be harvested 
diminishes with age (5).  Paediatric airway stenosis nearly always involves the 
subglottis (6). Early, during the process of data collection for this thesis, it became clear 
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that the lesional anatomy, anatomical sites and pathologies behind adult laryngotracheal 
stenosis differed greatly from the paediatric group.  
 
Illustration 1.4  Different sites of adult airway stenosis (central pictures are 
normal, right are stenosed). A=glottis, B=subglottis, C=trachea and D=bronchi. 
 
There was very little quality research to use as a guide to the types of cases that could be 
expected.  Most of the adult literature and „evidence‟ referred to subglottic and tracheal 
stenosis where the “gold standard” was cricotracheal or tracheal resection and success 
rates were quoted in various papers ranging from 70-90% (7).  However, these articles 
do not make clear the selection or exclusion criteria for surgery.  As well as open 
surgical procedures, some surgeons had considered endoscopic surgery for adult airway 
stenosis (8), however, the procedures were technically challenging and not widely 
adopted.  At the start of this research, it was accepted wisdom that surgery should only 
be undertaken on the airway once an airway stenosis had “matured” and the 
inflammatory changes had subsided (9).   
Systemic inflammatory disorders, such as Wegener‟s granulomatosis and sarcoidosis, 
sometimes lead to laryngotracheal airway compromise. Medical science has made it 
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possible to treat these, once potentially fatal, conditions. This has produced a group of 
patients who have had to live with the restrictions of their damaged airways, often 
progressing to airway stents or tracheostomies.  
 
Illustration 1.5 Myer-Cotton grading system for paediatric subglottic stenosis 
The most widely used grading system to describe the degree of airway stenosis is the 
Myer-Cotton grading system (10) which refers to the surface area of the stenosis 
(illustration 1.5) as opposed to the size of the patient‟s airway.  This grading system was 
developed to help with decision making in paediatric airway surgery with respect to 
conservative or surgical treatments.  In paediatrics, a decanulation was deemed a 
successful outcome and in the adult population, the outcomes were often graded as 
“excellent”, “good”, “satisfactory”, “failure” or “death” with little mention of 
swallowing or voice outcomes. 
In January 2004, a database was constructed using FileMaker Pro® (FileMaker Inc, 
Santa Clara, USA) installed on a small portable notebook computer. This has been used 
to collect prospective data on all new referrals of adult benign laryngotracheal stenosis 
made to the Airway Reconstruction Team based at the Royal National Throat, Nose & 
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Ear Hospital and Charing Cross Hospital, both in London.  The author of this thesis has 
been the operating surgeon on all the patients and has been responsible for entering all 
the surgical and out-patient information on the database.  All the anaesthetic data has 
been entered by the anaesthetist at the time of surgery in the operating room.  The 
database recorded the medical history, demographics related to the patient and details of 
each operation and out-patient visit.  Each surgical entry has been illustrated with 
photographs taken during the procedure.  In each case the definitive diagnosis, with 
respect to the aetiology of the airway stenosis, was made based on all the assessments 
discussed in this thesis. This is probably the largest prospective database on this 
condition. 
Since the start of this project in January 2004 and the commencement of writing the 
thesis in January 2010, just over 400 adult patients had been entered on the database.  
Of the relative aetiological factors presented in table 1.1, more than half the cases of 
adult laryngotracheal stenosis were due to a period of ventilation on an intensive care 
unit.  The incidence of stenosis in patients who were ventilated with endotracheal tubes 
or converted earlier to tracheostomies was very similar, only the site of the injury 
differed.  Early tracheostomy did, however, reduce the incidence of damage to the vocal 
folds and their mobility.  Unlike paediatric laryngotracheal stenosis, which almost 
always affects the subglottis (the narrowest part of the paediatric airway), in the adult 
population, one third of the patients had stenosis of the cervical trachea.  Nearly half of 
the adult patients had airway compromise due to other disease processes such as 
Wegener‟s granulomatosis, sarcoidosis and idiopathic subglottic stenosis.   
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      Table 1.1        
Four Hundred Consecutive Adult Referrals with Laryngotracheal Stenosis 
• 48% Acquired laryngotracheal stenosis  
34.75%     subglottic stenosis  
13.25%     tracheal stenosis  
• 14.75% Bilateral vocal cord mobility impairment 
8.75% nerve injury 
4.75% scar/fixation 
1.25% rheumatoid arthritis 
• 11.25% Wegener‟s granulomatosis  
• 9.75%   Idiopathic subglottic stenosis  
• 5.5%     Supraglottic stenosis    (2.5% sarcoid,3.0% other) 
• 3.25%   Previous papillomatosis treatment 
• 3.25%   Glottic web 
• 2.0%     Tracheomalacia (1.25% relapsing polychondritis) 
• 1.0%     Amyloidosis  
• 0.75%   Vascular lesion 
• 0.5%     Subglottic stenosis congenital 
 
This thesis has set out to look at the aetiology, incidence, screening and alternative 
procedures for the management of adult benign laryngotracheal stenosis.  Due to the 
diverse causes of adult airway stenosis, it has not been possible to apply this research to 
all 400 cases. Instead I have concentrated on previously difficult to treat groups and 
specific conditions drawn from this pool. A critical review of the literature and 
respective research is discussed in the appropriate chapters.  As a part of this project it is 
hoped that the treatment pathways, algorithms and outcome measures proposed could 
be adopted by other groups working in this field.  
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Chapter 2 
2.I  Embryology 
The first sign of the respiratory system is seen as an epithelial thickening and out-
pouching along the ventral aspect of the primitive foregut known as the respiratory 
diverticulum (RD).  This appears at the end of the fourth week of gestation.  The RD is 
separated from the hepatic diverticulum by the septum transversum (illustration 2.1), a 
structure that eventually develops into the central tendon of the diaphragm.  Inside the 
RD is the laryngotracheal groove which extends lengthwise in the floor of the gut just 
caudal to the pharyngeal pouches (11).   
  
Illustration 2.1  The larynx and respiratory system arise from an out-pouching of 
the primitive foregut called the Respiratory Diverticulum (RD)(11)  
 
As the upper foregut region and RD migrate superiorly, the RD gives rise to bilateral 
projections called bronchopulmonary buds which are drawn caudally.  These 
projections or buds soon divide into the right and left bronchial buds and grow into the 
pericardio-peritoneal cavities.  These primitive lung buds then subdivide into secondary 
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and tertiary bronchi.  Throughout foetal development, the surrounding pulmogenic 
mesoderm continues to develop into the lung parenchyma.  The larynx develops in the 
proximal end of the laryngotracheal groove between the fifth and sixth gestational 
weeks as three swellings which appear at the laryngeal aditus.  The anterior swelling 
becomes the future epiglottis and the lateral masses give rise to the future arytenoids.  
The two lateral swellings migrate cranially and medially to oppose each other 
(illustration 2.2).  Together with the epiglottic swelling, they surround a T-shaped 
laryngeal aditus (12).  The laryngeal lumen becomes occluded at the eighth week of 
gestation due to epithelial proliferation.   
   
Illustration 2.2  The embryological development of the epiglottis and 
arytenoids(11) 
 
If normal recanulation does not occur during the tenth gestation week, a laryngeal web 
develops.  The formation of the vocal and vestibular folds is related to the condensation 
of mesenchyme and the out-pouching of the laryngeal ventricle.  The two vocal folds 
separate during the third gestational month and failure of this process results in 
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congenital atresia of the larynx.  The thyroid cartilage develops from the fourth and fifth 
branchial arches as two lateral plates that fuse in the midline (illustration 2.3).  The 
cricoid cartilage develops from the fifth arch (13).  The rostral advancement of the 
tracheo-oesophageal septum results in the fusion of the dorsal cricoid lamina.  Failure of 
advancement results in either a fistula or a cleft.  The arytenoids are initially fused to the 
cricoid cartilage, but they eventually separate, forming the cricoarytenoid joints.  The 
intrinsic muscles of the larynx develop from the mesoderm of the fourth and fifth arches  
          
    Illustration 2.3 Branchial arch origins of the Larynx (13) 
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2.II  Anatomy 
The larynx is positioned between the tongue base and the trachea and separates the 
airway from the digestive tract.  It lies at the level of the second or third cervical 
vertebrae in the infant and descends to the adult position during the first few years of 
life to lie at the level of the fifth and sixth cervical vertebrae.  The male and female 
larynx differs little in size up until puberty.  The adult larynx undergoes significant 
growth and the female larynx to a lesser degree under the influence of the hormones 
responsible for secondary sexual characteristics.  The adult male larynx averages 44 mm 
in length and the female larynx 36 mm (14).  The antero-posterior length in the adult 
male averages 41 mm, and 26 mm in the female.  Contrary to traditional teaching, the 
diameter of the trachea relates to height regardless of sex (illustration 2.4), both in 
children and adults (15).
Illustration 2.4  Graph to show relationship between height and tracheal diameter 
(adapted from Griscom (15)) 
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The larynx is composed of several interconnected cartilages that are moved by muscles.  
The three unpaired laryngeal cartilages are the epiglottis, the thyroid and the cricoid 
cartilages and the three paired laryngeal cartilages are the arytenoid, the corniculate and 
the cuneiform cartilages (illustration 2.5).  The larynx has four synovial joints.  The 
paired cricothyroid joints are between the lateral aspect of the cricoid cartilage and the 
inferior horn of the thyroid cartilage and permit rotation of the thyroid cartilage on a 
horizontal axis.  This has the effect of shortening the cricothyroid gap.  The 
cricoarytenoid joints are present between the superior border of the lamina of the cricoid 
cartilages and the base of the arytenoid cartilages allowing for gliding and rotational 
movements of the arytenoid cartilages.   
        
Ilustration 2.5 Cartilages of the human Larynx (14) 
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The arterial supply to the larynx is from the superior and inferior laryngeal arteries 
which are branches of the superior and inferior thyroid arteries respectively (14).  The 
superior laryngeal artery accompanies the internal branch of the superior laryngeal 
nerve on each side and the inferior laryngeal artery enters the larynx with the recurrent 
laryngeal nerve.  Within the larynx, the two arteries join to form a vascular arcade from 
which a number of end arteries are given off to supply the endolarynx (16).  The venous 
drainage of the larynx follows its arterial supply.   
The lymphatic drainage of the larynx above the level of the vocal folds is to the superior 
and middle deep cervical lymph nodes which lie along the carotid sheath.  The 
supraglottic larynx has bilateral drainage and this has an impact on the spread of 
supraglottic malignancy.  The infero-glottic larynx drains to the paratracheal and the 
lower deep cervical lymph nodes.  Currently, the anatomical upper limit of the glottis is 
defined as the apex of the laryngeal ventricle.  The lower limit is defined as 1 cm below 
the most medial part of the vocal fold.  These limits reflect the changes in lymphatic 
drainage and have implications in the management of laryngeal malignancy (17). 
The vagus nerve carries sensory fibres from the larynx above the vocal folds.  The 
laryngeal mucosa is supplied by the internal branch of the superior laryngeal nerve and 
below the vocal folds the sensory supply is from the recurrent laryngeal nerve.  Motor 
supply to all the intrinsic laryngeal muscles, except for the cricothyroid, is through the 
recurrent laryngeal nerve, which is a branch of the vagus nerve.  Motor supply to the 
cricothyroid muscle is by the external laryngeal branch of the superior laryngeal nerve, 
itself a branch of the vagus nerve.  There is, however, some crossover between the 
superior and internal laryngeal nerves in respect to proprioceptive supply to the intrinsic 
muscles of the larynx.   
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The larynx as a whole can be elevated and depressed by the action of the suprahyoid 
and infrahyoid strap muscles.  Laryngeal elevation is an important mechanism for 
protecting the airway during swallowing and also has the effect of changing the length 
of the vocal tract as occurs during singing.   
The intrinsic muscles can also be divided into muscles that open and close the laryngeal 
inlet and muscles that regulate the vocal folds.  The posterior cricoarytenoid muscles are 
the principle abductors of the vocal folds.  The thyroarytenoid, vocalis and cricothyroid 
muscles, and the transverse and oblique arytenoid muscles, contribute towards 
adduction of the vocal folds.  The posterior cricoarytenoid muscle extends laterally from 
the posterior aspect of the cricoid cartilages to the muscular process of the arytenoid 
cartilage and rotates it laterally (illustration 2.6).  It is the principle respiratory laryngeal 
muscle and its bilateral paralysis can lead to acute airway compromise.   
  
Illustration 2.6  Posterior cricoarytenoid muscle action (14) 
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The lateral cricoarytenoid muscles are the principle adductors of the larynx.  The lateral 
cricoarytenoid muscles extend from the arch of the cricoid cartilage to the muscular 
process of the arytenoid cartilage rotating it medially.  This has the effect of bringing 
the vocal folds together for vibration and for airway protection during swallowing.  The 
oblique and transverse arytenoids muscles unite the arytenoid cartilages and maintain 
approximation of the posterior portion of the vocal folds during phonation.   
After closure of the glottis, the vocal cords can be tightened and lengthened by the 
cricothyroid muscles to change the pitch and tone of the voice.  The cricothyroid muscle 
has the effect of bringing the thyroid and cricoid cartilages together anteriorly, thus 
increasing the anterior posterior dimension of the larynx and tightening the vocal cords.  
The thyro-arytenoid muscles can finely regulate the tension and pliability of the vocal 
folds during phonation (illustration 2.6).   
The anterior relations of larynx are the suprahyoid and infrahyoid muscles and the 
thyroid gland.  Its most important lateral relations are the superior laryngeal nerves 
superiorly and the recurrent laryngeal nerves inferiorly.  Its posterior relations are the 
cricopharyngeus muscle, the upper oesophageal sphincter and the vertebral bodies.  
Postero-laterally the larynx is related to the carotid sheath which contains the common 
carotid artery, the internal jugular vein and the vagus nerve (14).   
The trachea is a tube that spans between the lower border of the cricoid cartilage of the 
larynx, at the level of the sixth cervical vertebra, to the carina at the level of the sternal 
angle.  At the carina, the trachea divides to give rise to the right and left main bronchi.  
In the adult, the trachea varies between 10-13 cm in length and in the adult is composed 
of approximately 20 C-shaped cartilaginous rings that are connected by fibrous bands 
and covered by respiratory mucosa.  Posteriorly, the tracheal wall is composed of a flat 
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fibro-muscular structure which spans between the arms of the C and contains the 
unpaired trachealis muscle (18). The trachealis constricts the trachea during a cough 
allowing the high velocity passage of air during a cough.  
 
Illustration 2.7 Segmental blood supply to the trachea (19) 
The trachea has a segmental blood supply (Illustration 2.7).  The cervical trachea 
receives its blood supply primarily from the inferior thyroid arteries.  The superior 
thyroid arteries do not directly supply the trachea, but can anastomose with the inferior 
thyroid arteries and supply blood to the trachea via the thyroid gland (18).  The lower 
cervical and thoracic trachea is supplied by direct branches of the brachiocephalic and 
the left subclavian artery, as well as the supreme intercostal arteries and the right 
internal thoracic artery.  The lower thoracic trachea and the carina are predominantly 
supplied by bronchial arteries that are direct branches of the aorta (20).  The diagrams 
are reproduced from „Surgery of the Trachea and Bronchi‟ by Grillo (19).  These 
arteries enter the tracheo-oesophageal groove laterally and divide into tracheal and 
oesophageal branches.  Tracheal branches, having contributed to the lateral longitudinal 
anastomosis, pierce the tracheal wall as transverse intercartilaginous arteries and divide 
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into anterior and posterior branches that supply the anterior and posterior parts of the 
trachea respectively.  These blood vessels terminate in a rich circumferential mucosal 
vascular plexus.  Venous drainage of the trachea appears to follow its arterial supply 
(20).  The oesophageal branches also make a contribution to the arterial supply of the 
posterior trachea.  The lymphatic drainage of the trachea is to the pre-tracheal, 
paratracheal and subcarinal lymph nodes (18).  The trachea appears to have a segmental 
lymphatic drainage with each segment of the trachea draining into the pre- and 
paratracheal lymph nodes closest to it.   
Sensory and motor innervation of the trachea has been extensively studied in animal 
models but not in humans.  Retrograde neurone staining techniques have shown that the 
afferent nerve supply to the trachea is provided by the vagus nerve.  Sympathetic 
neurones supplying the trachea are found throughout the sympathetic chain from C1 to 
T8, but have a higher concentration, at the severus, cervical and stellate ganglia (21).  
The vagus nerve also provides motor innervation to the trachea.  The cervical trachea 
receives its motor supply both from superior and recurrent laryngeal nerves and the 
thoracic trachea is predominantly supplied by the recurrent laryngeal nerves with a 
smaller contribution from the superior and para-recurrent laryngeal nerves (22).   
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Illustration 2.8 Anatomy and relations of the human trachea (A1 view from right, 
A2 view from left) (20) 
 
The trachea is an unpaired midline structure that is surrounded by loose, essentially 
avascular peri-areolar tissue throughout its course, except the point of its attachment to 
the thyroid isthmus (18).  Illustration 2.8 demonstrates the relations of the trachea (20).  
Posteriorly, the trachea is intimately related to the oesophagus throughout its course, 
except for its right posterior margin which lies directly against the vertebral bodies(18).  
Anteriorly the thyroid isthmus overlies the cervical trachea and is connected to it by 
means of the ligament of Berry.  The thyroid lobes lie over the antero-lateral and lateral 
portions of the cervical trachea.  Laterally, the trachea is related to the recurrent 
laryngeal nerves which are branches of the vagus.  The left nerve originates underneath 
the aortic arch and lies in the tracheo-oesophageal groove throughout its entire course, 
often posterior to the branches of the inferior thyroid artery.  The left vagus nerve itself 
lies antero-lateral to the trachea throughout its thoracic descent.  The right recurrent 
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laryngeal nerve loops around the subclavian artery and frequently lies between the 
branches of the inferior thyroid artery.  The brachiocephalic artery crosses the mid 
trachea obliquely to reach the right side of the neck where it gives rise to the right 
common carotid and the subclavian arteries which lie antero-lateral to the right cervical 
trachea.  The lower thoracic trachea and the carina are related to the aortic arch on the 
left and the superior vena cava and azygos vein on the right.  The pulmonary artery 
crosses in front and just inferior to the carina. 
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2.III  History of Airway Surgery 
2.III.a  Tracheostomy and Airway Intubation 
The earliest description of a surgical tracheostomy is found in the Rig Veda, the ancient 
Hindu book of medicine, that appeared as oral tradition at around 2000 BC (23).  Five 
centuries later, in Egypt, following the work of Imhotep, a technique resembling 
tracheostomy was first documented in written form to treat respiratory obstruction 
(Edwin Smith‟s Papyrus).  Hippocrates in Greece at around 460-380 BC described the 
intubation of the trachea of humans to support ventilation.  Alexander the Great (356-
323 BC) reportedly used his sword to cut open the trachea of a soldier suffering from an 
aspirated bone.  The first recorded successful tracheostomy was for treatment of a 
pharyngeal abscess by Antonio Musa Brasavola of Ferrara in 1546 (24).  Marco Aurelio 
Severino used tracheostomy during an epidemic of diphtheria in Napoli in 1610.  
Lorenz Heister in 1718 was the first to use the term “tracheostomy”.  Many descriptions 
are reported thereafter.  The first modern description of a tracheostomy was by 
Chevalier Jackson in 1909 (25).  Andreas Vesalius, a Flemish physician working in 
Padua, in 1543 reported the first tracheal intubation in an animal.  In early 1871, 
Trendelenberg from Germany performed the first endotracheal anaesthesia in man.  
General anaesthesia itself had been performed previously in 1846 in Boston using ether.  
The first elective surgical procedure performed using oro-tracheal intubation was by an 
Edinburgh surgeon, William MacEwen, in 1878 to remove an oral tumour. 
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2.III.b  Laryngoscopy 
Before the 1800‟s, physicians could only surmise how the larynx functioned from 
examination of autopsy specimens.  Diseases of the airway were usually infectious or 
inflammatory in origin.  The infections included syphilis, diphtheria and tuberculosis.  
Medical historians conventionally date the beginning of laryngoscopy as 1855, when 
Spanish voice teacher, Manuel Garcia, first visualised his own larynx using a dental 
mirror fixed at 45 degrees to a handle and a second hand-held mirror to reflect sunlight. 
This work was presented at the Royal Society of Medicine (26).  However, a more 
detailed review of the literature reveals that the French Accoucheur Leveret, in 1743, 
devised a bent mirror for examining the larynx and even a snare for removing laryngeal 
polyps (26).  In 1807, Bozzini, a German physician, published an account of his 
speculum called the “light conductor”.  His device was for examining internal cavities, 
including the larynx.  Benjamin Guy Babington was another predecessor of Garcia‟s.  In 
1829, he exhibited to the Hunterian Society of London an instrument which was a 
combination of an epiglottic retractor and laryngeal mirror.  This he used to examine the 
larynx (26, 27).   
Johann Czermak, Professor of Physiology at the University of Pest, first tried Garcia‟s 
mirror in examining patients.  In 1858, Czermak presented his work to the Viennese 
medical community.  Indirect laryngoscopy blossomed in the last decades of the 19
th
 
Century.  Surgical instruments were developed which allowed the laryngologist to cut, 
cauterise and remove laryngeal tissue with indirect visualisation.  In Vienna, the 
German surgeon, Billroth, performed the first laryngectomy in 1873 (28). 
The first physician to directly visualise the larynx, in 1864, was the Berlin 
laryngologist, Tobold (29).  His patient was a female singer with papillomatosis of her 
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larynx who was able to suppress her gag reflex such that a tongue depressor could be 
used to glimpse the larynx without instrumentation.  It was Gustave Killian who first 
performed suspension laryngoscopy in 1909.  He used a tubular spatula, an early 
laryngoscope, to visualise the larynx initially in cadavers, but later in patients.  
Chevalier Jackson was probably the first to describe the “sniffing the morning air” 
position (illustration 2.9) for microlaryngoscopy in his book dated 1915 (30). 
 
  
Illustration 2.9  Demonstrating the „sniffing the morning air‟ position originally      
described by Chevalier Jackson in his book of 1915 (30).  
 
2.III.c  Bronchoscopy 
Gustave Killian in Freiburg University in 1897 removed a bone splinter from the right 
main bronchus of a farmer using an oesophagoscope, forceps and a head mirror as a 
light source (31).  In 1904, Chevalier Jackson in Philadelphia produced a bronchoscope 
with a light bulb at its distal end and a suction device. Professor Harold Hopkins held is 
Chair in Physics at Reading University but his earlier work in optics was done at 
Imperial College. In addition to his theoretical work, his many inventions are in daily 
use throughout the world. These include zoom lenses, coherent fibre-optics and more 
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recently the rod-lens endoscopes which 'opened the door' to modern key-hole surgery 
(32). Rod lens endoscopes consist of a series of glass and air lenses that transfer the 
image from the tip of the device to the eye and became commercially available in 1966 
(illustration 2.10). These were adopted for use with bronchoscopes.   
 
 
Illustration 2.10 Design of the modern rod-lens endoscope developed by Prof 
Harold Hopkins (32) 
 
Also in 1966, Professor Shigeto Ikeda presented a bronchofibrescope at the 9
th
 
International Congress of Diseases of the Chest.  The ventilating bronchoscope 
appeared in 1976. 
2.III.d  Surgery for Laryngotracheal Stenosis 
The Rig Veda noted that the trachea could re-unite “when the cervical cartilages are cut 
across, provided they are not entirely severed”.  This description dates from about 2000 
BC.  The earliest description of surgery for laryngo-tracheal stenosis was by L.Von 
Schroetter in Vienna in 1871.  He described two techniques.  The first involved the use 
of metal “olives” after placement of a tracheostomy.  The second procedure was 
dilatation of the airway with hard rubber bougies delivered through the mouth (33, 34).  
In 1885, O‟Dwyer in New York (35) described similar techniques of dilatation that 
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became used widely in the USA.  Gluck and Zeller in 1881 demonstrated healing after 
end-to-end tracheal anastomosis in dogs and believed that the technique could be 
applied in man (36).  Primary anastomosis of the trachea after limited resection for post-
traumatic stenosis was performed by Kuster in 1886 in man (37).  Nowakowski in 1909 
(38) described complex methods of repair of cervical tracheal defects and through 
cadaver studies placed the limit of tracheal resection at 3-4 cm.  This was following 
cadaveric studies.  It was many years later before Conley successfully resected the 
second and third tracheal rings for scar in 1953 with primary end-to-end anastomosis 
(39).  In 1968, Grillo reported the length of trachea that could be resected for post-
intubation stenosis at 4.5 cm (approximately 7.2 rings).  He discovered that the length 
that could be resected in older patients was progressively shorter because of the reduced 
elasticity between the cartilaginous rings.  He further demonstrated that it would be 
possible, with additional manoeuvres involving release of pulmonary ligaments and 
suprahyoid laryngeal release, to resect a further 2 cm (40).   
Open approaches for the treatment of subglottic stenosis can be traced as far back as the 
late 1800s and early 1900s.  Killian in Germany described an operation referred to as 
“laryngo-tracheostomy” (34).  A vertical skin incision and a median vertical fissure of 
the larynx and trachea were created.  A fistula was maintained and progressively larger 
soft rubber tubes were inserted through the tracheostomy site. There is also a 
description in the German literature in 1896 (41) describing the use of rib cartilage graft 
in a two stage procedure to close an open tracheal wound. These original papers were 
essentially case reports but modifications of these techniques are still used in modern 
airway surgery (42). 
In 1927, M F Arbuckle in St Louis, described his experience with three children who 
had been treated unsuccessfully with repeated intubations after a diphtheria throat 
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infection.  The larynx and subglottis were exposed after a median vertical incision 
through the skin and the airway.  Arbuckle excised all visible scar tissue and placed a 
skin graft over the denuded area within the lumen of the airway.  The graft was held in 
place with a rubber balloon attached inferiorly to a string which was brought out 
through the tracheotomy.  He also described a similar technique with a balloon which 
was held by a stay suture from the outside, transfixing the larynx, graft and balloon.  In 
each case the balloon was removed after 8 days.   
Schmiegelow (43) from Copenhagen described, in 1927, a surgical technique which he 
said he had been using since 1910.  Via a laryngo-tracheal fissure, he entirely removed 
any structures or scar tissue encroaching on the lumen such that it appeared normal in 
size.  He then placed an India rubber drain slightly wider than the lumen, fixed into 
position using silver wire through the soft tissues and skin of the neck.  This “stent” was 
left in place for several weeks or months. 
Before the 1930s the majority of stenoses of the airway resulted from infections and 
inflammatory processes.  Often this was exacerbated by iatrogenic injuries from 
surgery.  In 1921 Chevalier Jackson (25) from Philadelphia cautioned against the 
placement of a “high tracheotomy” which he described as on or near the cricoid 
cartilage.  Le Jeune and Owens (44) from New Orleans noted in 1935 that 90% of their 
cases of laryngo-tracheal stenosis were caused by disease or trauma.  They advocated 
complete dissection of all scar, granulation, cartilage and osseous tissues via 
laryngofissure and application of a skin graft over a stent, their argument being that 
primary tissue healing where there is skin approximation produces less scar tissue than 
healing by secondary intention.  Jackson in his article of 1936 (33) stated that all cases 
of congenital or acquired stenosis of the larynx were curable.  He also stated that the 
wearing of a canula (tracheotomy) would dominate the entire life of a person and create 
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an inferiority complex.  Jackson favoured the placement of elastic rubber core moulds 
changed weekly and slowly increasing in size.  These rubber stents were placed above 
the tracheotomy.  Jackson admonished the cutting of the cricoid cartilage even in 
laryngeal atresia as “it is the only complete ring in the airway”.  Some of the principles 
described by Jackson are part of modern laryngology teaching. The work of Le Jeune 
and Owens has formed the basis of some techniques employed in this thesis (section 
2.III.e). 
In 1938, Edward Looper from Baltimore described the use of the hyoid bone as an 
autologous material for grafting in airway reconstruction.  He described it as being 
advantageous over the use of rib or ear cartilage (7).  This is the first reference to 
cartilaginous graft tissue for airway reconstruction.  As well as performing the first 
tracheal resection in 1953, John Conley of New York (39) summarised several 
techniques for treatment of subglottic stenosis.  He performed a laryngofissure, removed 
all scar tissue and placed a split skin graft over a Vaseline gauze over a foam rubber 
sponge.  He also mentioned that autologous cartilage could be used to assist in 
reconstructing the tubular form of the trachea.  He did not discuss specific cases but the 
ideas are in use in paediatric airway reconstruction today (45).   
In 1971, Grahne of Helsinki (46) continued to completely remove scar tissue, but 
described a hole placed through an Aboulker stent to accommodate a metal 
tracheostomy tube.  This stent was left in place for 4 months.  By the 1970s, the 
principal cause of airway stenosis was no longer infectious diseases, high 
tracheostomies or surgical dilatations.  The principal cause now was a period of 
prolonged ventilation using an endotracheal tube.  In 1972, Fearon and Cotton in 
Toronto (47) published an experimental procedure where thyroid cartilage was used to 
augment an anteriorly split thyroid cartilage in a monkey.  They also demonstrated that 
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there was no inhibition of laryngeal growth following this.  In 1974, Evans and Todd in 
London (48) reported the use of rib cartilage in laryngo-tracheoplasty, but favoured a 
castellated laryngofissure to expand the airway over a piece of rolled silastic sheet used 
as a stent for 6 weeks.  Cotton in Cincinnati in 1978 (42) described in detail laryngo-
tracheal reconstruction (LTR) with an anterior costal cartilage graft.  Later, in 1984, 
Cotton (49) published a series of 100 cases of LTR in children over a decade.  He 
emphasised that the stenosis should be mature before undertaking open surgery.  In 
1985, Fearon and McMillin in Toronto (50) described cricoid resection and thyro-
tracheal anastomosis in primates.  They demonstrated that there was no interference 
with normal laryngeal growth following this.  Ranne in Kansas City is credited with the 
first cricoid resection in patients (51), published in 1991.  This procedure, originally 
described by Pearson (52), was adopted by Monnier in Switzerland, who subsequently 
published his series in 1993 (53).  Robin Cotton‟s group in Cincinnati, when 
considering an open procedure for subglottic stenosis, primarily perform anterior and 
 posterior augmentations.  In only 15% of cases, usually those that have failed 
augmentation surgery, do they consider cricotracheal resection.   
One other technique, originally described by Herberhold (54), was the use of preserved 
tracheal allografts. These held the promise of being able to treat long-segment tracheal 
stenosis in children and adults without the need for immunosupression. These grafts 
consisted of chemically treated cadaveric tracheas to remove donor cells and 
antigenicity. The simplicity of the technique was the ability to tailor the size and shape 
of the tissue to suit the patient‟s requirements (illustration 2.11). However, like other 
teams (55, 56) our unit discovered that, following an intense inflammatory response 
lasting several weeks, these grafted tracheas were replaced in time by host scar tissue. 
When the technique worked, it appeared to do so if the scar tissue retained the size and 
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shape of the original graft. Herberhold‟s publications did not give detailed follow-up 
data to allow full appreciation of the long-term results. 
  
 Illustration 2.11. A preserved tracheal homograft is cut to the desired size and shape   
(left) and sutured into the airway as an anterior augment (right). 
 
Resection of the damaged airway had become the „gold standard‟ for treating 
laryngotracheal stenosis in adults at the start of this research.  Grillo (7) had the largest 
experience of this technique in adult patients and most other publications were case 
series. He achieved „successful‟ outcomes in the majority of his patients, however, the 
possibility of bias based on patient selection cannot be ruled out. These results are all 
the more difficult to interpret as there were no standardised and validated outcome 
measures in widespread use. As Abraham Maslow (57), a psychologist, wrote in 1966 
“it is tempting, if the only tool you have is a hammer, to treat everything as if it were a 
nail.”  
2.III.e  Tracheobronchial Stenting 
Charles Thomas Stent was a British dentist in the late 19
th
 Century.  He developed 
dental impression material that was used as a template to support skin grafts for repair 
of oral trauma.  Initially the term “stent” was used to describe artificial structures for 
preserving the viability and function of tissue.  Today, the term is used to describe 
devices for maintaining the patency of tubular structures, including the tracheo-
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bronchial tree.  Early experience of stents was gained through their use in the biliary 
tree, oesophagus, urinary tract and blood vessels.  There has likewise been a 
proliferation of devices for airway stenting.  There are currently a variety of silicone and 
expandable metal stents.  The metal stents can be uncovered, covered or partially 
covered (hybrid).  Wire stents tend to be covered with polyurethane, although Teflon 
sheeting is used in some designs.  The next generation of stents will be reabsorbable or 
bioengineered in other ways, negating the need for subsequent removal. 
In benign and malignant disease, stents have been used to palliate the effects of large 
airway obstruction caused by extrinsic compression, endoluminal disease or loss of 
cartilaginous support.  Indications in benign disease include long length stenoses, failed 
previous repair, patient co-morbidities that restrict reconstructive surgery or patient 
preference.   Stents are also used temporarily following airway surgery. 
The first airway stent was a metal alloy stent described by William Hankins of St Louis, 
USA,  in 1952 (58).  However there were problems related to repeated obstruction and 
migration of this stent, this led to the development of the silicone T-tube, first used by 
Montgomery in the 1960‟s (59).  The T limb prevented migration of the endolumenal 
tube. In 1982 Westaby described his modification of this silicone stent, which included 
a bifurcation at the lower end, allowing stenting of the trachea and both bronchi (60). In 
the 1990‟s, Dumon produced the first dedicated endobronchial silicone stent (61).  
Current metal stents tend to be made from steel or nitinol (a titanium and nickel alloy 
with a memory) wire mesh.  The Gianturco metal stent is an uncovered stainless steel 
mesh stent and was first described in 1986 (62).  
Although patients with metal stents enjoy immediate palliation of symptomatic tracheal 
stenosis, metal stents are associated with a high incidence of obstruction with 
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granulation (63).  They are also susceptible to metal fatigue and fracture over time.  
Based on personal experience and a review of the literature (64),  I feel that uncovered 
or hybrid metal stents should only be used in a select group of patients with a short life 
expectancy.  If not removed within the first few weeks of deployment, they become a 
permanent fixture in the airway (illustration 2.12).   
        
Illustration 2.12  A partially uncovered (hybrid) wire stent inserted in the airway to deal 
with a benign post-intubation stenosis has caused worse damage to the airway and had to 
be removed via laryngotracheal-fissure and sharp dissection. 
 
During the period of this research a 36-year-old female patient was referred to The 
Airway Reconstruction Unit. She had had an uncovered metal stent inserted in the left 
main bronchus to deal with compression from a thoracic lymphoma 8 years earlier.  
She received chemoradiotherapy and made a complete recovery from this malignancy.  
However, years later she was being treated  for repeated airway compromise due to 
granulation and wire fragments obstructing the left main bronchus.  She later presented 
to a local emergency department with a small haemoptysis and died some hours later 
from a massive haemorrhage.  The post mortem examination revealed migration of the 
wire stent into the pulmonary artery.  
Silicone stents also have complication rates, ranging from 21.5% (65) to 42% (66).  
There is a high incidence of bacterial colonisation of all stents, which can lead to 
granular tissue formation (67, 68), the most common organisms being staphylococcus 
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aureus and pseudomonas aeruginosa in most series. The difficulty in culturing the 
airway and stents by conventional flexible or rigid bronchoscopy is that the passage of 
these devices introduces contamination from oral and pharyngeal secretions. Our study 
was unique in that we used suspension laryngoscopy and an apnoeic technique for 
„clean‟ removal of the stent before starting supraglottic jet ventilation(67) in a paralysed 
patient.   
The Airway Reconstruction Team have over 15 years experience of using 
tracheobronchial stents of all designs.  It is widely accepted that wire stents have a 
higher incidence of granulation formation, especially at their ends.  Some authors report 
that silicone stents have a higher incidence of mucus plugging than wire stents (63).  
However, this experience largely relates to the use of stents in the bronchi.  In the upper 
trachea, biofouling and mucus plugging is much greater in wire stents than in silicone 
stents.  This may be due to the relative lower humidity in this area.  The incidence of 
stent migration is widely reported as being higher in the subglottis than in the remainder 
of the tracheo-bronchial tree.  The reason for this appears to be due to the fact that the 
subglottis is a fixed structure which is narrower than the trachea, especially with the 
expansion allowed by trachealis.  Hence there is a natural tendency for stents to be 
pushed down.  Stents placed high into the subglottis also run the risk of damaging the 
vocal folds and causing granulation in this area.  There is very little data on migration 
rates of different tracheo-bronchial stents. Table 2.1 lists the largest recent published 
series for airway stent, for both malignant and benign lesions. The author and his 
predecessor, Professor David Howard, have for over 15 years been using the vertical 
limb of a silicone T-tube as a stent. Different diameters of T-tubes are available and can 
be cut to a suitable length and are placed in the airway under general anaesthesia and 
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suspension laryngoscopy.  The stent is held in place with a suture through the tissues of 
the neck which is buried under the skin(69).   
 
Author Year Pathology Stent type 
Number of 
Stents in 
Series 
Stent 
Migration 
Rate  (%) 
 
Dumon et al (65) 1996 Mixed Silicone 926 9.5 
 
Wood et al (66) 2003 Mixed Silicone 209 5.0 
 
Lemaire et al (70) 2005 Malignant Metal wire 172 2.9 
 
Cosano et al (71) 2005 Mixed Metal wire 116 8 
 
Ryu et al (72) 2006 Benign Silicone 75 51 
 
Madden et al (73) 2006 Benign Hybrid 31 3.2 
 
Mitsuoka et al (74) 2007 Mixed Silicone 35 5.7 
 
Murgu et al (75) 2007 Benign Silicone 15 53.3 
 
Breitenbucher et al (76) 2008 Malignant Hybrid 62 5 
 
Gottlieb et al (77) 2009 Benign Metal wire 706 3 
 
Dooms et al (78) 2009 Benign Metal wire 20 65 
 
Dutau et al (79) 2010 Benign Silicone 117 5.9 
 
Charokopos et al (80) 2011 Benign Metal wire 11 18.2 
 
Chung et al (81) 2011 Mixed Metal wire 149 32 
  
Table 2.1 Illustrates the quoted migration rates for different types of airway stents for 
benign, malignant or mixed benign/malignant case series 
 
A departmental audit has shown that migration of this type of stent, following failure of 
the suture, occurred in 2:200 cases (1%) without detriment to the patient.  This review 
included patients in whom the stent was left in for more than a year.  This is the lowest 
migration rate of any endoluminal stenting device.  The added advantage of using this 
stenting technique is that it is not reliant for its fixation on firm adherence to the 
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tracheal wall.  As a result, ciliary action continues to take place between the stent and 
the tracheal wall.  This limits the degree of mucus plugging. 
Insertion of tracheo-bronchial stents 
Silicone stents usually have to be placed under general anaesthesia, using a ventilating 
rigid bronchoscope.  The team uses a technique of suspension laryngoscopy with 
supraglottic jet ventilation and placement of a silicone stent with rigid stent forceps.  
Visualisation is assisted by a 0°, 30 cm Hopkin‟s optical endoscope, which is 4 mm in 
diameter or a flexible bronchoscope.  Wire stents come preloaded in delivery devices 
and can be passed parallel to a flexible bronchoscope in a spontaneously breathing, 
sedated patient, or using fluoroscopic screening techniques.  Wire stents can also be 
inserted under general anaesthesia.  Stent removal is easiest using a general anaesthetic 
technique. This allows the use of rigid biopsy or grasping forceps to firmly grip the 
stent even if embedded in granulation.  Uncovered wire stents that have been in place 
more than three months will usually require an open surgical approach for removal (63). 
Post-operative care of a tracheo-bronchial stents 
All patients with stents are prescribed daily saline nebulisers. Carbocysteine can be 
added in those patients where there is evidence of mucus plugging.  There is no research 
evidence to support the use of any of these measures.   
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Different types of Airway Stents 
 
 
Ilustration 2.13  Two types of laryngeal stents. These have to be closed superiorly to 
prevent aspiration. Eliachar (Hood Laboratories) stent and over-sewn silastic T-tube 
(white) 
 
 
 
 
Illustration 2.14  Various tracheal stents. Cut length of silastic T-tube (left), Boston 
Scientific partially covered wire stent (middle of left picture), Dumon silastic stent (right 
of left picture), Alveolus Aero expanding wire stent (82) covered with polyurethane (right) 
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Illustration 2.15  Showing superficial skin graft, with epidermal surface in contact with 
paraffin-gauze sheet (left), draped over a silastic stent and sutured in place (middle). The 
finished composite stent is used for laryngotracheal reconstruction. This covered stent is 
associated with a reduced foreign body response and keratinocytes have fibro-inhibitory 
properties (83). 
 
2.III.f  Lasers 
Otolaryngology was the first surgical discipline to successfully apply the CO2 laser.  
Jako (84) collaborated to develop the endoscopic attachment to a CO2 laser and 
performed the first in vivo experiment on the canine larynx in 1969.  Bredemeir in 1971 
attached the manipulating arm of the CO2 laser to the operating microscope providing 
binocular vision and depth of field.  Strong and Jako (85) began applying the CO2 laser 
to laryngeal microsurgery.  The laser delivery system was further developed by Ossoff 
and Karlan (86) allowing delivery of the CO2 laser under direct visualisation through 
the bronchoscope (illustration 2.16).  
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Illustration 2.16  Carbon dioxide laser micromanipulator modified for use with the 
ventilating bronchoscope 
 
 The laser allows precise ablative or cutting manoeuvres in the airway with reduced 
bleeding as compared to cold steel.  Laser exposure time can be minimised by adjusting 
time of exposure, pulsing and super pulsing, and also adjusting the power delivery.  
Using the smallest spot size also minimises adjacent tissue damage.  The CO2 laser has 
a shallow depth of penetration with minimal adjacent thermal effect.  The carbon 
dioxide laser operates at an invisible wave length (10.6 micrometres) and consequently 
requires an aiming beam which consists of a superimposed helium-neon laser.  In the 
adult airway, the laser is set between 6-10 watts continuous delivery with the finest spot 
size to enable radial cuts in airway lesions.  Treatment for papillomatosis requires a 
significantly lower power setting and super pulsing (1-5 watts).  The spot size can also 
be reduced to use the laser in a superficial ablative mode.  Developments in the use of 
the CO2 include computerised scanning devices which attach to the micromanipulator 
and allow lasering to a defined depth and specific pattern as dictated by the software of 
the device.  The disadvantage of the carbon dioxide laser is that it has not been possible 
to use it in a fibre delivery format until recently.  Omniguide (Cambridge, 
Massachusetts, USA) have developed a fibre delivery system for the CO2 laser.  It 
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essentially consists of a tube with a shiny inner surface which allows the carbon dioxide 
laser beam to travel down its lumen.  When the laser makes contact with the wall of this 
tube and reflected, heat is dissipated into this wall.  As a result, this fibre is contained 
within a larger tube through which helium gas is delivered as a cooling agent.  Currently 
no aiming beam is available with this laser. Lumenis Surgical (USA)  have recently 
launched a CO2 laser fibre, which also reflects the laser inside a reflective tube, but has 
an aiming beam. The cooling for this laser is with air pumped down the same channel as 
the laser light. Unlike the Omniguide system, which can precipitate air emboli if used 
below the carina, the Lumenis system is said to be safer (company communication). 
The KTP laser emits a wavelength of 532 micrometres and this is preferentially 
absorbed by haemoglobin and other red pigments.  This makes the KTP laser very 
useful in the treatment of vascular lesions.  A fibreoptic delivery system enables its use 
in the distal airway, including the bronchi.  When compared with the CO2 laser, its 
tissue penetration is significantly deeper (4 mm versus 0.9 mm).  There is therefore a 
risk of excessive scar formation due to greater tissue injury. The use of the KTP laser 
should be limited in airway surgery except in rare cases of bronchial surgery and 
occasionally for tracheobronchial papillomatosis.   
The microdebrider was first used in respiratory papillomatosis in 1999 (87).  The 
advantage of the microdebrider in tracheobronchial papillomatosis is in its ability to 
engage papilloma only and avoid damage to the healthy underlying epithelium.  In 
addition, it avoids the potential risk of virus particles in the laser plume to theatre staff.  
It is therefore the preferred tool for tracheal papillomatosis.  
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2.III.g  Mitomycin-C 
Mitomycin-C (MMC), a potent antibiotic derived from the Streptomyces caespitosus 
bacteria, can modify wound healing at the molecular level and has been used to interfere 
with post surgical scar formation.  Available since the 1960‟s as a systemic 
chemotherapeutic agent in the treatment of solid tumours, Mitomycin-C was first 
applied topically for the treatment of superficial bladder tumours.  Later, 
ophthalmologists pioneered its use in preventing scar tissue after surgery.  It was first 
reported in the ENT literature for the treatment of tracheal scarring after tracheal 
reconstruction in a small case series (88).  The mechanism of the drug‟s anti-cellular 
action has not been definitively characterised.  It is known to be a pro-drug that is 
activated into toxic forms that produce oxygen free radicals creating DNA strand 
breaks.  Mitomycin-C also induces apoptosis in fibroblast cells (89).  A number of 
randomised prospective animal studies have shown impressive results in prevention of 
post-operative glottic and subglottic stenosis following surgery to the airway (90-93).  
Its use in airway surgery has become fairly routine, despite no randomised controlled 
trials proving its efficacy.  It is used in various concentrations and durations of 
application because optimum guidelines have not been firmly established.  Its use in the 
airway in the USA is for 0.4 mg/ml, although some units have used higher 
concentrations (0.6 mg/ml).  Philippe Monnier (Lausanne, Switzerland) has used 
Mitomycin at a concentration of 2 mg/ml applied topically for 2 minutes.  This 
concentration and application time has been adopted by Great Ormond Street Hospital 
in London.  For this research we have used Mitomycin at 1 mg/ml applied topically for 
2 minutes.  At one time, it was used routinely in the Airway Reconstruction Unit, but no 
discernible difference in symptom free intervals was apparent when comparing 
endoscopic surgery before Mitomycin and after Mitomycin.  There is also concern 
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expressed regarding the long-term consequences of having used Mitomycin for benign 
disease.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
57 
 
Chapter 3 
3.1  Surgery and Anaesthesia for Patients with Airway Compromise 
Endoscopic airway assessment is performed by respiratory physicians, thoracic 
surgeons and otolaryngologists.  Pulmonologists and thoracic surgeons are trained to 
use both flexible and rigid bronchoscopes.  Flexible bronchoscopy is usually 
performed in the spontaneous breathing and sedated patient who has had topical 
anaesthetic applied to the upper aero-digestive tract.  This technique allows assessment 
of the dynamic airway, the trachea and bronchi with the ability to perform the full 
spectrum of interventions.  However, with a flexible bronchoscope placed through a 
narrow stenosis, the patient‟s airway becomes obstructed.  Similarly, attempted 
dilatation of an airway stenosis leads to temporary airway obstruction.  The rigid 
ventilating bronchoscope (illustration 3.1) requires the patient to be paralysed and 
ventilated by a face mask or endotracheal tube until the bronchoscope is inserted.  For 
assessment of the airway beyond an area of stenosis, the bronchoscope has to be forced 
through the stenosis.  This has the effect of dilating the stenosis, but also causes 
stripping of the mucosa in a longitudinal fashion.   
  
Illustration 3.1 Rigid ventilating bronchoscope (left) and flexible bronchoscope (right) 
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Neither flexible bronchoscopy nor rigid bronchoscopy allows prolonged access or 
endoscopic surgery on the larynx or subglottis. 
Suspension laryngoscopy is performed routinely by otolaryngologists for access to the 
supraglottic and glottic larynx.  Laryngologists are also comfortable operating on the 
subglottis via the microscope or rigid endoscopes.  The advantages of the microscope 
are binocular vision, depth of field, superior axial illumination and it allows two hands 
free for instrumentation.  Also, the laser can be used with a “line-of-sight” technique 
through a micromanipulator attached to the microscope.  Many otolaryngologists still 
use the ventilating bronchoscope for tracheal or bronchial assessment and surgery.  
Suspension laryngoscopy allows the use of both optical rigid endoscopes and flexible 
bronchoscopes to access the airway.  The advantages are that the patient is paralysed 
and the full spectrum of rigid instrumentation, dilators, lasers and stents can be inserted 
and used with relative ease.  As the patient is ventilated using a supraglottic jetting 
technique, lasers can also be used without the risk of airway fires (illustration 3.2).  
  
Illustration 3.2 Suspension laryngoscopy (left) and Mistral (Acutronic, Switzerland) 
automated high frequency jet ventilator (right) 
 
 Paediatric airway surgery performed by an otolaryngologist differs in that the child is 
usually breathing spontaneously and oxygen or a combination of oxygen and an 
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anaesthetic gas is delivered by a naso-tracheal tube withdrawn into the hypopharynx.  
Endoscopes and instrumentation can then be passed through the glottis to access the 
trachea and bronchi.  This type of prolonged spontaneous breathing technique is not 
possible in an adult patient.  Adults tend to lighten from anaesthesia much quicker with 
the associated risk of laryngospasm.  Also, access to the larynx in an adult is much 
easier in a paralysed patient.   
I prefer a technique of suspension laryngoscopy and supraglottic jet ventilation via a 
cannula attached to the laryngoscope (illustration 3.2).  Illustration 3.3 demonstrates the 
differing views of the glottis in the same patient having supraglottic jet ventilation, 
subglottic jet ventilation and a microlaryngoscopy endotracheal ventilating tube.  
   
Illustration 3.3 Demonstrates the improving access to the posterior glottis and subglottis 
when ventilating with a microlaryngoscopy endotracheal tube (left), subglottic jetting 
catheter (middle) and supraglottic jetting (right) 
 
 The jetting is delivered at high frequency (up to 100 jets per minute) using an 
automated device by Mistral (Acutronic, Swizterland).  This device has built-in safety 
that sets an alarm if either the delivery of the jet or the return of gas is obstructed in the 
airway.  There has been no incidence of a pneumothorax using this device is adult 
patients in our department over the last 10 years.  This amounts to nearly ten thousand 
procedures.  Pneumothorax has been described when using jet ventilation delivered by a 
„manual jet‟ Sanders type device (94).  This is probably related to the fact that the 
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delivery of the anaesthetic agents is less well controlled and there is no safety cut-out 
mechanism.   
3.II  Anaesthetic Technique 
It is the practice in the Airway Reconstruction unit that all patients with airway stenosis 
have anaesthesia induced with an intravenous bolus of Propofol 3 mg/kg, Fentanyl 1-1.5 
µg/kg and Atracurium 0.5 mg/kg for muscle relaxation.  The vocal cords are sprayed 
with Lidocaine at 4 ml of 4% solution through an atomiser device.  Intermittent positive 
pressure ventilation is established using a classical laryngeal mask airway (LMA) 
(Intavent, Orthofix, UK).   
  
Illustration 3.4 Laryngeal Mask Airway in place 
Once ventilation is established, the patient is transferred from the anaesthetic room to 
the operating theatre.  The patient is transferred to the operating table and the laryngeal 
mask airway (illustration 3.4) is only removed when the surgeon is ready to perform 
suspension laryngoscopy and supraglottic jet ventilation can take place.  Total 
intravenous anaesthesia is maintained using an infusion of Propofol and Alfentanil.  At 
the end of the operation, the laryngoscope is removed and the LMA is re-inserted to 
support intermittent positive pressure ventilation.  At this stage, neuromuscular block is 
antagonised with Neostigmine 2.5 mg and Glycopyrrolate 0.5 mg.  The exception to the 
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use of an LMA is in a patient who already has a tracheostomy in place.  The 
tracheostomy can be removed and the stoma covered with a wet swab to allow 
unencumbered access to the airway while performing supraglottic jet ventilation. 
3.III  Is it Safe to Paralyse a Patient with a Stenosed Airway? 
3.III.a  Introduction 
The technique of paralysing and taking over the ventilation of a patient who has a 
severely compromised airway is contrary to anaesthetic teaching and understanding.  
Traditional teaching is for a patient with an airway compromise to be slowly “breathed 
down” with an anaesthetic agent and oxygen combination (an example is oxygen and 
Sevoflurane).  The argument for this practice is that if the patient‟s airway obstructs at 
any point during the induction, he or she will no longer breathe in anaesthetic gases and 
wake up.  There is no research in the literature to support this practice, yet it is passed 
down from one generation of anaesthetists to another.  A clear understanding of 
ventilatory changes associated with induction of anaesthesia and a safe approach to 
management that is based on sound physiological principles is essential in ensuring 
patient safety.   
To address this, a collaborative study was undertaken with the anaesthetic team. This 
compared spontaneous and positive pressure ventilation in patients with laryngotracheal 
stenosis to determine the optimum method of ventilation in this patient group.   
3.III.b  Materials 
Prospective study 
Surgical anaesthetic records of 30 adult patients with laryngotracheal stenosis with or 
without a tracheostomy undergoing endoscopic airway surgery in our unit over a nine 
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month period in 2006 were prospectively studied.  Information about patient 
demography and lesion characteristics at the time of surgery was recorded.  Formal 
ethical approval for this observational study was sought but not deemed necessary by 
the local ethics team. The reason for this was the fact that all the measurements reported 
in this present study formed part of our standard clinical practice and no additional tests 
were performed.  
Patients  
There were 19 male and 11 female patients, and the mean age was 47 (19 SD) years 
(range 17-82 years) of ASA grade III or IV. The commonest aetiologies were post-
intubation tracheal stenosis which occurred in 23 (77%) patients and idiopathic 
subglottic stenosis in 23%.  Airway lesions were on average located 31 mm below the 
vocal folds (SD 10) with a range of 5-50 mm.  Twelve lesions (40%) caused luminal 
obstruction of about 0-50% (Myer-Cotton grade I) while 9 lesions represented 51-70% 
airway narrowing (Myer-Cotton grade II).  A further 9 lesions led to an airway 
obstruction between 71-79% (Myer-Cotton grade III).   
3.III.c  Methods 
All patients underwent spirometry and flow volume loop examinations in the 
anaesthetic room before general anaesthesia.  None of the patients received pre-
medication.  Measurements were performed according to the American 
Thoracic/European Respiratory Society guidelines (95) using a MicroLoop portable 
spirometer.  Anaesthesia was induced as described above and at the end of the surgical 
procedure, the laryngeal mask was replaced to support ventilation until the patient was 
able to manage spontaneous breathing and control of reflexes.  The anaesthesia details 
are as described in section 3.II. 
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Flow volume loop measurements were obtained at the beginning of each procedure, 
after muscle paralysis, before establishment of supraglottic positive pressure ventilation 
and before any surgical manipulation had occurred.  In all cases, the driving pressure 
was 20 cm H2O, the ventilation frequency was 10 per minute and the inspiratory to 
expiratory (I-E) ratio was 1:1.  These ventilatory settings are chosen to minimise auto-
PEEP (positive end expiratory pressure).  After steady-state conditions were reached, 
anaesthetised flow volume loops and inspiratory and expiratory tidal volumes (TVs) 
were recorded using a Datex Ohmeda AS3 anaesthetic monitor.   
Awake spirometry and flow volume loop variables were calculated using Spida 5.0 
software. To assess the degree of airway obstruction within individual patients between 
awake and anaesthetised conditions, the ratio of peak expiratory (PEF) and peak 
inspiratory (PIF) rates was calculated (96). 
3.III.d  Results 
The mean PEF/PIF ratio measured from awake flow volume loops of 2.4 (standard 
deviation 1.3) decreasing to 1.0 (0.1) during anaesthesia (p = <0.001, students T test) 
(illustration 3.5).  The mean inspiratory and expiratory tidal volumes were 647 
millilitres (193) with a range of 267-1,153, and 560 (158) range 219-930 respectively.  
In all cases, oxygen saturation remained above 95% throughout induction of 
anaesthesia.  There was a significant correlation between awake PEF and anaesthetised 
expiratory tidal volume, but not between awake peak inspiratory flow rate (PIF) and 
anaesthetised inspiratory tidal volume. (Spirometry findings are in Table3.1). 
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Illustration 3.5 Awake flow-volume loops (A) obtained from a patient with extrathoracic 
airway stenosis showing significant diminution of the inspiratory component.  
Anaesthetised flow volume loops (B) from the same patient showing near symmetrical 
inspiratory and expiratory components. Awake peak expiratory flow (PEF) to peak 
inspiratory flow (PEF) measurements (C). During spontaneous ventilation, most 
extrathoracic intralumenal airway lesions selectively impair inspiratory airflow as a result 
of negative intratracheal pressure generated during inspiration. This elevates the PEF/PIF 
ratio. Anaesthetised PEF/PIF ratios obtained from the same patients (D), showing a highly 
significant reduction in the physiological degree of airway obstruction with positive 
pressure ventilation through a laryngeal mask airway. 
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Table 3.1  Spirometry findings 
Spirometry variables 
     Age 45 years  Age > 45 years 
FEV1 (L)  Grade I stenosis  3.28±.98 1.81-422] 2.19±.30 [1.81-2.55] 
  Grade II stenosis 2.46±.14 [2.29-2.55] 1.82±.55 [1.13-2.63] 
  Grade III stenosis 2.03±.78 [.67-2.59] 1.61±.81 [.95-2.79] 
FVC (L)  Grade I stenosis 4.50±.74 [3.50-5.43] 2.82±.17 [2.64-3.05] 
  Grade II stenosis 3.52±.57 [2.94-4.07] 2.88±.69 [1.69-3.54] 
  Grade III stenosis 3.21±1.01 [1.95-4.67] 2.36±1.07 [1.58-3.93] 
MEF50 (L/s) Grade I stenosis  3.48±1.45 [1.58-5.92] 2.46±1.02 [1.19-3.97] 
  Grade II stenosis 2.26±.33 [2.02-2.63] 1.73±.77 [1.07-3.05]] 
  Grade III stenosis 1.94±1.06 [.16-2.88] 1.49±.96 [.62-2.87] 
     All ages 
PEF (L/s) Grade I stenosis  3.80±1.03 [2.64-5.43] 
  Grade II stenosis 3.09±.69 [1.69-4.07] 
  Grade III stenosis 2.83±1.07 [1.58-4.67] 
MIF50 (L/s) 1.9  1.2 [.7 – 5.6] 
PIF (L/s) 2.0  1.2 [.7 – 5.7] 
All variables were expressed SD and [range]. 
Myer-Cotton stenosis grading system: Grade I: 0-50% lumen stenosis; Grade II: 51-70% 
lumen stenosis; Grade III: 71-99% lumen stenosis; Grade IV: no lumen: FEV1: Forced 
Expiratory Volume in one second; FVC: Forced Vital Capacity; MEF50: Maximal Expiratory 
Flow at mid vital capacity.  Variables found to be independently associated with FEV1, FVC 
and MEF50 on backward multiple regression were Myer-Cotton grade of the stenosis and 
patient age which was dichotomized at 45; PEF: Peak Expiratory Flow.  The only variable 
found on backward multiple regression to be independently associated with PEF was Myer-
Cotton grade of the stenosis. MIF50: Maximal Inspiratory Flow at mid vital capacity; PIF: Peak 
Inspiratory Flow.  No variables were found to be independently associated with MIF50 and 
PIF. 
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3.III.e  Discussion 
This study found that in patients undergoing general anaesthesia for extra-thoracic intra-
luminal laryngotracheal stenosis, intravenous induction of anaesthesia, muscle paralysis 
and positive pressure ventilation through an LMA is an effective method of ventilating 
patients during anaesthesia, regardless of the severity of the stenosis.  The degree of 
upper airway obstruction observed and quantified using flow volume loops was 
significantly less than when anaesthetised flow volume loops were recorded under 
conditions of muscle relaxation and positive pressure ventilation in comparison with 
awake spontaneous ventilation.  There was also a significant correlation between 
anaesthetised expiratory tidal volume and awake peak expiratory flow, but not between 
anaesthetised inspiratory tidal volume and awake peak inspiratory flow.   
These observations can be explained by the physiological principles that govern air flow 
through the upper airway during inspiration and expiration and the impact of an extra-
thoracic intra-luminal airway stenosis on ventilatory dynamics.  During spontaneous 
inspiration, there is a negative extra-thoracic intra-tracheal pressure that causes 
indrawing of the mobile tracheal segments, further narrowing the lumen and limiting 
inspiratory air flow.  In contrast, during expiration, there is a positive intra-tracheal 
pressure which improves airway dimensions and air flow (97).  Thus, under conditions 
of spontaneous ventilation, laryngotracheal stenosis relatively impairs inspiratory air 
flow as detected on flow volume loop examination (98).  With positive pressure 
ventilation, however, there is a positive intra-tracheal pressure during both phases of 
ventilation delivered during inspiration by the anaesthetic machine and during 
expiration by the elastic recoil of the lungs (97).  With positive pressure ventilation 
therefore, the mechanics of both inspiration and expiration are favourable in respect of 
their impact on the stenosis.   
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These findings have implications for managing patients with laryngotracheal stenosis 
undergoing general anaesthesia.  The optimal method for inducing anaesthesia in these 
patients is controversial.  The traditional view is that spontaneous respiration is 
maintained and anaesthesia introduced with a volatile inhalation anaesthetic given by a 
face mask (99).  This is based on the assumption that this is safer than IV induction and 
muscle paralysis because if apnoea occurs, the patient will stop inhaling the anaesthetic 
and will awaken to regain airway control and spontaneous ventilation.  Our results 
demonstrate the this approach is unsafe in patients with intraluminal laryngotracheal 
stenosis and that muscle paralysis and supraglottic positive pressure ventilation using an 
LMA is more effective.   
The use of an LMA is already recognised as being integral to managing the difficult 
airway.  The Difficult Airway Society guidelines indicate that an LMA should be used 
as a rescue device after unanticipated failure to intubate the trachea and after failure of 
mask ventilation (100).  Thus, the use of the laryngeal mask airway immediately after 
induction of anaesthesia in patients with laryngotracheal stenosis who can be considered 
to be anticipated impossible intubations is both logical and consistent with published 
guidelines.  We have found that lesion consistency (soft fibro-inflammatory lesions or 
mature fibrotic lesions) does not appear to have a bearing on the improvement in 
ventilation after transition from spontaneous to positive pressure ventilation.  However, 
large pedunculated and mobile supraglottic lesions can obstruct the laryngeal inlet.  
Assessment of size, mobility and site of lesions is therefore essential before this method 
is used.  In our practice, this involves visualisation of the supraglottis and the 
laryngotracheal complex with flexible nasendoscopy before induction of anaesthesia in 
all patients.  This assessment generally is performed in the out-patient department and 
findings appropriately documented.   
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In the presence of an extra-thoracic airway stenosis, spontaneous ventilation is 
associated with significant ventilatory impairment, even in awake, upright patients as a 
consequence of the effect of the stenosis on ventilatory dynamics.  Spontaneous 
ventilation during induction of anaesthesia makes use of these same “disadvantaged” 
ventilatory dynamics. An increased collapsibility of the upper airways (101), added 
work of respiration (102) and reduced functional residual capacity add to this 
disadvantaged physiology.  Therefore, spontaneous ventilation during induction of 
anaesthesia is less reliable and more dangerous (103).   
In contrast, the use of muscle relaxants followed by positive pressure ventilation 
through an LMA lessens the detrimental impact of the stenosis on the ventilatory 
dynamics, achieving adequate ventilation to maintain safe levels of oxygenation.  We 
have used this method extensively in this group of patients and have not encountered 
major problems related to induction of general anaesthesia.   
In conclusion, this study demonstrates that in the presence of an upper airway 
obstruction as a result of an intra-luminal, extra-thoracic, laryngotracheal stenosis, 
placement of a laryngeal mask with muscle paralysis and positive pressure ventilation is 
associated with improved ventilatory dynamics compared with spontaneous ventilation.  
It is proposed that in patients with known laryngotracheal stenosis undergoing shared 
airway reconstructive surgery or in patients who present as an emergency and in who 
extra-thoracic laryngotracheal stenosis is expectedly diagnosed, an LMA with positive 
pressure ventilation offers the most physiological method of achieving and maintaining 
a safe airway during induction of anaesthesia.   
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Chapter 4 
4.I  Aetiology of Adult Post-intubation Laryngotracheal Stenosis 
In 1950, anaesthesiololgist, Peter Safar, established the concept of “advanced support of 
life”, keeping patients sedated and ventilated in an intensive care environment.  During 
the polio epidemic in Copenhagen in 1952 (where paralysed patients had to be 
ventilated for prolonged period), Bjorn Ibsen set up the first Intensive Care Unit (ICU) 
(23).  This led to an ever widening use of mechanical ventilation to treat respiratory 
failure.  The iatrogenic lesions that resulted provided a whole new field of endeavour 
for surgeons.  In the 1960s, scores of papers appeared in Europe and North America, 
describing surgical resection of post intubation strictures. Prevention of post intubation 
injury quickly became a priority once the origin of these lesions was evident.  Initially 
high pressure cuffs were used and risked ischaemic injury to the mucosa and necrosis of 
the cartilage of the trachea.  Carroll and colleagues in 1969 recommended a cuff with a 
large volume and low pressure which only resulted in small increases in tracheal wall 
pressure with over-inflation (104).  Although the incidence of post intensive care unit 
airway stenosis is unknown and can only be approximated at between 1- 4%(105-108), 
a significant early injury is evident in 47% of patients (109).  This is despite the use of 
these high volume, low pressure cuffs on endotracheal and tracheostomy tubes. This is 
the only paper in the literature where the trachea has been examined at the time of 
endotracheal tube removal. Unfortunately it does not make clear the definition of 
„significant injury‟.  
The anatomical and pathological differences between stomal and cuff stenoses and other 
post intubation injuries were described at this time by Pearson, Grillo and Harley.  They 
also stressed the importance of allowing florid inflammation to subside prior to surgical 
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correction (110-113).  They demonstrated that surgical resection and anastomosis 
produced better results than repeated dilatation, steroid injection or cryotherapy.  The 
results of treating post intubation stenosis with resection by the same colleagues 
achieved an 87.5% “cure” in 200 patients in 1992. The definition of „cure‟ appears to 
include patients with a suboptimal airway.  Couraud and colleagues reported a 96% 
success rate in 217 patients in 1994, and Grillo and colleagues cited a 94% success in 
503 patients in 1995 (4, 114, 115).  They also described the correction of post intubation 
stenosis involving the subglottic area as being more difficult than lesions of the trachea.  
The aetiology of post intubation stenosis injuries was initially unclear. At first it was 
thought to be due to irritation from the materials from which tubes and cuffs were 
made(116).  Later it became clear that pressure necrosis from tubes and cuffs leading to 
circumferential injury and contracture was the principal explanation(117).  
The risk factors for laryngotracheal stenosis following a period of ventilation on the 
intensive care unit include: sizing of endotracheal tubes, excessive lateral cuff pressure 
due to poor cuff pressure monitoring, hypotension, local infection, duration of 
intubation, use of steroids and other causes of reduced patient immunity, patient 
movement and agitation, tracheostomies and bilateral injuries of posterior vocal cords.  
The majority of patients ventilated on ICUs do not appear to develop airway stenosis. 
Although there are many aetiological factors, patients who tend to scar excessively 
following injury, may self select for airway stenosis although there is no clinical study 
to support this.   
With respect to endotracheal tubes, modern tubes are of a high volume, low pressure 
design to reduce the risk of airway injury.  To prevent ischaemic damage, the cuff 
should not exceed a pressure greater than the capillary perfusion pressure of the mucosa.  
The mean capillary blood pressure is about 20 mmHg.  This is 27.2 cm H2O pressure 
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(118).  The recommendation is that the cuff inflation pressure, of a ventilation tube, 
should not exceed 30 cm.  Seegobin (119)  studied four types of large volume, low 
pressure cuff types.  Following periods of endotracheal intubation, photographs were 
taken of the circumferential trachea at the site of cuff contact.  Photographs were taken 
for varied cuff pressures after a period of 15 minutes.  The conclusion of the study was 
that lateral wall pressures above 30 cm of water compromise mucosal capillary blood 
flow leading to pressure necrosis of the adjacent mucosa and eventually the cartilage.   
The other risk factors for laryngotracheal injury in a ventilated patient on the ICU 
(illustration 4.1) probably include gastric reflux, infection, coexisting health problems 
(such as diabetes mellitus and arteriopathy) and altered immunity as part of the stress 
response. There is, however, no research to support these as potential risk factors. 
  
Illustration 4.1  Typical appearance of tracheal injury at extubation on the ICU 
 
Post tracheostomy stenosis had been described as early as 1886 when Colles found four 
strictures in 57 patients treated for diphtheria (120).  In my series of 400 adult patients 
with benign laryngotracheal stenosis the incidence of airway stenosis from endotracheal 
tubes was approximately the same as the incidence from tracheostomies. Damage to 
vocal fold anatomy and impairment of vocal cord mobility is more common with 
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endotracheal tubes (121, 122). Surgical management of bilateral vocal fold immobility 
is always a compromise between voice and airway. There is very little evidence 
supporting early tracheostomy on ICUs (123). The TracMan study was a multicentre 
UK study designed to look at the timing, morbidity and mortality associated with 
tracheostomies on intensive care units. Although the trial phase of this multicentre study 
took place in 2004, the main phase of the study failed to progress.  Although this thesis 
cannot comment on the morbidity and mortality associated with early versus late 
tracheostomy, following review of the 400 patients in the database, some conclusions 
can be reached. There is a real risk of damage to the normal function of the glottis and 
vocal folds that exists with endotracheal intubation that does not occur in patients with a 
tracheostomy. As the surgical results of restoration of impaired glottic function remain 
suboptimal, early tracheostomy would minimise the risk of glottis stenosis and bilateral 
vocal fold mobility impairment. 
 
4.II  Theories of Wound healing  
The classical model of epithelial wound healing is divided into three sequential yet 
overlapping phases (124).  Using injury to the skin as an example; a set of complex 
biochemical events take place to repair the damage.  Within minutes post-injury, 
platelets aggregate at the injury site to form a fibrin clot.  This clot acts to control active 
bleeding through haemostasis.  The first phase of wound healing is the inflammatory 
phase, in which, bacteria and debris are phagocytosed and removed. Factors are 
released that cause the migration and division of cells involved in the proliferative 
phase.  The proliferative phase is the second phase of wound healing and is 
characterised by angiogenesis, collagen deposition, granulation tissue formation, 
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epithelialisation and wound contracture.  Fibroblasts grow and form a new provisional 
extra-cellular matrix by excreting collagen and fibronectin.  Re-epithelialisation of the 
epidermis occurs in which epithelial cells proliferate and grow across the wound bed, 
providing cover for the new tissue.  At the same time, the wound is made smaller by the 
action of myofibroblasts which establish a grip on the wound edges and contract 
themselves using a mechanism similar to that in smooth muscles (illustration 4.2).   
 
Illustration 4.2  To show healing of a skin wound by secondary intention. The 
myofibroblasts contract to approximate the epithelium and resorption of fibrosis takes 
place. 
 
Once the cells‟ roles are close to complete, redundant cells undergo apoptosis (125).  
The third phase of wound healing is the maturation and remodelling phase.  Collagen 
is remodelled and realigned along tension lines and cells that are no longer needed are 
removed by apoptosis.  The remodelling phase can last from 3 weeks to 2 years.  
It is clear that keratinocytes have a significant effect on fibroblast wound healing 
activities and the lack of an epidermis results in fibrosis of the underlying or adjacent 
tissues (83).  Epidermal cells regulate the activity of dermal fibroblasts.  In particular, 
epidermal keratinocytes decrease collagen production and increase the replication rate 
of these cells.  Therefore, early wound closure will decrease wound fibrosis (126).   
Approximately 130,000 patients each year, in the United Kingdom, are ventilated on 
intensive care units (127) and very few have subsequent laryngotracheal stenosis.  The 
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factors at play in the patients who do develop laryngotracheal stenosis are discussed 
later in this chapter.  There is very little research to date on the variability of wound 
healing in this group of patients.  It is already recognised that some patients are prone to 
hypertrophic scar formation and others have a more aggressive healing biology that 
results in the formation of keloid scars.  It is therefore likely that some of the patients 
who go on to develop laryngotracheal stenosis, do in fact have a more aggressive 
healing biology.  This needs to be investigated in a future research project.  I decided at 
the outset, in order to minimise scar tissue formation and wound contracture, with open 
reconstructive procedures requiring stenting, the stent would be covered by a superficial 
skin graft (dermis outmost) as a biological dressing.  This was to use the ability of 
epidermal keratinocytes to down regulate fibrosis and scarring (83).  In a 
circumferential injury in the airway (illustration 4.3), covering the wound with 
keratinocytes in one sense replicates early wound closure.  One adverse side effect of 
this approach is that there is a degree of keratosis within the airway where keratinocytes 
have colonised the wound.  This decreases over time and in only one case it has been 
necessary to laser ablate these colonies of keratinocytes.   
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Illustration 4.3  The process of repair of a circumferential injury, in an organ with a 
lumen, is the same as for  healing by secondary intention. However, the process of healing 
by contracture continues because there are no epithelial ends to come together.  
 
 
 
Illustration 4.4 If the circumferential airway injury is separated by new tissue (grey) then 
it is not possible for healing and contracture to produce a significant stenosis. This may 
explain the successful outcomes in cases of adult airway repair with primary rib cartilage 
or tracheal homografts. (If the augment tissue survives, even for a few weeks, it will 
separate any attempts at healing by circumferential contracture.) 
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4.III  What is the Incidence of Post-intubation Laryngotracheal 
Stenosis in Adult Patients in the UK 
The incidence of adult post-intubation laryngotracheal stenosis in the UK is unknown.  
For the purpose of this research, an estimate of its incidence was made by calculating 
the incidence within one individual primary care trust (PCT).  A PCT is a body which 
commissions and purchases secondary and subspecialist services on behalf of a defined 
population of patients.   
A review was carried out of  the number of referrals over a 3-year period (2004-2006) 
from those PCTs in the Greater London area which are in the geographical vicinity of 
the two hospitals offering a subspecialist airway reconstruction service.  The average of 
the number of cases referred per year was divided by the overall population of adult 
patients within the referring PCTs to obtain the rate.  Over this period, these units 
received 13.3 patients per year from a catchment area of 2.72 million, which gave an 
incidence of 4.9 cases per million per year.   
Assuming that the national variation in incidences is comparable with local variation 
within Greater London, the extrapolated number of new cases likely to arise in England 
per year is 197, with a binomial 95% confidence interval of 170-226.  This 
methodology only provides a rough estimate and in particular there can be no certainty 
that every patient referred for airway reconstruction from this catchment area is referred 
to these units. This can lead to underestimation.  It is not likely, however, that this 
calculation omits a large number of thoracic surgical cases as the overall number of 
tracheal operations performed for adult post-intubation laryngotracheal stenosis by 
thoracic surgeons is relatively small (Professor Peter Goldstraw personal 
communication).  It must be accepted that there are significant methodological 
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limitations in the absence of longitudinal population level epidemiological research in 
this area. 
The average number of admissions to all intensive care units in the UK is 130,000 per 
annum (127).  It is not precisely known how many patients receive mechanical 
ventilation and for how long, but 34.2% of UK patients stay in intensive care units for 
more than 2 days and this group has a survival rate of 70.2% (128).  An international 
study of 15,757 patients estimated that 32.9% of intensive care patients receive 
mechanical ventilation for more than 12 hours with a survival rate of 69.3% (129).  We 
can therefore assume that only 33% of UK intensive care unit patients receive 
mechanical ventilation and that their survival rate is 70%, which gives an estimate of 
30,030 annual survivors of mechanical ventilation and therefore represents an estimate 
of the at risk population of the UK.   
The incidence of late post-intubation laryngotracheal stenosis can be estimated from a 
prospective study of 654 consecutive intensive care patients undergoing mechanical 
ventilation receiving post extubation bronchoscopy and long-term follow-up.  This 
identified 12 cases of severe glottic, subglottic or tracheal stenosis 6-12 months 
following extubation among the 389 survivors.  This translates to an incidence of post-
intubation laryngotracheal stenosis of 3.1%.  If a lesser degree of subglottic or tracheal 
stenosis is to be considered, the incidence of late post intubation laryngotracheal 
stenosis rises to 4.6% (109).  The same paper identifies significant tracheal and airway 
injury at the time of extubation at 47%.  This gives an estimate of the incidence of 
severe late post-intubation laryngotracheal stenosis of 926 new cases per year.  Based 
on the number of referrals to the airway reconstruction team, I have estimated that the 
annual population incidence to be 197 (130).  This reveals a discrepancy in that as many 
as 4 out of 5 patients with post-ICU laryngotracheal stenosis may not receive treatment.  
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There must therefore be a considerable pool of patients who are suffering a respiratory 
handicap which is potentially treatable.  If these findings are confirmed, they lend 
support to the establishment of routine post ICU follow-up clinics where post-intubation 
laryngotracheal stenosis and other ICU complications can be identified early and 
treated.  The difficulty, however, remains that a number of these patients may live some 
distance from the intensive care unit where they were treated and may not return for 
follow-up. Routine post-ICU screening could be performed by primary health care 
practitioners at 3 to 6 months using standard spirometry and a modification of the 
Empey Index (131) as discussed in section 6.1. The cost effectiveness of such a 
screening programme would have to be weighed against improvements in quality of 
life. This would need to be preceded by a dedicated study looking at the airway 
following discharge from the ICU. 
 
4.IV  Out-patient Evaluation 
The majority of patients referred to the Airway Reconstruction unit already have a 
diagnosis of airway stenosis as they have been seen by a respiratory physician and 
appropriately investigated. Some „breathless‟ patients, with inflammatory diseases such 
as sarcoidosis and Wegener‟s granulomatosis, are referred for examination of the airway 
to screen for laryngotracheal airway compromise. A much smaller number of patients 
are referred because they have failed extubation or decannulation on the ICU and 
laryngotracheal airway compromise is suspected. An accurate clinical history is 
therefore important.  It is also important to determine the duration of symptoms and 
whether there were preceding health problems contributing to dyspnoea. Details related 
to the period of time on the intensive care unit and whether the patient was intubated or 
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weaned with a tracheostomy should be determined.  A history of vasculitis or 
connective tissue disorders is also relevant. The patient should be questioned as to 
whether there is a cough, about the degree of limitation to daily activities, voice changes 
and swallowing problems.  Clinical examination should determine whether there is 
stridor or voice changes.  The degree of recession of the chest, if present, is also 
important to document.  Flexible endoscopic examination of the upper aerodigestive 
tract will allow assessment of vocal cord function, evidence of reflux, demonstrate 
pooling of secretions and may also determine the site and degree of airway stenosis.  A 
detailed assessment of vocal cord function and swallowing is vital if laryngotracheal 
surgery is to be considered (table 4.1).   
The body mass index also has a bearing on a patient‟s oxygen demand and the likely 
success of surgery (section 4.VIII.c).  Significant pre-existing lower respiratory tract 
pathology may also be a contraindication to decannulation.   
Baseline respiratory function tests, which include flow volume loops, are arranged in all 
patients and computer tomographic (CT) imaging of the airway if not already 
performed.  The problem with assessing airway stenosis on a CT scan relates to the fact 
that imaging is a form of sampling.  Unless fine cuts are made through the airway at 1-2 
mm, the apex of the stenosis may be missed and the degree of stenosis underestimated.  
Similarly, if there are secretions overlying the apex of the stenosis, then it may be 
overestimated. CT scans help to confirm airway compromise and act as a guideline to 
its severity.  Definitive assessment of the airway injury is made at laryngotracheoscopy 
under anaesthesia.   
 
 
80 
 
 
 
 
 
Table 4.1  Outpatient assessment of patients with chronic airway compromise 
 
History - Aetiology 
  - Disability 
  - Voice/swallowing problems 
 
Examination - Stridor and voice 
  - Chest recession on breathing 
  - Body morphology (body mass index) 
  - Fibreoptic nasal endoscopy  
 Vocal cord mobility 
 Evidence of GORD 
 Pooling of hypopharyngeal secretions 
 view of subglottic stenosis (not always possible) 
- Fibreoptic endoscopic view of airway via tracheotomy 
  
Investigations - High definition computed tomography (CT) with reconstruction 
  - Respiratory function test 
 spirometry 
 flow volume loops 
 testing exercise limits 
- Videofluoroscopy/fibreoptic endoscopic evaluation of swallowing    
   (FEES) 
      -  Investigations for GORD 
 -  Blood tests for inflammation, vasculitis and sarcoidosis 
 
4.V  Airway Assessment Under Anaesthesia 
The procedure is performed in the operating room. General anaesthesia is introduced 
intravenously and muscle relaxants are administered in all cases (96).  A total 
intravenous anaesthesia technique is maintained throughout the procedure and the 
airway is initially secured with a laryngeal mask airway (LMA).  (The anaesthetic 
technique is described in detail in section 3.II). The LMA is replaced with high-
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frequency (up to100 cycles/min) supraglottic jet ventilation delivered through a 
suspension laryngoscope.  I prefer the Dedo-Pilling  (Pilling, USA) laryngoscope for 
endoscopic airway surgery with the laryngostat supported on a  modified Mayo Table 
which is attached to the operating table. The airway and lesion are visualised using a 
combination of microscope and 4mm, 0 degree, 30cm Karl-Storz rigid endoscope. 
 
 
Illustration 4.5 Showing the set-up in an airway theatre. The patient‟s face is covered with 
wet swabs while the laser is being used 
 
 
4.VI  Objective Airway Sizing 
4.VI.a Introduction 
Objective sizing of laryngotracheal stenosis can be performed using computed 
tomography (CT), especially high resolution imaging with multi-planar reconstruction 
(illustration 2.3).  This provides the best anatomical information (132).  CT scans 
cannot, however, differentiate between the true lumen and overlying secretions which 
introduces inaccuracies in the presence of blood, mucous or crusting (133).  
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Furthermore, a CT scan works on the principle of cross-sectional sampling of anatomy 
and since the calibre of the airway is not orientated perpendicular to the plane of the 
scan, the combination of slice thickness and image reconstruction can introduce further 
inaccuracies (118).  High definition CT scans which largely overcome these problems 
are expensive and introduce a high dose of radiation, making them unsuitable for 
monitoring patients through what can be a multi-stage treatment process (illustration 4.6 
right).   
Pulmonary function testing (134) does provide an indication of the severity of airway 
stenosis, but does not provide accurate anatomical information.  Other methods 
proposed for airway sizing have included acoustic reflection techniques (135).  
Endoscopy is the main tool for assessing and treating laryngotracheal stenosis.  It allows 
direct visualisation of luminal pathology, observation of laryngotracheal dynamics and 
institution of endolumenal therapy (133, 136, 137).  Robin Cotton of Cincinnati 
Hospital, Ohio, originally devised a grading system of airway stenosis in paediatrics 
based on leaks around different sized endotracheal tubes at ventilating pressures of just 
beyond 30 cm of water.  The system was revised into the Myer-Cotton grading system.  
This classifies subglottic stenosis into 4 grades (Illustration 4.6 left).   
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Illustration 4.6  The Myer-Cotton Grading System (left) for paediatric laryngotracheal 
stenosis (10). CT scan with image reconstruction to show subglottic stenosis (right). 
 
The grades relate to the surface area of the stenosis and provide a guide to the type of 
management necessary for the patient.  Symptomatic paediatric laryngotracheal stenosis 
grade II and III is most appropriately managed with a laryngotracheal reconstruction 
using cartilaginous augmentation either anteriorly, or anteriorly and posteriorly placed 
in the subglottis.  Cricotracheal resection is reserved for a grade III or grade IV stenosis 
which does not involve the vocal folds or used as a salvage procedure after failed 
laryngotracheal reconstruction.  The Myer-Cotton grading system is useful tool for 
stratifying airway stenosis so that guidance on surgical management can be formulated.  
In terms of symptoms, resistance to air flow is inversely proportional to the fourth 
power of the radius of the airway at the stenosis.  As a result, there can be an 
exponential increase in air flow resistance (symptoms) within one Myer-Cotton grade 
(illustration 4.7).  
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Illustration 4.7 To show the relationship between airway radius and Myer-Cotton 
grades of stenosis (Resistance  1 / radius4) 
 
As the Myer-Cotton grading system does not measure absolute cross-sectional diameter 
of the airway, there can be errors in its assessment, for example when there is an hour 
glass deformity of the trachea associated with a stenosis.  Quantitive assessment of 
airway cross-section is, however, compounded by the fact that endoscopic images lack 
calibration and suffer from a non-linear optical distortion which is a function of the lens 
to object and centre to periphery distances (133, 136-138); variables not easily 
measurable in vivo.  Moreover, a hand held endoscope invariably has a small, but 
difficult to determine, tilt in relation to the airway.  I therefore felt that a method had to 
be devised for precise determination of airway dimensions. 
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4.VI.b  Analysis of Airway Assessment 
Experimental validation - Impact of tilt 
It is impossible in a clinic setting to guarantee perfect alignment between the 
endoscopes and the instruments introduced intra-luminally and the long axis of the 
airway, nor is it easy to measure such angles of tilt (illustration 4.8).  The first objective 
was therefore to assess the impact of tilt on image characteristics to determine whether 
accurate measurements could be made independently of it.  Images of a 9 mm diameter 
circle with a 4 mm 0° Karl Storz endoscope (Karl Storz, Tuttlingen, Germany).  The 
endoscope was mounted on a micromanipulator with the tip suspended 15 mm above 
the circle and images were taken with tilt between 0° and 45° (illustration 4.8).   
 
  
Illustration 4.8  Experiment set-up to evaluate the effect of endoscopic tilt on image 
characteristics. With the endoscope perpendicular to the object being measured, the 
endoscopic image of a circle is circular (y = x; panel A). If, however, the endoscope is tilted 
(α), the endoscopic representation of a circle tends to be an ellipse, with the relationship 
between the short and long diameters of the apparent ellipse (x´ and y´; panel B) a 
function of cos(α)(133) 
 
Three measurements of the surface area of the endoscopic image of the circle were 
obtained with planimetry software (Carnoy, Laboratory of Plant, Flanders) using the 
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apparent horizontal and vertical diameters of the image for calibration.  The ratio of 
averages of the two sets of measurements was expressed as a function of endoscopic tilt.  
All measurements were then averaged to give a biaxial calibrated calculation of the 
surface area.  Measurement accuracy was assessed by comparing the calculated surface 
area with the actual value (πr2, r = 4.5) and expressed as a function of tilt. 
 
Experimental validation - Impact of lens distortion 
Four circles with diameters of 6, 9, 12 and 15 mm were drawn.  A 22 mm diameter 
circle was concentrically drawn around them.  A number of 4 mm diameter circles were 
then drawn so as to occupy the space between the centre and periphery of the 22 mm 
circle.  A 3 cm long tube of 22 mm internal diameter was then placed over the outside 
circle to simulate a lumen (illustration 4.8).   
A 4 mm 0° Karl Storz endoscope was held by hand within the lumen to take images.  
Images were obtained at different „lens to object‟ distances with the examiner 
attempting to minimise image tilt and maintaining the endoscope at the centre of the 
lumen (illustration 4.9).  The 4 mm diameter circles were used for biaxial image 
calibration and from their „known‟ dimensions, the surface area of the central circles 
were calculated by an examiner blinded to the dimensions.  Measurement accuracy was 
calculated as the percentage of the measured surface area to the actual values (πr2: 
where r = 3, 4.5, 6 & 7.5 mm) expressed as a function of the percentages of the field of 
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endoscopic view occupied by the lumen (% FOV)
 
Illustration 4.9  shows the experimental set-up used to obtain endoscopic images for 
experimental validation. The endoscope was held above the image within the lumen of a 
30mm long bronze tube with an internal diameter of 22mm (top panel). As the endoscope 
is withdrawn, smaller portions of the endoscopic image and more of the luminal wall will 
be visualised (middle panel). This was used to determine the %field of view (%FOV: b/a) 
occupied by the measured image (bottom panel). This was used as an indicator of the 
distance between the endoscope lens and the object being measured. 
 
4.VI.c  Materials and Methods 
The cross-sectional areas of the stenosis was evaluated in ten patients undergoing 
microlaryngoscopy and endoluminal laser therapy and dilatation for upper airway 
stenosis.  A circular endoscopic probe in the shape of a ring of 4mm internal and 
4.36mm external diameter was designed in such a way that the ring was at right angles 
to the long axis of the handle.  The probe was introduced into the lumen of the airway 
alongside the endoscope (illustration 4.10). 
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Illustration 4.10 The probe (left) is used to determine the length and location of an upper 
airway stenosis. The probe is advanced to the lower level of the stenosis and the position is 
marked on the probe handle (c). The probe is then withdrawn to the proximal level of the 
stenosis (b), and then to the level of the vocal folds (a).The length bc marked on the probe 
handle denotes the length of the stenosis and ab the distance from the vocal folds. 
Endoscopic view of the probe in position at level of stenosis (right). 
 
The probe was advanced under endoscopic vision to a level just beyond the level of the 
stenosis.  Gentle traction was used to confirm that the probe was resting at the distal 
level of the stenosis.  The position of the handle of the probe in relation to the edge of 
the laryngoscope was marked with a sterile marking pen.  The probe was then 
withdrawn to the proximal level of the stenosis, and its position confirmed under 
endoscopic vision, and then to the level of the glottis.  Each position was marked with 
the marking pen.  From these marks the location of the stenosis in relation to the vocal 
folds and the length of the stenosed segment were calculated. The cross-sectional area 
of the stenosis was measured at its narrowest point and photographs taken with the 
probe in position. Two independent observers calculated the cross-sectional area of the 
stenosed airway, Pearson‟s coefficient of correlation was used to assess inter-observer 
concordance. 
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4.VI.d  Results 
Assessing the impact of endoscope tilt 
Illustration 4.11 shows the impact of endoscope tilt on image properties.  As the 
endoscope is progressively tilted the apparent dimensions of the captured image change 
as a function of the cosine of the tilt angle.  As this angle is unknown in the clinical 
setting, the image was calibrated using both horizontal and vertical diameters of the 
circle. Using biaxial calibration the effect of tilt on measurement accuracy was 
eliminated.  All subsequent measurements were taken with biaxial image calibration. 
 
 
Illustration 4.11 Bottom panel – impact of uncorrected endoscopic tilt on apparent image 
dimensions. Top panel – Biaxial calibration eliminates the impact of endoscopic tilt on 
measurement accuracy 
 
 
Assessing the impact of endoscopic distortions 
Previous work has shown that the visuo-spatial distortion, which is inherent to the 
optics of the wide-angle lenses used to obtain endoscopic images, is a function of the 
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distance between the lens and object being measured, and the distance from the centre 
to the periphery of the endoscopic image.  Objects at the periphery of the endoscopic 
view appear smaller than central objects (radial distortion), and the degree of this 
central-to-peripheral distortion changes as a function of the distance between the 
endoscope lens and the object being measured (distance distortion).  In other words, a 
small object located at the centre of the endoscopic field, viewed with the endoscope 
some distance away from it will suffer less distortion than a large object occupying 
most of the field of view, with the endoscope placed close to it (133, 136, 137, 139).   
 
 
Illustration 4.12 Effect of lens-to-object distance, expressed as %FOV, and the accuracy of 
obtaining surface area measurements. For a small object placed at the centre of the field 
of view (6mm circle), the impact is negligible because the diameter of the object is 
comparable to that of the calibrating probe. However, for a larger object (12mm circle), 
occupying both the centre and periphery of the endoscopic image, the impact is 
considerable and increases as the endoscope moves closer to the object. 
 
 
Illustration 4.12 (bottom panel) shows that the surface area of a small, centrally 
positioned object, calibrated with a single centrally placed circular calibrator, could be 
precisely determined independent of radial or distance distortions. By contrast, the 
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dimensions of larger objects, spanning into the periphery of the endoscopic image, 
could not be accurately determined if a single calibrator was used (top panel). A 
centrally placed calibrator increasingly underestimated true dimensions as visuospatial 
distortion increased with increasing lens-to-object proximity. The reverse was true if a 
peripherally placed calibrator was used. 
Illustration 4.13 shows measurements obtained from a 12mm diameter circle with the 
endoscope lens in close proximity.  Three calibrating circles, placed at the centre, mid-
periphery and periphery of the image were used to biaxially calibrate the image.  Using 
the central calibration alone, the true surface area was underestimated.  While using the 
peripheral calibrator, the true surface area was overestimated.  However, combining the 
three calibrations (i.e. “sampling” the endoscopic field of view at different radial 
points), the average of the three calibrations was a highly accurate measurement.   
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Illustration 4.13 Overall measurement accuracy, combining the principles of biaxial and 
radial span calibrations. Accurate surface area measurements could be obtained 
regardless of the size of the object being measured (6, 9, 12, 15mm circles), and the 
distance between the endoscope and the object. Inset An illustration of the principle of 
covering the „radial span‟ of the object being measured. 
 
 
 
 
 
Obtaining an overall measurement 
Taking the above observations into account, we obtained measurements from circles of 
different diameters, with the endoscope placed at different distances from them using 
the following rules: 1. Trying to place the endoscope at the centre of the lumen and 
attempting to minimize tilt. 2. Obtaining biaxial calibrations 3. Calibrating the image at 
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more than one radial point in such a way that the calibrators traversed the radial extent 
of the area being measured (illustration 4.13 inset).  Illustration 4.13 also shows overall 
measurement accuracy for circles of different sizes using this method, indicating that 
cross-sectional area could be calculated from endoscopic images with >95% accuracy, 
independently of the size of the object, lens-to-object distance, and without the need to 
make assumptions about the degree of optical lens distortion. 
 
Clinical Application 
Ten adult patients with an average age of 48 years (range 24-63) were anaesthetised 
with total intravenous anaesthesia. Supraglottic jet ventilation allowed unencumbered 
surgical access to the airway.  Table 4.2 shows the background and quantitive 
measurements of length, location and cross-sectional area of stenosed airways in 10 
patients.   
Two independent observers calculated airway cross-sectional from intra-operative 
images.  Pearson‟s co-efficient of correlation was 0.98 with a slope and interceptor 0.93 
+/- 0.05 and 7.67 +/- 3.02 mm respectively indicating a high degree of inter-observer 
concordance (illustration 4.14).   
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Table 4.2  Background and Measurements of Stenosed Airways in 10 patients 
Age  Sex Aetiology  GD
1
 SL
2
 Pre-CS
3
 Post-CS
4 
     mm mm mm
2
  mm
2
 
 
24 M post-intubation 42 10 9.4  3.3* 141.2  4.1 
51 F Amyloidosis  30 10 71.9  2.9 75.1  3.1 
41 F Post-intubation 39 10 32.3  1.1 122.0  2.0 
60 M Post-intubation 35 6 47.2  0.5 124.7  4.4 
43 F Idiopathic  23 17 14.2  3.4* 164.7  4.1 
41 F Papillomatosis  21 9 14.0  3.4* 164.7 1.8 
58 M Wegener‟s  33 5 41.2  5.9 131.7  10.4 
46 F Post-intubation 54 7 142.1  2.1 146.6  3.4 
63 F Post-intubation 38 10 63.9  2.7 185.3  1.9 
54 M Post-intubation 44 9 46.3  1.3 156.1  2.0 
 
All measurements are  standard deviation 
1. Glottic Distance (Distance from vocal folds to the proximal level of the stenosis; „ab‟ 
on illustration 4.10). 
2. Stenosis Length (bc on illustration 4.10). 
3. Pre-treatment cross-sectional area of the stenosis. 
4. Post-treatment cross sectional area of the stenosis. 
*. These patients had a tracheostomy at the time of endoluminal surgery 
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Illustration 4.14  Correlation between clinical measurements of airway dimensions 
obtained by two independent observers. The measurements are displayed with vertical 
and horizontal error bars (1 SD). The Pearson coefficient of correlation was 0.98, with a 
slope of 0.93 +/- 0.05 and an intercept of 7.67 +/- 3.02mm, indicating a high degree of 
interobserver concordance. 
 
4.VI.e  Discussion 
By investigating each of the confounding variables under controlled laboratory 
conditions and developing a simple set of clinically applicable rules, we have been able 
to accurately calculate airway cross-section from endoscopic images.  This was 
achieved without need to measure the angle of tilt, making assumptions about the optics 
of the endoscope or the lens to object distance.   
The effect of tilt was eliminated by using a circular calibrator with biaxial calibration.  
To correct for visuo-spatial distortion, rather than pre-calibrating a designated 
endoscope, attempting to make measurements at a predetermined lens to object 
distance, or trying to calculate the degree of optical distortion with post-acquisition 
signal processing, we again made use of the calibrator probe and simple mathematics.  
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This was based on the assumption that with a probe at the level of the stenosis, it would 
be subject to the same degree of optical distortion as the stenosis itself.  By using the 
probe to cover the radial span of the area being measured and averaging the 
measurements, we consistently obtained measurements with >95% accuracy within the 
diameter ranges of neonatal, paediatric and adult airways, independent of tilt and radial 
or distance distortions.  The calibrator probe could be introduced through and beyond a 
stenosis without compromising the airway.   
The technique is limited in that it requires suspension laryngoscopy and tracheoscopy 
using a rigid endoscope.  Most physicians assess airways using flexible bronchoscopy.  
The majority of airway surgeons continue to grade stenosis based on the stratification of 
the Myer-Cotton grading system.  Due to conventional teaching, most airway surgeons 
continue to perform assessments and surgeries using rigid ventilating bronchoscopes.  
This therefore limits the wider clinical use of our technique and presently confines it to 
experimental comparison of different surgical techniques where accurate measurements 
of airway dimensions are required as a comparison with physiological outcome 
measures.   
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4.VII Outcome of Early Endoscopic Treatment of Acute Inflammatory 
Airway Lesions in Post-intubation Airway Stenosis 
4.VII.a Introduction 
In clinical practice, the majority of patients with post-intubation upper airway stenosis 
have mature fibrotic airway scars with minimal evidence of ongoing airway 
inflammation.  These patients typically have had an intubation episode in the relatively 
distant past and some of them have been treated for “adult onset asthma” for some time 
before the diagnosis is secured.  Less commonly, patients are referred within a few 
weeks of extubation with airway symptoms during the active fibro-inflammatory phase 
of tracheal injury (illustration 4.15). 
 
 
Illustration 4.15 Endoscopic (left) and histological (right) views of acute airway 
granulation 
 
 
Illustration 4.16 Endoscopic (left) and histological (right) view of „mature‟ airway scar 
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These two presentations occur at different times within the natural history of the same 
disease process.  The early phase of the post-intubation airway stenosis is characterised 
by mucosal ulceration and pericondritis followed by the formation of exophytic 
granulation tissue.  As healing progresses, granulation tissue is gradually replaced with 
mature fibrotic tissue and the wound contracts giving rise to the classical picture of 
mature airway scar (illustration 4.16).  It is already known that inflammatory conditions 
in the airway do respond to intra-lesional steroids (108).  In this study, a comparison is 
made of the results of treating patients with acute fibro-inflammatory airway lesions 
with intra-lesional steroids, laser reduction of granulation tissue and balloon dilatation, 
with those patients presenting with mature airway lesions who are initially treated with 
radial laser incisions, balloon dilatation and topical Mitomycin-C application.  The aim 
of this study was to investigate whether early intervention can affect outcome contrary 
to traditional teaching which recommends waiting for maturation of inflammatory tissue 
before treatment (7). 
4.VII.b  Methods 
Between 2003 and 2005 Thirty-one patients with a new diagnosis of post-intubation 
airway stenosis were treated.  To ensure uniformity of surgical approach, this series did 
not include patients who were referred to our unit with previous surgical treatments.  
There were 18 males and 13 females and the average age of presentation was 47 ± 2.7 
years (Mean ± SEM; range 23 to 72).  A wide range of clinical conditions necessitated 
respiratory support on intensive care unit, with pneumonia being the commonest 
indication (illustration 4.17). 
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Illustration 4.17  Indications for intubation on the Intensive Care Unit.  
Eleven patients in this series had been referred with airway symptoms within an average 
of three months from an episode of intubation on an intensive care unit (mean 2.3 ± 0.3 
months).  These patients invariably had an inflamed airway with obstructive exophytic 
granulation tissue (illustration 4.15).  The remaining twenty patients presented on 
average 47 months following intubation.  In these patients airway symptoms were 
caused by a mature fibrotic scar with minimal airway inflammation (illustration 4.16).  
There were no significant differences between the two groups with respect to sex 
distribution, ventilation time or the use of tracheostomy in the ICU, tracheostomy at the 
start of laryngotracheal surgery, site of lesion, extent of airway injury, or the length of 
follow-up. Table 4.3 provides further comparative information about patient and 
treatment characteristics. 
 (10) 
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Table 4.3 Patient, lesion and treatment characteristics 
       Fresh Stenosis Mature Stenosis  
Demographics 
 Number of patients    11  20 
 Age (years ±SEM)    46.6 ± 4.9 47.5 ± 8.9 
 Male Sex     64%  55% 
Lesion Characteristics at the start of treatment 
 ITU Ventilation Time (days)   28.7 ± 8.7 28.5 ± 5.2 
 Tracheostomy on ITU    6 (55%)                16 (80%) 
 Extubation to first treatment time (months)                2.3 ± 0.3 47.4 ± 13.3 *  
 Distance from glottis (cm)                  2.6 ± 0.5 3.3 ± 0.45  
 Myer & Cotton Grade 
11
** 
  I     0  2 (10%) 
  II     1 (9%)  6 (30%) 
  III     10 (82%) 9 (45%) 
  IV     1 (9%)  3 (15%) 
Treatment 
 Prosthetic airway in situ at first treatment                 4 (36%) 9 (45%) 
 Patients needing stents during treatment                 5 (45%) 8 (40%) 
 Median Treatment Episodes   1 (1-2)  2 (1-6) *** 
 Endoscopic Therapy    13  36 
 External Surgery                    0  6 (30%) 
  Tracheal Resection     -  2 
  Trachea / Cricoid Cartilage Resection           -  1 
  Sternohyoid Flap                   -  2 
  Tracheal Homograft     -  1 
 Mean Follow-up (months)                13.8 ± 1.2 15.4 ± 1.8 
* p < 0.0001 (Unpaired Student‟s t-test) 
** Chi-square tests for independence and trend were not significant (p>0.1) 
*** p < 0.03 (Mann-Whitney-U test) 
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Anaesthesia and the surgical approach are described in section 3.II. Mature lesions were 
treated with radial incision with a carbon dioxide laser, taking particular care to preserve 
intact mucosal bridges between incisions to avoid circumferential restenosis.  The 
airway was then dilated with a CRE
TM
 Pulmonary Balloon Dilator (Boston Scientific, 
Natick, MA, USA), followed by a three-minute topical application of mitomycin C at a 
concentration of 1mg/ml.   
Fresh granular lesions on the other hand were treated with intralesional steroid injection, 
followed by laser reduction of the granulation tissue and balloon dilatation.  40-80mg of 
methylprednisolone acetate (Depo-Medrone®; Pharmacia; Walton-on-the-Hill, UK) 
was injected using a 27 gauge BD Valu-Set™ butterfly needle (BD Infusion Therapy, 
Helsingborg, Sweden) with the wings cut, and the needle grasped using microlaryngeal 
forceps (Xomed Ltd, Watford, UK).  The needle was bent to slight angles to allow the 
tracheal wall to be injected, and was advanced into the airway under endoscopic vision.  
The granular lesions were injected circumferentially at the base (llustration 4.18).   
 
Illustration 4.18 Shows a 27 gauge butterfly needle (left) adapted for intralesional steroid 
injection (right) 
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The granulation tissue was then reduced with a carbon dioxide laser, preserving intact 
mucosal bridges whenever possible.  Care was exercised to avoid over-aggressive 
photoresection of the lesion.  The trachea was then dilated using a CRE™ Pulmonary 
Balloon dilator.  A soft silastic stent was placed in all patients who had a stenosis 
greater than 70% and longer than 5mm for a period of four weeks to aid healing.  
Details of the material used and the method of stent placement and removal used have 
previously been described (69). 
Data Analysis   
Demographic information and details regarding the precipitating ventilation episode,  
the indication and length of ventilation, the time taken from extubation to the initiation 
of the first treatment were obtained.  Characteristics of the lesion at the start of the 
treatment, and the nature and timing of each treatment episode were recorded.  
Intervention-free interval was the time between one treatment episode and the next 
surgical treatment performed to restore airway patency as previously defined (140). 
Data was presented either as means with standard errors or as percentages when 
appropriate.  Parametric normally-distributed data was compared using unpaired 
student‟s t-test, and binomial data were compared using the chi-square test.  
Intervention-free intervals were calculated, and illustrated using the method of Kaplan 
and Meier, and compared with log-rank statistics.  A stepwise Cox proportional hazards 
ratio model was constructed to identify potential independent predictors of intervention-
free interval.  Data was analyzed and displayed using SPSS release 12.0 for Windows 
(SPSS Inc., Chicago, IL, USA). 
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4.VII.c  Results 
Patients in the “mature stenosis” group required a median of 2 surgical interventions 
(range 1-6).  Patients with fresh stenoses on the other hand required fewer procedures 
(range 1-2) (p < 0.03; Mann-Whitney-U test).  Six patients in the mature stenosis group 
required external laryngotracheal reconstruction. This included three tracheal resections, 
two airway augmentations using the pedicled sternohyoid flap (141), and one tracheal 
homograft (table 4.2).  By comparison, none of the patients in the fresh stenosis group 
required an external approach airway reconstruction (p < 0.001; chi-square test). 
The average intervention-free interval in the fresh stenosis group was 17 months and 
this was achieved with a single endoscopic operation in the majority of patients.  
Airway appearances at follow-up in this group did not demonstrate evidence of 
recurrent granulation tissue or stenotic scarring (illustration 4.19).   
                                  
Illustration 4.19 Early granular subglottic stenosis treated (A) and appearance six months 
after treatment (B). Patient remained well until dischargee 19 months later. 
 
By contrast, the average intervention-free time in patients with mature stenoses was 9 
months, with 55% of patients in this group requiring more than one procedure.  The 
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difference in the intervention-free interval between the two groups was statistically 
significant (p < 0.02; log-rank analysis) (illustration 5.20).  To which group patients 
belonged was the only factor predictive of the intervention-free interval on Cox 
regression analysis.  In particular, length of intubation, anatomy of the lesion at the start 
of treatment, and the need for prosthetic airway support at the start of treatment did not 
influence the intervention-free interval. 
               
Illustration 5.20 Intervention-free interval as a function of the maturity of the airway 
lesion at the time of treatment (Kaplan-Meier analysis) 
 
4.VII.d  Discussion 
The results of this study show that intra-lesional steroid injection, reduction of 
granulation tissue and balloon dilatation can be a viable and effective treatment for 
acute post-intubation airway stenosis.  Patients receiving this treatment required 
significantly fewer surgical interventions, had significantly longer intervention free 
intervals and did not require external approach laryngo-tracheal reconstruction surgery 
compared with patients presenting later with mature airway lesions.  It is also evident 
from this research that patients with early granular airway stenosis treated with intra-
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lesional steroids appear to regain normal airway appearances (illustration 4.19) and 
remained free of recurrent scarring and stenosis which often blights endoscopic 
treatment for mature airway stenosis.  This study shows that early treatment of acute 
airway lesions may prevent the development of long-term sequelae which are more 
difficult to treat.  These findings have important implications for the post-intubation 
management of intensive care patients.  Given that early intervention could improve the 
outcome of this condition, it lends to the argument for screening patients for upper 
airway obstruction after long-term intubation on intensive care units.  Whilst half of 
patients (109) have a significant tracheal injury at the time of extubation, and 4% go on 
to have long-term airway compromise, fortunately the natural history of this condition is 
towards spontaneous resolution.  However, there is very little research and the actual 
incidence of post-intubation airway compromise is probably underestimated. Screening 
for post-ICU patients is discussed in chapter 6 of this thesis.  
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4.VIII  Outcome of Endoscopic Treatment of Adult Post-intubation 
Subglottic and Tracheal Airway Stenosis 
 
4.VIII.a  Introduction 
The primary objective of airway reconstruction is to restore and maintain a safe and 
patent airway capable of meeting the ventilatory demands of the patient while 
minimising the risk of further iatrogenic injury to the laryngotracheal complex and the 
structures that surround it.  Tracheal and cricotracheal resection have become the 
standard of care for tracheal and subglottic stenosis respectively.  The efficacy of these 
techniques in treating post-intubation airway stenosis have been well documented (4, 7, 
111, 142, 143).  By contrast, endoscopic laryngotracheoplasty has largely been viewed 
as ineffective and temporising, suitable at best for treating a subset of patients with thin 
and mild lesions (18).  The treatment philosophy of primary open surgery rests almost 
exclusively on evidence published following retrospective analysis of data generated 
towards the end of the last century (142) and while its efficacy in selected cases is not 
disputed, it is a treatment approach that even in the very best of hands can lead to 
significant morbidity and prolonged hospitalisation, and carries major risks including 
peri-operative mortality (144).  It was felt important as a part of this thesis to explore a 
minimally invasive approach which, if effective, would have clear advantages over first 
line employment of major open surgery.  
 
 
 
107 
 
4.VIII.b  Methods 
Between the end of 2003 and 2006, 62 patients with post-intubation tracheal 
stenosis were all treated initially with an endoscopic approach.  Demographic 
information, indications for surgery and the duration of the intubation event, use 
of tracheostomy, lesional characteristics and follow-up durations were all 
prospectively recorded.  Details of endoscopic and open surgeries, 
decannulation, insertion and removal of airway prostheses, and post-operative 
complications and surgical outcomes were recorded.           
 
Illustration 4.21 Details of medical events precipitating intubation and ventilation. (SAH= 
subarachnoid haemorrhage, RTA= road traffic accident). 
 
There were 34 males (55%) and the average age at presentation was 45±16 years.  Most 
patients (53, 86%) had a tracheostomy during their intensive care stay, and 30 patients 
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(48%) were tracheostomy-dependent at the time of their first treatment.  Illustration 4.21 
and table 4.4 provide further information about patient and lesion characteristics. 
Table 4.4 Patient and lesion characteristics. 
Number of patients      62 
Age (± SD) [range]      45.6 ± 16 [16 – 72] 
Male sex (%)       34 (55) 
Length of intubation (days ± SD)    26 ± 28 [4 – 140] 
Intubation-to-first-treatment latency (months ± SD)  29 ± 47 [1 – 230] 
Tracheostomy during acute episode    53 (86) 
Tracheostomy at first visit     30 (48) 
 
Characteristics of the lesion at first endoscopy 
 Glottis-to-lesion distance (mm ± SD)   36 ± 19 [5 – 100] 
 Myer and Cotton Grade 
  I      0 
  II      11 (18 
  III      40 (64) 
  IV      11 (18) 
 Height of the lesion (mm ± SD)               18 ± 12 [5 – 55] 
 
Details of anaesthesia are discussed in 3.II, however, there are subtle differences in the 
surgical technique and for this reason there is some repetition. Patients underwent 
diagnostic laryngotracheoscopy, followed by endoscopic lumen-restoring surgery.  The 
airway was visualized with a combination of microscopic and endoscopic techniques, 
using an operating microscope and a 4mm 0
o
 Karl-Storz airway endoscope (Karl Storz 
GmbH & Co KG, Tuttlingen, Germany).  Carbon dioxide laser was delivered using a 
microscope-mounted Sharplan
®
 Acuspot
®
 micromanipulator (Lumenis UK Ltd, 
London, UK). Lesions beyond the microscope‟s line of sight were treated with KTP 
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laser delivered via 0.4mm disposable fibreoptic filaments (Laserscope, San Jose, CA, 
USA).  Fresh granular lesions were treated with 60-80mg of methylprednisolone acetate 
(Depo-Medrone®; Pharmacia; Walton-on-the-Hill, UK) circumferentially injected at 
the base of the lesions as previously reported. (145)  Laser radial incisions were made 
into the lesion, taking care to preserve mucosal bridges between the cuts to prevent 
circumferential restenosis.  Dilatation was undertaken using the CRE™ Pulmonary 
Balloon dilator (Boston Scientific, Natick, MA, USA), followed by topical mitomycin C 
application (Kyowa Hakko UK Ltd, Slough, UK; 1mg/ml for 3 minutes).  Patients with 
Myer-Cotton grade 4 lesions and patients with grade 3 lesions >15mm in length also 
received a silicone stent cut from soft silastic Montgomery T-tubes (Boston Medical 
Products, Westborough, MA).  Stent diameter was chosen based on an estimate of 
tracheal diameter, and the length was 1-2cm longer than stenosis length.  Stents were 
introduced through the laryngoscope using laryngeal forceps and sutured with a 2-0 
polypropylene (Prolene; Ethicon Inc, Somerville, NJ) as previously described. (69)  
Stents were removed during a subsequent laryngotracheoscopy.  The suture was 
endoscopically cut using laryngeal microscissors and the stent was removed with 
forceps.  The decision to redeploy a stent was based on the degree of residual 
inflammation and was made on a case-by-case basis.  At the start of therapy patients 
were usually readmitted within eight weeks or sooner if symptomatic, for a further 
laryngotracheoscopy, during which further endoscopic laryngotracheoplasty, if 
indicated, was undertaken.  The process was repeated until a normal airway was 
attained and maintained.   
Patients whose lesions proved recalcitrant to endoscopic therapy, and this usually 
became evident by the third procedure, underwent open laryngotracheal surgery.  The 
operative techniques used have previously been described (143, 146-148).  As a rule, 
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patients undergoing endoscopic surgery, including those who were stented, were 
admitted to the surgical high-dependency unit overnight and were discharged home on 
the morning following surgery.  
 
Data Analysis 
Data were presented as means with standard deviations or binomial percentages where 
appropriate.  Actuarial statistics was used to determine success rates for decannulation 
and attainment of a prosthesis-free (no stent/tracheotomy) airway, and Cox regression 
was used to determine independent predictors of failure to attain a prosthesis-free 
airway.  Actuarial analysis was also used to determine predictors of success or failure of 
endoscopic therapy alone to achieve a cure.  In patients who were successfully treated 
using purely endoscopic techniques, ordinal regression was used to investigate whether 
any pre or perioperative factors were associated with the need to perform multiple 
endoscopic procedures.  Data were analyzed and illustrated using SPSS release 12.0 for 
Windows (SPSS Inc., Chicago, IL).  P < 0.05 was considered significant. 
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4.VIII.c  Results 
Endoscopic assessment and surgery were the initial treatment for all patients.  The mean 
number of endoscopic operations was 2.3 ± 1.4 [range 1 – 5].   
Table 4.5  Details of endoscopic surgery. 
Number of patients       62 
Number of endoscopic operations performed per patient (%) 
 1       23 (37) 
 2       16 (26) 
 3       11 (18) 
 4       5 (8) 
 5       7 (11) 
Number of intralumenal stents deployed per patient 
 0       28 (45) 
 1       15 (24) 
 2       8 (13) 
 3       6 (10) 
 4       4 (6) 
 5       1 (2) 
Overall stent deployment time (months ± SD) [range]               12.4 ± 12.5 [0.5 – 39] 
Stent deployment time (excluding long-term stents)  6.7 ± 5.7 [0.5 – 26] 
Use of topical mitomycin C during therapy   47 (76) 
Use of intralesional steroids during therapy   18 (29                                                                            
 
Table 4.5 provides details of endoscopic surgeries performed.  In patients where 
endoscopic therapy was successful in achieving a cure, Kruskal Wallis analysis 
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identified morbid obesity (BMI > 45), use of mitomycin -C (MMC) or use of steroids, 
and the Myer-Cotton grade of the lesion at the start of therapy as predictors of the 
number of endoscopic treatments required.  Factors remaining significant following 
ordinal regression were use or steroids or MMC, and morbid obesity.  Endoscopic 
surgery had an actuarial success rate of 72% in curing postintubation tracheal stenosis 
(illustration 4.22). 
 
Illustration 4.22 Actuarial success rate of endoscopic surgery to treat postintubation 
tracheal stenosis ((log-rank analysis). (A) shows likelihood of endoscopic success as a 
function of the height of lesion. (B) Likelihood of success as a function of time from 
intubation to first treatment. (C) overall success rate of endoscopic surgery. 
 
Univariate log-rank analysis identified Myer-Cotton grade and height of the lesion, 
tracheotomy at the start of therapy, and whether the patient was referred to the airway 
unit within six months of intubation were identified as predictors of endoscopic success.  
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Factors remaining independently significant on Cox regression analysis were the 
vertical height of the lesion, and whether the patient was referred within six months of 
intubation (illustrations 4.22 and 4.23).  Ninety six percent of patients with lesions 
shorter than 3cm were successfully managed endoscopically, but the success rate fell to 
20% in patients with lesions longer than 30mm who underwent a full trial of endoscopic 
surgery with curative intent (illustration 4.23). 
 
Illustration 4.23 Likelihood of success of endoscopic management of a lesion as a function 
of its height. The numerators above the bars refer to the number of cases that were 
successfully managed with endoscopic surgery, and the denominators are the overall 
number of patients within that group. 
 
Fourteen patients (23%) underwent open airway surgery.  The average time from start 
of therapy to open surgery was 16±11 months [range 1–39].  There were 11 
augmentation procedures, consisting of hyoid-on-sternohyoid pedicled flaps (n=4) 
(147), Eliachar sternohyoid flap (n=4) (146), tracheal homografts (n = 3) (148), and 
three tracheal resections (143).  One tracheal homograft was extruded into the airway 
and removed endoscopically, necessitating a total of five endoscopic procedures, 
ultimately resulting in a patent airway and an MRC Dyspnea grade of II (149).  Two 
augmentation procedures failed due to recurrence of stenosis at the lower border of the 
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augment, necessitating reinsertion of internal stents.  These two patients were referred to 
us after failure of tracheal resection in one case, and failure of endoscopic procedures, 
cartilage augmentation, and tracheal resection in another.  Neither patient was a 
candidate for further resection.  The remaining 11 procedures were successful in 
achieving and maintaining normal airways.  The average number of endoscopic 
procedures following open surgery was 1.2 ± 1 (range 0 – 3), including a postoperative 
laryngotracheoscopy in all patients. 
In 98% of patients, re-intervention occurred within six months of the previous therapy 
(illustration 4.24).  Patients who did not require re-intervention retained scores of 1 to 3 
on the Medical Research Council Dyspnoea Scale.  
 
Illustration 4.24 Cumulative distribution of the likelihood of the need for surgical 
reintervention. 
 
One patient with a tracheotomy died from an unrelated cause before treatment could be 
completed.  All other patients were decannulated within an average of 2±3.6 months.  A 
Cox regression model was constructed to determine predictors of delayed 
decannulation.  Variables entered were patient age sex and body mass index, height, 
Myer-Cotton grade of the lesion, use of internal stents and use of open surgery.  None 
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of these variables were found to be associated on univariate or multivariable analysis 
with time to decannulation.  Another outcome assessed was freedom from any airway 
prosthesis (stent/tracheotomy).  Stents were deployed in 34 patients (55%) for an 
average of 12.4±12.5 months [range 1–39] (table 4.4).  Overall, 83% of patients 
achieved a prosthesis-free airway (illustration 4.25).   
 
Illustration 4.25 Actuarial decannulation rate ((black line) and attainment of a prosthesis-
free airway (grey line) 
 
Statistically significant univariate predictors of attaining a prosthesis-free airway were 
the Myer-Cotton grade of the lesion, presence of a tracheotomy at the start of therapy 
and the patient‟s body mass index (BMI).  The only independent predictor of failure to 
attain a prosthesis-free airway on multivariable analysis was BMI>45.  In these patients, 
although the lesion itself could be treated, the airway remained dynamically 
compromised due to anterior bulging of the trachealis (illustration 4.26).  These patients 
were maintained on long-term intralumenal airway stents and were encouraged to lose 
weight.  
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Illustration 4.26 The top two figures show endoscopic airway appearances of two patients 
with morbid obesity and excessive anterior bulging of posterior tracheal membrane 
leading to dynamic airway compromise. The bottom figure shows a patient who continues 
to suffer with dynamic airway collapse. 
 
There was one death due to mucus plugging of a stent in a heavy smoker two weeks 
following an otherwise uneventful procedure.  There were three deaths from unrelated 
causes.  There were two neck infections following augmentation surgery which settled 
with antibiotics and one case of stitch infection associated with stent placement.  There 
were two cases of stent migration which necessitated emergent airway intervention with 
no permanent sequelae.  Seventy stents were placed during the study period, with the 
six complications described above, this gives a complication rate of 8.5%.  There were 
no major complications in patients who underwent endoscopic therapy without stent 
deployment. 
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4.VIII.d  Discussion 
The findings show that minimally invasive surgery is effective in treating post-
intubation tracheal stenosis.  The present series consists of an unselected group of 
consecutive patients who were initially treated endoscopically with almost three 
quarters (72%) of patients being successfully managed without open surgery.  For those 
patients who required open surgery, initial endoscopic laryngotracheaoplasty restored 
luminal patency, allowing a proportion of patients to be decanulated during the first 
visit.  When initial decanulation was deemed to be unsafe, stent placement above the 
tracheostomy restored voice, which some patients had been deprived of for many years.  
Moreover, initial endoscopic lumen restoration followed by mobilisation of the 
inflammatory process with stent and mitomycin-C made it possible for most patients 
requiring open surgery to be managed with airway augmentation rather than resection.  
Tracheal resection was preserved for patients who had long segment complete or near 
complete collapse of cartilaginous tracheal support.  These results stand in contrast with 
much of the published literature on the treatment of post-intubation tracheal stenosis 
which favours tracheal resection and anastomosis as a first line therapy (7, 142, 143).  
The effectiveness of the endoscopic approach demonstrated in this study may be due to 
advances in minimally invasive surgery and anaesthesia, but may also be due to changes 
in post-intubation tracheal stenosis as a disease entity.  In this study, the majority of 
cases of airway compromise were caused by encroachment into the airway lumen by 
circumferential granular or mature scar tissue, with reasonable cartilaginous support, 
rather than localised structural failure and withering of the trachea.  In cases where the 
cartilaginous tracheal rings had disintegrated and resorbed, open surgical procedures 
had to be considered.   
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Predictors of success of endoscopic surgery were early referral to the Airway 
Reconstruction Unit and the vertical height of the lesion.  I hypothesise that patients 
with short intubation to treatment latencies were more likely to have granular lesions 
which respond well to intra-lesional steroids, laser and dilatation.  
The association between vertical lesional height and success of endoscopic surgery has 
previously been noted (7, 18). Illustration 4.23 shows that the majority of lesions <30 
mm could be endoscopically managed, but the likelihood of a successful outcome with 
endoscopic techniques falls significantly for lesions longer than 30 mm.  These findings 
have refined my treatment approach.  Endoscopic airway assessment is performed in all 
patients under general anaesthesia and initially lumen restoring endoscopic surgery is 
attempted in all patients.  Assessment and initial endoscopic treatment provides 
valuable information in respect of the degree of tracheal cartilaginous support and 
selecting those patients in whom airway augmentation or tracheal resection should be 
considered.  The initial endoscopic approach also allows restoration of vocal function to 
a sizeable proportion of patients and a number of them are decannulated during the 
initial visit.  The endoscopic approach also allows treatment of the intra-luminal 
inflammatory process.  The best outcome for open surgery is achieved in patients with 
minimal or no ongoing inflammation (4). This study has also raised the Unit‟s threshold 
for stenting patients.  The only treatment related mortality in this series was related to 
acute stent obstruction in a patient who was poorly compliant with post-operative 
advice.   
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Algorithms & treatment philosophy 
The difficulty in treating adult laryngotracheal stenosis is that there are not sufficient 
numbers of patients to run randomised trials comparing different techniques.  Also, the 
injuries differ significantly in anatomical sites and in relation to the anatomy of the 
injury itself.  This is the reason that different endoscopic techniques have been 
employed depending on the nature of injury evident at the time of examination on the 
operating table.   The resulting algorithms represent the current philosophy of the 
department in the management of new patients presenting with Laryngotracheal stenosis 
(illustration 4.27). 
 
Illustration4.27 Algorithm for the management of adult post-intubation 
laryngotracheal stenosis 
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4.IX  Endoscopic Tracheoplasty for Treating Tracheostomy Related  
Airway Stenosis 
4.IX.a  Introduction 
A less common variant of post-ventilation tracheal stenosis is seen in a small number of 
tracheostomy patients.  This is caused by over-resection or fracturing of anterior 
tracheal rings during tracheostomy.  At decannulation, there is scarring and contracture 
at the stoma site which draws in the lateral ring remnants as a result of the wound 
contracture leading to a “Lambda-shaped” stenotic deformity and airway compromise.  
The lesion usually extends over 1-2 tracheal rings with normal proximal and distal 
trachea.  The trachealis is not involved and there is usually a small anterior bridge not 
contributing to the stenosis (illustration 4.28).   
 
Illustration 4.28  Formation of „lambdoid‟deformity (D) of trachea. On decannulation, 
excessive scar contracture at the stoma draws in remnant tracheal cartilage rings (B-D). 
These encroaching cartilage rings can be ablated with a CO2 laser (E) to produce a near 
normal airway (F).  
 
Tracheal resection and anastomosis has been recommended for this condition (7), but 
this is a major operation with associated morbidity and a small mortality rate.  This 
prospective study set out to look at endoscopic resection of these collapsed tracheal 
121 
 
cartilages without injuring the normal trachealis and leaving an anterior strip at the apex 
of the lesion untouched (illustration 4.28E).  This avoids causing a circumferential 
injury and exacerbating the stenosis.  
 
4.IX.b  Patients and Methods 
Between April 2004 and 2006, 11 patients were treated with a new diagnosis of airway 
compromise due to post-tracheostomy lambdoid deformity.  To ensure uniformity of 
approach, this series did not include patients who had received airway treatment prior to 
referral to our institution.  As this was simply a modification of an endoscopic lasering 
technique used for over a decade on the unit, ethical consideration was not specifically 
sought.   
General anaesthesia was intravenously induced as described in section 3.II, and 
suspension laryngoscopy with supraglottic jet ventilation and the use of a microscope is 
the standard approach to this surgery. The CO2 laser was used using a „line-of-sight‟ 
technique delivery through a micromanipulator device.  In all cases, the lesions were 
treated with the carbon dioxide laser at 8-10 watts continuous setting.  The proximal and 
distal trachea is used as a guide to the limits of resection and the collapsed cartilage is 
vapourised on each side (illustration 4.29).  
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Illustration 4.29  Two cases (above and below) of a „lambdoid‟ tracheal stenosis treated 
endoscopically with the CO2 laser with results at 8 weeks (right) 
 
The resection initially was conservative, but it was soon evident that it could be 
extended to the tracheal fascia if necessary.  At the end of the surgery, a CRE™ 
Pulmonary Balloon dilator (Boston Scientific, Natick, MA, USA), 15-18 mm was used 
to expand the airway.  An important consideration is to preserve the mucosa over the 
trachealis and at the apex of the lambda deformity to avoid a circumferential laser 
injury.  In this series of 11 patients, topical mitomycin-C was applied on a neuro-
surgical patty at a concentration of 1 mg/ml for 3 minutes.  One patient in addition had a 
laryngofissure and anterior augmentation with hyoid bone on sternohyoid pedicled 
muscle as an anterior augmentation flap for a concomitant glottic stenosis. 
Patient demographics and details of the event requiring tracheostomy placement were 
obtained.  Lesion characteristics and the nature and timing of treatments were recorded.  
The degree of dyspnoea at last follow-up was evaluated using the Medical Research 
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Council (MRC) dyspnoea scale (150).  Data was presented either as mean values with 
standard deviation or binomial percentages when appropriate.  A timeline plot was used 
to illustrate the number and nature of the treatment episodes that each patient received.  
Data were analysed and displayed using SPSS12 for Windows (SPSS Inc, Chicago, 
Illinois, USA). 
4.IX.c  Results 
There were 7 males and 4 females and the average age at presentation was 56 ± 14 years 
(Mean ± SD; range 20 to 70).  None of the patients had a tracheostomy at the time of 
presentation.  One patient had an MRC Dyspnoea grade of 3, and the others had grades 
of 4 or 5.  Table 4.6 provides further information about patient and lesion 
characteristics.   
Table 4.6    Patient characteristics         
 
        
 
# Age Sex Aetiology 
M-C                       
Grade 
SH                      
(mm) 
G1-L-D          
(mm) 
Follow-
up 
(months) 
MRC Dyspnea 
Grade  at last 
follow-up 
                  
1 64 F Peritonitis II 8 35 32 II 
2 70   Cardiac surgery II 7 42 28 II 
3 40 F Intracranial bleed III 8 36 23 II 
4 61 M Burn III 12 15 20 II 
5 60 F COPD III 20 10 19 III 
6 20 M RTA II 21 39 17 I 
7 70 M Peritonitis III 9 40 15 II 
8 60 M Neurosurgery II 7 40 13 I 
9 62 M Liver transplant III 10 42 10 II 
10 51 M Peritonitis III 10 49 8 I 
11 59 F RTA III 10 45 7 I 
M-C Grade: Myer and Cotton Grade.  
SH: Stenosis Height; Gl-L-D: Glottis to Lesion distance.  The methodology for measuring SH and Gl-L-
D has previously been described.  
RTA: Road Traffic Accident 
COPD: Chronic Obstructive Pulmonary Disease 
MRC Dyspnoea Grade 
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The median number of endoscopic treatments required to achieve a cure was 3 (range 1-
5) and three patients required endolumenal stent placement as part of their treatment.  
The median number of endoscopic treatments per patient fell from 4 at the start of the 
series to 2 at the end, when more extensive initial cartilage resections were being 
undertaken (p = 0.08).  Illustration 4.30 provides a detailed treatment timeline for all 
patients.   
                   
Illustration 4.30  Treatment timelines for individual patients. *Laryngofissure procedure 
for concomitant glottis reconstruction 
 
The average follow-up was 17 ± 8 months (range 7-32) and no patient required re-
intervention after six months of symptom-free follow-up.  At the last follow-up, with 
the exception of one patient with pre-existing chronic obstructive pulmonary disease, all 
patients achieved and maintained MRC Dyspnoea Scale grades of I or II.  All patients 
returned to their pre-injury level of physical activity.  There were no cases of dysphagia, 
and, with the exception of one patient with concomitant glottic stenosis who had mild 
dysphonia, all patients had normal voices at the last follow-up. 
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4.IX.d  Discussion 
The results of this study show that endoscopic tracheoplasty can be an effective 
treatment and a viable alternative to tracheal resection for airway stenosis caused by 
post-tracheostomy stomal contracture.  The lambdoid tracheal deformity is a specific 
and predominantly anatomical cause of post-intubation airway stenosis.  This is a 
relatively uncommon cause of post-intubation tracheal stenosis occurring in 9.6% of the 
patients that we treated for post-intubation airway compromise.  Traditionally, tracheal 
resection end-to-end anastomosis has been recommended as a first line treatment for 
this condition (7) and given that the combination of a short length of stenosis and 
favourable wound healing, these patients are likely to do well following this operation.  
However, tracheal resection remains a major procedure with associated morbidity and 
very occasionally mortality.  It also requires a prolonged hospital stay.   
The net effect of my technique is to achieve what is essentially an endoscopic tracheal 
resection but without open neck surgery and tracheal anastomosis.  There was a learning 
curve associated with this technique as initial concerns were related to possible surgical 
emphysema or haemorrhage into the airway.  At the outset, I decided to re-examine the 
airway at 4-6 weeks and remove any granulation tissue with microsurgical instruments 
or a minimal lasering technique.  Depending on the appearance of the airway at the 
second visit, the patient was either placed under surveillance or rescheduled for 
endoscopy to ensure that any further granulation tissue was treated before it progressed 
and mature scar.  Initially, patients were kept in hospital overnight for observation, but 
later, the majority of the patients were discharged home the same day.   
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4.X  The Prefabricated Sternohyoid Myocartilaginous Flap 
4.X.a  Introduction 
Section 4.VIII above shows that over 72% of adult patients with post-intubation 
laryngotracheal stenosis can be treated endoscopically and most of the remaining 
patients can be managed using standard open surgical resection or augmentation 
techniques.  However, it became evident that a minority of patients who had long or 
multi-segment disease with concomitant tracheomalacia failed to respond to standard 
therapy.  Grillo (7) has already demonstrated that 4 cm of trachea can usually be 
resected in an adult patient and with pulmonary ligament and suprahyoid laryngeal 
release techniques  another 2 cm could be made available for an extended resection. 
Extended tracheal resection carries a higher morbidity and mortality rate (151).   
However, three patients had been referred to The Unit over the period of this study 
having failed resection and augmentation procedures.  Tissue engineering for tracheal 
and bronchial reconstruction is a new development which is still not widely available 
and certainly was not on the horizon when these patients were being treated.  Primary 
augmentation with rib graft in adult patients is difficult for two reasons.  First, rib grafts 
do not reliably survive when used as a primary augment in adults (5) and second, unlike 
paediatric airway reconstruction, in adults the only cartilaginous part of the rib is the 
costo-sternal junction.   
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4.X.a  Methods 
Stage 1.  
Details of anaesthesia and endoscopic surgical techniques have previously been 
described in section 3.II.  During the first stage of the procedure, costal cartilage is 
harvested from the fifth, sixth and, if required, seventh rib on the right side of the 
thorax.  A transverse neck incision is made and a subplatysmal dissection carried out 
superiorly to the level of the hyoid and inferiorly to the level of suprasternal notch.  A 
number of these patients have had previous cervical surgery and the most intact 
sternohyoid muscle is exposed.  The pieces of cartilage are sliced to a thickness of 2-3 
mm and sutured end-to-end with a resorbable suture material as demonstrated in 
illustration 4.31. 
  
Illustration 4.31 Costal cartialge is havested, sliced 3mm thick and sewn end to end 
as shown (left). This construct is then sewn to the anterior surface of the left 
sternohyoid muscle (right). 
 
The length of this cartilage construct is marginally longer than the length of the 
damaged airway and the end pieces of cartilage are tapered as demonstrated.  This 
construct is then sutured on to the anterior surface of the sternohyoid muscle with 
absorbable sutures medially and laterally.  The wound is closed above the construct and 
a wound drain is usually not necessary. 
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Stage 2 
The second stage of the procedure is performed 10-12 weeks later.  There is a preceding 
ultrasound scan to confirm that this cartilaginous construct has survived. The neck 
wound is re-opened and subcutaneous dissection extended from the hyoid to the 
suprasternal notch.  The sternohyoid muscle with its cartilaginous construct is mobilised 
as a single composite flap.   
                  
Illustration 4.32 Composite myocartilaginous pedicled flap (left) is mobilised 
retaining the blood supply from the inferior thyroid artery (middle). The flap is 
rotated to act as an extended anterior augment to the airway, split anteriorly 
(right) 
 
The muscle can be mobilised and even detached from the hyoid as its principle blood 
supply is through the inferior thyroid artery.  This allows the composite 
myocartilaginous flap to be mobilised in a longitudinal fashion and used as an anterior 
laryngotracheal augment.  As a part of the second stage, a laryngotracheofissure is 
performed and where there is a tracheostomy tube already present, it is lowered into a 
new position in a healthy part of the trachea.  Where no previous tracheostomy was 
present, a new tracheostomy site is fashioned in a healthy part of the lower trachea.  
Any scar tissue encroaching into the lumen of the damaged airway is surgically 
removed.  However, it is important not to breach the posterior tracheal wall.  A length 
of silastic tubing extending just beyond the injured airway is fashioned from a 
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Montgomery silastic T-tube.  This T-tube is covered with a superficial skin graft as 
described in the section on stents 2.III.e.  This stent, with its biological dressing, is then 
secured in the airway with a 2.0 Ethilon suture as previously described (69).  The 
sternohyoid myocartilaginous flap is then rotated on its pedicle and secured into the 
airway using a suitable resorbable monofilament suture (illustration 4.32).  A temporary 
wound drain is placed and the surgical site is closed.  The wound drain is usually 
removed 24-72 hours later and the tracheostomy is removed 3-5 days later.  The stent 
and the skin graft is removed after a period of 3 weeks using suspension laryngoscopy 
and endoscopic techniques.   
4.X.c  Results 
Table 4.7   Patient Details      
  
     Patient 1 Patient 2 Patient 3 
Age 30 20 18 
Gender Male Female Female 
Etiology Intubated for 2 weeks                                   
(motor vehicle accident) 
Intubated for 2 weeks                                           
(motor vehicle accident) 
Neonatal postintubation                                                                
Subglottic stenosis 
Pre-Referral                                           
Treatment 
Tracheotomy                                                  
(in situ for 9 months) 
Tracheotomy                                                                                                           
Rip-graft laryngototracheoplast                              
Montgomery T-tube insertion                               
Multiple dilations 
Rib-graft laryngotracheoplasty                                                   
Tracheotomy                                                                               
Arytenoidectomy                                                                                       
Hyoid-on-strnohyoid augmentation                               
Persistent tracheo-cultaneous fistula 
Lesion                                         
Characteristics 
Grade III lesion at 1 cm                     
Grade II lesion at 6 cm                    
Intervening tracheomalacia 
Grade III lesion at 5 cm                                      
Tracheomalacia up to cricoid                                                
Damaged trachel rings below the main lesion 
Anterior glottic web                                                                                 
Grade III subglottic lesion  
(due to collapsed cricoid) 
Airway Status                          
Pre-treatment 
D4 D4 D2 
 
 
Airway Status                          
Post-treatment 
D2 D1 D1 
 
Prospective information about the demographics, clinical, surgical and airway outcomes 
were obtained. In none of the cases had there been resorption of the construct. Table 4.7 
illustrates patient details.   
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4.X.d  Discussion 
This procedure addresses some of the limitations associated with previous approaches to 
airway reconstruction.  The ability to make a precise 3-dimensional cartilaginous 
construct allows for the creation of a flap with the right size, shape and contour tailored 
to address the reconstructive requirements of a particular lesion.  This has proven 
incredibly useful in the area of paediatric reconstruction.  A reliable technique had to be 
devised for those patients who had failed previous airway surgery, including tracheal 
resection.  With this technique, a thin cartilaginous construct is formed which is allowed 
to derive a blood supply both from the sternohyoid muscle and the overlying platysma 
muscle over 3 months.  During dissection, the fibres of the platysma are not removed 
from the anterior surface of the construct.  It was also fortuitous that the pieces of 
cartilage did not fuse, but instead were united with fibrous union (illustration 4.33) 
allowing mobility of flexion of the neck.  This virtually mirrored the biomechanical 
properties of the normal trachea and I hypothesise that this prevented tracheomalacia.  
The thin layer of platysma fibres present protect the exposed cartilage and form a 
surface for respiratory re-mucosalisation.  The net result is a reconstruction that 
introduces fresh vascularised tissue into the airway, restores normal tracheal 
dimensions, mirrors the biomechanical properties of the trachea and achieves a luminal 
surface that although is initially lined by squamous epithelium, is soon replaced by 
respiratory epithelium which is capable of supporting mucociliary transport.   
The major limitations of this procedure are that it is staged.  It had to be performed in 
this manner to guarantee that there is a viable composite flap for reconstruction.  The 
second limitation of this procedure is that it creates 3 surgical sites which include the 
neck, chest and thigh.  It does, however, provide a solution to a difficult problem where 
previous techniques have failed.  It is a method of reconstructing complex recalcitrant 
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long segment tracheal stenoses.  Until tissue engineering techniques for these types of 
injuries are proven and readily available, this new surgical technique provides a further 
option for managing difficult adult laryngotracheal stenosis. 
 
Illustration 4.33 Histological appearance of a segment of the myocartilagenous flap, 
stained with Masson‟s trichrome and visualized with 25 magnification.  A. The 
musculocartilagenous interface.  Skeletal muscle (m) and cartilage (c) are joined together 
by a vascular fibrous stromal layer.  The presence of vacuolated cartilaginous nuclei 
(black arrow) confirms cartilage viability.  B. Two separate pieces of cartilage (c1 and c2) 
are joined together by a vascular fibrous joint (j).  These histological appearances confirm 
that separate pieces of cartilage integrate to form a single rigid fibrocartilagenous 
construct, which is viable, and is closely adherent to the underlying sternohyoid muscle. 
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4.XI  Bilateral Vocal Cord Mobility Impairment 
Bilateral vocal fold palsy (BVFP) or bilateral vocal fold immobility (BVFI) are both 
terms commonly used to describe the lack of movement of both vocal folds.  The terms 
do not, however, include cases where there is reduced mobility rather than immobility.  
The term bilateral vocal cord mobility impairment (BVCMI) is more accurate and 
preferred as it includes cases were there may be partial recovery or some degree of 
motion in at least one of the vocal folds.  The analysis of the cases in the series is part of 
a future research project, but some of the preliminary findings are included in this 
thesis. It is quite clear that there are three mechanisms of injury: 
1. Bilateral denervation (thyroid surgery or neck and chest malignancy) 
2. Cricoarytenoid joint fixation (rheumatoid arthritis or trauma) 
3. Inter-arytenoid scarring (post intubation) 
The management of bilateral vocal fold mobility impairment remains controversial and 
unsatisfactory.  It is my experience that the majority of current techniques lead to a 
compromise between voice, airway and swallowing.  Bilateral recurrent laryngeal nerve 
injuries leave the vocal folds in the paramedian position and patients suffer with 
significant shortness of breath and demonstrate stridor.  They often end up with a 
tracheostomy in the acute situation.  Various techniques have been described to manage 
this problem and these include laser to the posterior vocal fold or arytenoid and suture 
lateralisation of the vocal folds.  Various reinnervation techniques have been described, 
which include ansa cervicalis to recurrent laryngeal nerve, ansa to thyroarytenoid 
neuromuscular pedicle, and hypoglossal to recurrent laryngeal nerve as well as various 
muscle nerve pedicle procedures.  Most of these techniques lead to synkinesis and work 
best with unilateral cord palsies in restoring voice (152).  More promising techniques, as 
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yet unpublished and pioneered by Professor Jean-Paul Marie in France, involve a 
technique of mobilising one division of the phrenic nerve or accessory phrenic nerve 
and anastomosing it to the posterior cricoarytenoid muscle.  This manages to produce 
abduction on inspiration in the more successful cases.  Other groups have looked at 
reanimation of the paralysed human larynx with implantable electrical stimulation 
devices (153).  These techniques are, however, in very early stage clinical trials.  The 
patients in this series have to date been managed by a unilateral or a bilateral laser 
partial arytenoidectomy as shown in illustration 4.34. 
  
Illustration 4.34  Showing right laser arytenoidectomy procedure for grade I 
BVCMI 
 
The partial arytenoidectomy is performed very posteriorly into the body of the arytenoid 
cartilage, on the one side initially, and can be repeated in the opposite arytenoid if 
necessary.  All patients need to be preassessed for baseline swallowing function.  This 
technique has been successful in decannulating all patients with bilateral recurrent 
laryngeal nerve palsies and improving respiratory function in the others.  However, the 
price paid by the patient is a breathy quality to the voice.  This very posterior technique 
has the advantage that the whole vocal fold does not become lateralised as in techniques 
where the vocal process of the arytenoid is lasered or where a suture lateralisation is 
employed.  Further research needs to be undertaken in this area to compare quality of 
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voice and improvement in respiratory function using different surgical techniques.  
Unfortunately, the numbers of these cases are very small and rather than being referred 
to specialist centres, are managed by surgeons in their individual hospitals.   
The second type of injury leading to BVCMI is fixation of the cricoarytenoid joints.  In 
this series, there were a number of cases where this was related to rheumatoid arthritis 
affecting the cricoarytenoid joints.  Fixation of the cricoarytenoid joint does occur as a 
result of trauma leading to dislocation or subluxation of the cricoarytenoid joint.  This 
generally occurs as a result of attempts at airway intubation, direct laryngoscopy or 
blunt laryngeal trauma.  The incidence of these injuries is very small (122) and 
described at approximately 0.1% of tracheal intubations.  Bilateral subluxation and 
fixation as a result of trauma is even more unusual (case reports only).  The 
management of bilateral fixed cricoarytenoid joints is similar to that of recurrent 
laryngeal nerve palsy in that a laser arytenoidectomy can be performed unilaterally or 
bilaterally depending on the symptoms.  It is even more important to assess swallowing 
difficulties in these patients as connective tissue disorders often lead to problems with 
the cervical spine and consequently impact on swallowing. Illustration 4.35 
demonstrates a laser arytenoidectomy in a patient with fixation of the cricoarytenoid 
joints due to rheumatoid arthritis.  Illustration 4.35 (centre) shows degeneration material 
exuding out of the cricoarytenoid joint during the laser procedure.   
                    
Illustration 4.35  GradeII BVCMI, Right laser arytenoidectomy performed, 
Degenerative material from cricoarytenoid joint (centre) 
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The third cause of fixation of the arytenoids relates to inter-arytenoid scarring.  This is 
mostly a post-intubation finding.  There were cases in this series where vocal process 
granulomas coalesce to form adhesions between the arytenoids, but sparing the inter-
arytenoid mucosa (illustration 4.36). 
                           
Illustration 4.36  Left picture shows vocal granulation tissue formed as a result of 
endotracheal intubation coalescing. If undivided this will become mature scar 
tissue (right) and lead to ankylosis of cricoarytenoid joints. 
 
In the case of illustration 4.36 (left), this adhesion can simply be divided and normal 
vocal fold function will return.  If this granular injury is allowed to mature such as in 
illustration 4.36 (right) then there will be ankylosis of the cricoarytenoid joint and even 
division and balloon dilatation will not restore vocal fold function and the compromise 
between voice and airway remains as in the cases described above.  In the cases of inter-
arytenoid scarring, distinction must be made between early granular inflammatory 
(illustration 4.38) injury (grade III) and mature scar tissue between the arytenoids (grade 
IV).  Grading of bilateral vocal fold mobility impairment is therefore as follows: 
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 Grade I – CAJs mobile/no scar 
 Grade II – CAJs fixed/no scar 
  Grade III – Early granular/inflammatory injury between the arytenoids 
  Grade IV – Mature scar between arytenoids (thin/thick) 
 
 
Illustration 4.37 Relative incidence of grades of Bilateral Vocal Cord Mobility 
Impairment (BVCMI) presenting to the Unit. 
 
Management of grade 1 and grade 2 injuries has already been described.  Grade 3 
injuries present early and usually demonstrate a granular inflammatory injury between 
the arytenoids.  This must be treated with steroid injection, gentle reduction of 
137 
 
granulation tissue, mitomycin-C topical application and balloon expansion of the 
posterior glottis at 2-3 weekly intervals to prevent mature scar formation between the 
arytenoids.  Illustration 4.37 demonstrates grade 1-4 injuries and the percentage of each 
type of injury presenting to The Unit.   
 
Illustration 4.38 To show the difference in the treatment of mature interarytenoid scar 
versus non-mature scar (granulation) 
 
It is evident that grade 3 injuries are the type least frequently seen.  Illustration 4.39 
shows a thin web of inter-arytenoid scarring which could be treated by division with a 
sickle knife, balloon dilatation and then mitomycin-C application. This procedure, if 
repeated at 3-4 weekly intervals, may produce resolution of this injury.   
  
Illustration 4.39 Thin interarytenoid scar 
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The majority of the mature inter-arytenoid scar cases are thicker and more fibrotic as 
demonstrated in illustration 4.40, which shows an attempt at a large laser 
arytenoidectomy, with subsequent reformation of the scar and narrowing of the 
posterior glottis (illustration 4.40 right).   
   
Illustration 4.40  Thick interarytenoid scar (left), extended laser arytenoidectomy and scar 
division (centre), unfortunately the scar tissue quickly reforms (right) 
 
The only technique that I have been able to use successfully in managing this type of 
dense posterior interarytenoid scar is to perform an anterior laryngofissure and posterior 
cricoid split, dividing this scar and separating it with a piece of costal cartilage 
(illustration 4.41) as a temporary spacing device. This provides separation of the 
posterior scar tissue so that recurrent interarytenoid scar and contracture does not recur.   
   
Illustration 4.41  Posterior rib graft (as a ‘spacer’), is the only solution to separating thick 
interarytenoid scar. Case from illustration 4.40 above, following successful treatment (right). 
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In a large number of cases, this piece of cartilage is resorbed and cannot be considered 
as a reliable augment.  Fortunately, the glottic aperture enlarges and patients can be 
decannulated.  More research needs to be done in the area of bilateral vocal fold 
mobility impairment and this is a potential project for the future.  Currently, all efforts 
must be made at prevention and it is therefore recommended that intensive care units 
consider early tracheostomy in patients who are potentially going to be ventilated for 
more than one week.  Early intervention with steroids and mitomycin-C in grade 3 
lesions also needs to be promoted.  The future management of grade 1 lesions probably 
lies in laryngeal pacing or novel reinnervation techniques.  The management of grade 2 
and 4 lesions will, for the time being, be an unsatisfactory compromise between voice 
and airway. 
 
Illustration 4.42  Algorithm for management of bilateral vocal fold mobility impairment (BVFMI). 
MLT=microlaryngoscopy and tracheoscopy, CAJ=cricoarytenoid joint, PAPC=posterior 
arytenoidectomy and posterior cordectomy and GT=granulation tissue 
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Chapter 5 
Management of Inflammatory Conditions  
5.I  Wegener‟s Granulomatosis 
Wegener‟s granulomatosis (WG) is a multi-system inflammatory disease with an 
underlying vasculitis involving small and medium sized vessels.  There is associated 
granuloma formation and necrosis (illustration 5.1), and the condition classically 
involves the upper and lower respiratory tracts and the kidneys.   
    
Illustration 5.1  HE stain pathology slides of Wegener‟s Granulomatosis. Left, slide (x25) 
of respiratory mucosa showing granulomas. Right, slide (x200) showing vessels in 
respiratory epithelium with acute inflammatory infiltrate (vasculitis). 
 
Wegener‟s granulomatosis is believed to have been first described in 1931 by Klinger 
(154) who reported a patient with destructive sinusitis, nephritis and disseminated 
vasculitis.  In 1936, Wegener clearly defined the disease as a distinct clinical and 
pathological entity (155).  A Scottish otolaryngologist, Peter McBride (156) may in fact 
have been the first to describe the condition in 1897 in the British Medical Journal in a 
paper entitled “photographs of a case of rapid destruction of the nose and face”. 
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More than 80% of patients with Wegener‟s granulomatosis experience rhinological 
morbidity and 20-40% experience otological morbidity at some point during their lives 
(157).  Seventeen to 23% of patients with Wegener‟s granulomatosis develop a 
subglottic stenosis (158).  This subglottic inflammation and narrowing does not 
uniformly respond to systemic immunosuppresives and may persist despite adequate 
disease control in other organ systems (158).  Sometimes, localised subglottic stenosis 
may occasionally be the only presentation of WG.  This type of focal disease may make 
it difficult to justify the use of systemic corticosteroids and cytotoxic drugs. 
The diagnosis of Wegener‟s granulomatosis is often made on clinical presentation when 
a patient has had the appropriate symptoms for a prolonged period of time.  As well as 
the otolaryngological manifestations already mentioned, patients usually also have 
involvement of the lungs and kidneys and there may be an element of renal failure.  
The Chapel Hill Consensus Conference on defining vasculitides (159), agreed the 
diagnosis of WG was supported by the following: 
• Appropriate clinical history 
• granulomatous inflammation involving the respiratory tract 
• small-medium vessel necrotising vasculitis  
• positive cytoplasmic-pattern antineutrophil cytoplasmic antibodies (cANCA) to 
proteinase 3 (PR3) 
• necrotising glomerulonephritis. 
The condition should therefore be managed in a multi-disciplinary setting which 
includes renal, respiratory and rheumatological physicians, as well as an 
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otolaryngologist.  The presence of a positive cANCA may aid in the diagnosis, but 
positivity is not conclusive and negative ANCA results are not sufficient to reject the 
diagnosis.  A definitive diagnosis of Wegener‟s granulomatosis can be made by a 
biopsy of suspicious lesions (demonstrating granulomatous inflammation) in 
conjunction with positive serological analysis.  However, it must be recognised that up 
to 20% of patients with untreated active Wegener‟s granulomatosis lack cANCA (160) 
or may show positivity later on in the disease history. 
Intra-lesional corticosteroid injections have previously been employed to treat subglottic 
stenosis in Wegener‟s granulomatosis (161).  However, the results have been 
inconsistent.  Also there has been no study looking at the treatment of Wegener‟s 
granulomatosis involving the remainder of the tracheo-bronchial tree.  The treatment 
options described, apart from medical therapy, include tracheostomy (162) and stenting 
(163).  The use of tracheostomies and long-term stents can lead to airway complications 
which are difficult to treat (4, 164).   
The purpose of this prospective study was to determine the effectiveness of intra-
lesional steroids with carbon dioxide laser radial cuts and dilatation as a treatment of 
airway compromise due to active tracheo-bronchial WG thus preventing infective 
complications during the active phase of the disease while minimising the risk of long-
term iatrogenic morbidity.   
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5.II  Endoscopic Treatment of Airway Wegener‟s Granulomatosis 
5.II.a  Methods  
Over the period of the study eighteen patients with airway compromise due to active 
WG were treated at our institution.  All patients had active granulomatous lesions 
obstructing the central airways and no patient had a mature fibrotic airway scar.  There 
were equal numbers of males and females.  The average age at diagnosis was 40±16 
years (±SD; range 13–74 years).  Four patients presented with primarily 
tracheobronchial WG, while the remaining patients with systemic disease had an 
average time from diagnosis to airway treatment of 6.3±5.3 (range 1–23) years. The 
subglottis and the cervical trachea were affected in all patients, while five patients had 
concomitant bronchial lesions.  The average lesion height was 7.8±2.7 (range 4– 5mm), 
and tracheal lesions were on average located 22.7±9.5mm below the glottis.  There were 
one, ten and seven Myer-Cotton grades I, II and III tracheal lesions respectively (10). 
Bronchial lesions were restricted to a main bronchus in three patients and affected the 
ostia of one or more of the lobar bronchi in two patients.  An example of the 
characteristic computed tomography changes and associated endoscopic findings in a 
patient who presented with grade V shortness of breath (as determined by the Medical 
Research Council Dyspnoea Scale) (149) and pneumonia are shown in illustration 5.2 
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Illustration 5.2  CT findings for patient pneumonia (A-D) due to WG related bronchial 
obstruction (E). Patient had endoscopic treatment (F) and responded to antimicrobial 
therapy (F) 
 
Prospective data was collected between 2004 and 2006 on all new patients referred with 
a diagnosis of Wegener‟s granulomatosis affecting their airways and who had not 
previously undergone treatment before referral to The Airway Reconstruction Unit. 
All the procedures were performed under general anaesthesia with a total intravenous 
anaesthesia technique (section 3.II).  The airway was initially secured using a 
supraglottic laryngeal mask which was substituted in the operating theatre with a dedo 
pilling suspension laryngoscope through which high frequency supraglottic jet 
ventilation was delivered.  The airway was visualised with a combination of 
microscopic and endoscopic techniques.   
For subglottic/tracheal procedures the airway was visualized with a combination of 
microscopic and endoscopic techniques, using a standard operating microscope and a 
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4mm 0
o
 Karl-Storz airway endoscope (Karl Storz GmbH & Co KG, Tuttlingen, 
Germany).  Lesions were treated with 60-80mg of methylprednisolone acetate (Depo-
Medrone®; Pharmacia; Walton-on-the-Hill, UK) circumferentially injected at the base 
of the lesions.  This was delivered via a 27 gauge BD Valu-Set™ butterfly needle (BD 
Infusion Therapy, Helsingborg, Sweden) as previously described. (145).  A carbon 
dioxide laser was then used to make radial incisions into the lesion, preserving intact 
bridges between the cuts to prevent circumferential re-stenosis.  Laser surgery was used 
both to reduce the lesions and to improve the efficacy of the subsequent balloon 
dilatation.  The subglottis/trachea was then dilated using a CRE™ Pulmonary Balloon 
dilator (Boston Scientific, Natick, MA, USA).  In seven patients, topical mitomycin C 
(MMC) (Kyowa Hakko UK Ltd, Slough, Berks, UK) at a concentration of 1mg/ml was 
applied for 3 minutes at this point.  Mitomycin C was used in selected patients with 
high-grade or recurrent lesions. 
For patients undergoing treatment for bronchial lesions the operative sequence was 
almost identical, consisting of intralesional steroid injection, radial laser incision and 
balloon dilatation.  The differences lay in the choice of equipment, and the fact that no 
patient received topical mitomycin C.  The carinal/bronchial region was visualized 
either with a 4mm 0
o
 Karl-Storz airway endoscope, or a flexible channelled 
bronchoscope introduced through the laryngoscope (illustration 5.6A).  Intralesional 
steroids were delivered using transbronchial eXcelon™ needles (Boston Scientific, 
Natick, MA, USA) introduced via the channel of the bronchoscope (illustration 5.6B).  
KTP laser was delivered to the lesion via 0.4mm disposable fibreoptic filaments 
(Laserscope, San Jose, CA, USA) (Illustration 5.6C).  Dilatation was performed using a 
bronchial CRE™ Pulmonary Balloon dilator (Boston Scientific, Natick, MA, USA) 
(illustration 5.6D and 5.6E).  Since all patients with bronchial lesions had retention of 
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secretions, suction catheters were introduced alongside the bronchoscope and guided 
into the main and lobar bronchi to remove retained and often infected secretions.  
Examples of the results of treatment for both tracheal and bronchial lesions are shown 
in Illustration 5.3 
Patients were observed for a few hours following the procedure on a surgical high-
dependency unit and were subsequently managed in a multidisciplinary team facility 
 
Illustration 5.3  Intra-operative results of treating a tracheal lesion (A). Intra-operative 
results of treating a bronchial lesion (B). The white streaks are displaced 
methylprednisolone. 
 
 
Illustration 5.4  Timeline plot detailing treatments received by individual patients 
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Illustration 5.5  Kaplan-Meier plot of intervention-free period following endoscopic 
treatment of active Wegener‟s granulomatosis 
 
 
 
Illustration 5.6   Diagram to outline the steps for treating bronchial WG. Suspension 
laryngoscopy and flexible bronchoscopy (A). Lesional steroid injection (B). KTP laser used 
to make radiate cuts into lesion (C). Pulmonary balloon insertion (D) and dilatation (E). 
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Data Analysis   
Demographic information, characteristics of the lesions at the start of the treatment, and 
the nature and timing of each treatment episode were recorded.  Intervention-free 
interval was defined as the time between one treatment episode and the next surgical 
treatment performed to restore airway patency as previously defined. (145).  Data are 
presented either as means with standard deviations or as percentages when appropriate.  
Intervention-free intervals were calculated and illustrated using the method of Kaplan 
and Meier, and compared with log-rank statistics.  A stepwise Cox proportional hazards 
ratio model was constructed to identify potential independent predictors of the 
intervention-free interval.  Ordinal regression was used to identify predictors of the 
number of treatments required to achieve a sustained symptom-free period.  Data were 
analyzed and displayed using SPSS release 12.0 for Windows (SPSS Inc., Chicago, IL, 
USA). 
5.II.b Results 
Eighteen patients underwent a total of 31 procedures, a median number of one 
procedure per patient (range 1–4).  No patient required a tracheostomy or a 
tracheobronchial stent and no open surgical procedures were undertaken.  There were 
no cases of significant postoperative haemorrhage or infection.  Ordinal regression was 
undertaken to identify independent factors associated with the number of treatments 
each patient received.  Variables entered into the model were patient age and sex, 
vertical height and Myer-Cotton grade of the lesion, distance from glottis, presence of 
concomitant bronchial lesions and whether or not mitomycin-C had been used at any 
time during treatment.  No independent predictors of the number of treatment episodes 
per patient were identified.  The treatment timelines for all patients in the series are 
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shown in illustration 5.4.  The overall mean intervention-free interval following 
endoscopic treatment was 26.1±2.8 months (±SEM) (illustration 5.5).  There was no 
significant difference in the durability of endotracheal and endobronchial treatments (p 
>0.8; log-rank analysis).  Univariate log-rank analysis and multivariable Cox regression 
failed to identify any factors predictive of the post-procedural intervention-free period.  
Variables entered were lesional height and Myer-Cotton grade of the lesion, age and sex 
of the patients, and use of MMC.  Topical mitomycin-C was used in seven patients with 
high-grade or recurrent lesions. It did not significantly increase the intervention-free 
interval and was associated with one patient developing stridor within one month of 
treatment due to airway crusting (illustration 5.7) which was managed endoscopically 
with no permanent sequelae. 
  
Illustration 5.7  Shows subglottic crusting and airway compromise in one of the 
patients with topical mitomycin-C application. 
 
5.II.c  Discussion 
The results of this study show that active obstructive tracheobronchial WG can be 
satisfactorily managed with endoscopic surgery, intralesional steroid therapy and 
balloon dilatation.  Our findings are in accordance with the experience of Hoffman and 
Eliachar (161) and Langford and colleagues (158) who studied subglottic stenosis due 
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to WG.  The present work extends the application of this treatment approach to 
bronchial lesions and differs from the above studies in excluding revision cases with 
mature fibrotic scars, focusing instead on patients with airway compromise due to active 
tracheobronchial WG without prior treatment. 
There exists a divergence of opinion regarding the optimal treatment of active 
obstructive tracheobronchial WG.  The traditional view, which continues to be 
advocated, (165) has held that, with the exception of life-threatening lesions, which 
need to be bypassed with a tracheostomy or opened with a stent, (163) active 
obstructive WG should not be approached surgically.  Surgery should instead be 
directed towards decannulation and reconstruction of mature airway scars, once active 
inflammation has been brought under control. This treatment strategy is difficult to 
accept, given that tracheobronchial WG poses a serious, but essentially localized 
problem which has an underlying inflammatory cause.  Given the advances in shared 
airway surgery and anaesthesia, the acute obstructive component of this problem can be 
treated with minimally-invasive surgery and dilatation. Furthermore, evidence is 
accumulating to suggest that the underlying inflammation can be adequately treated 
with high-dose intralesional steroid therapy. (145, 158, 161)  It was possible, using this 
approach, to reduce the requirement for placing a tracheostomy from 40-50% (162, 
163)to zero. 
Current medical management of WG is based on classifying patients into severe 
generalised, early systemic, or limited disease. The first is defined as disease which 
poses an acute threat to life or function of a vital organ, and the latter as disease 
manifestations that do not pose such threats (160).  Treatment of severe generalised 
disease necessitates induction immunosuppression with steroids and cyclophosphamide, 
(166) whilst early systemic disease may be managed with steroids and methotrexate 
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(167).  Limited disease may not require systemic immunosuppression at all.  Patients 
with obstructive tracheobronchial WG may be classified as having severe disease, since 
airway obstruction impedes ventilation and mucociliary clearance, causing ventilatory 
insufficiency and pulmonary infection respectively which can be acutely life-
threatening.  The findings of the present study together with those of Hoffman and 
Langford (158, 161) suggest that local treatment of airway obstruction can effectively 
convert the disease from a severe form to a more limited one.  Tracheobronchial WG 
often runs a course independent of other manifestations of WG (158), and effective 
local treatment of airway lesions can lead to early tapering of systemic 
immunosuppression in selected patients. This multidisciplinary treatment strategy, 
which is consistent with earlier recommendations, (158, 161) was deployed in all the 
patients in the present study and enabled a reduction in steroid dosage and use of 
steroid-sparing agents. Moreover, in those patients whose disease activity at distant sites 
necessitates continuing immunosuppression, treatment of tracheobronchial lesions leads 
not only to symptomatic benefit, but by improving mucociliary clearance, reduces the 
likelihood of pulmonary infections developing in immunocompromised individuals.  
 
None of the patients in the present series required a tracheostomy or a stent, a finding 
that is in keeping with previous observations (158).  Performing a tracheostomy, with its 
attendant severe impact on quality of life, or a stent procedure on any patient with 
tracheobronchial WG now seems unnecessary.  Especially given that even patients with 
severe airway obstruction can be safely anaesthetized and treated with specialised 
shared-airway techniques.  It must, however, be acknowledged that both of these 
procedures will continue to be performed on patients who acutely present with life-
threatening airway compromise locally, who may not be safe for transfer to the nearest 
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airway unit.  In these cases we recommend referral to an airway unit once the 
obstruction has been safely bypassed, so that lesions can be treated and the patient 
decannulated.  For those patients who do require a stent, we urge that whenever 
possible, a removable stent like the Aero™ tracheobronchial stent (Alveolus Inc, 
Charlotte, NC, USA) be deployed, and removed at the earliest opportunity.  If this is not 
locally available and a permanent stent is deployed as a life-saving procedure, the 
patient should be rapidly referred to an airway unit so that the stent can be removed 
before it is encased in granulation and scar tissue.  There is no justification for placing 
and retaining a permanent stent for a benign disease with a favourable long-term 
prognosis(168) given the significant long-term complications that are associated with 
the placement of permanent stents for benign conditions. (169, 170).  
 
In conclusion, the findings of this study show that active obstructive tracheobronchial 
Wegener‟s Granulomatosis can be satisfactorily managed with minimally-invasive 
surgery undertaken using specialist shared-airway techniques, obviating the need for 
airway bypass surgery or stenting.  This, in selected patients, can in turn reduce the need 
for and the duration of, high-dose systemic corticosteroids and cytotoxic therapy.  
Given the high incidence of tracheobronchial involvement in WG, we suggest that all 
patients with unexplained pulmonary symptoms should be screened for central airway 
stenosis with flow-volume loops as part of their diagnostic work-up and a physician-led 
coordinated multidisciplinary approach to the management of tracheobronchial WG 
should be adopted.  Surgery for this condition should be conservative and aimed at 
relieving mechanical obstruction and delivering intralesional steroids.  Wegener‟s 
lesions are benign and transitory, and our research shows that placing permanent stents, 
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or performing complete circumferential endoluminal resections to achieve „normal‟ 
intraoperative airway appearances are strongly contraindicated in this condition. 
This study looked at the use of the KTP laser as a radiate cutting tool after steroid 
injection and before balloon dilatation in bronchial stenosis.  The KTP laser does run 
the risk of collateral injury to the airway leading to further scarring and in safety terms, 
there is also risk to adjacent cardiopulmonary structures. There is also a significant 
learning curve in using fibre lasers through a bronchoscope. The next area of research 
will look at the use of a cutting balloon device (171) for bronchial stenoses. This allows 
cutting and dilatation to be performed in one simple manoeuvre without the potential 
risks of a laser. 
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5.III  Idiopathic Laryngotracheal Stenosis 
Idiopathic subglottic stenosis (ISS) is a rare, slowly progressive, fibro-inflammatory 
process of unknown cause which leads to narrowing of the airway in the subglottic 
region and usually involves the first and second tracheal rings. This form of airway 
stenosis should strictly be called laryngotracheal stenosis as it involves the proximal 
trachea and extends up to the glottis (illustration 5.8).  
 
Illustration 5.8 Shows typical appearance of idiopathic subglottic stenosis 
It occurs predominantly in women post puberty, but has been reported in males (172-
176).  During the period of this research, the team have treated 50 patients with this 
condition.  Only one of these is male.  All the patients are Caucasian and of European 
origin.  The diagnosis is one of exclusion and our criteria for making this diagnosis are 
included in the table 5.1 below.  In each case, the anti-neutrophil cytoplasmic antibody 
(ANCA) and angiotensin converting enzyme (ACE) tests have to be repeated at 
intervals as neither test is 100% sensitive.  Tissue for histology is also sent at each 
surgical procedure (illustration 5.9).   
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Illustration 5.9 HE staining (x25) of tissue biopsy of idiopathic subglottic stenosis. 
Respiratory epithelium (left) with stroma consisting of acute and chronic 
inflammation (polymorphs, histiocytes and plasma cells) and fibrosis. 
 
Table 5.1  Diagnostic criteria for idiopathic subglottic stenosis. 
Clinical Features Serum Biochemistry 
 Female patient (Males very rare) 
 No history of laryngotracheal injury 
 
o No endotracheal intubation or 
tracheotomy / no occurrence of 
exertional dyspnoea within two years of 
intubation/tracheotomy. 
o No thyroid/anterior neck surgery. 
o No neck irradiation. 
o No caustic or thermal injuries. 
o No significant anterior neck trauma 
(blunt or penetrating). 
 
 No history of auto-immunity 
 
o Negative history for vasculitis, formally 
ascertained through a vasculitis-specific 
systemic enqiry and semi-quantified 
using the Birmingham Vasculitis Activity 
Scale (BVAS).  
o No history to suggest sarcoidosis or 
amyloidosis. 
 
 Negative titres for: 
 
o  Angiotensin Converting Enzyme (ACE) 
o Antinuclear Antibody (ANA). 
Rheumatoid Factor (RF) 
o Anti-Neutrophil Cytoplasmic Antibody 
(ANCA) 
 
Gross lesion morphology 
 The stenosis must include the subglottis  
Histopathology * 
 Exclusion of other pathological entities (e.g. 
tumours, vasculitides, amyloidosis…) 
 
 Fibrosis restricted to lamina propria with 
normal perichondrium / cartilage 
 
 Mixture of granulation and fibrosis with a 
prominence of keloidal fibrosis 
* This is established with a deep endoscopic biopsy at the time of first treatment. 
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Unfortunately, seven of the women in my series were treated for asthma for many years 
and were finally intubated for supposed asthma which had proven refractory to medical 
treatment.  At the point of extubation, they were then diagnosed with post-intubation 
airway stenosis.  An assumptive diagnosis of idiopathic subglottic stenosis was made in 
these patients based on the history, anatomy of the lesion and the fact that tests for other 
causes of airway stenosis had proven negative. In addition these patients were ventilated 
for very short periods, making the diagnosis of post-intubation laryngotracheal stenosis 
unlikely.  Each of the 50 patients in this series has had histological tissue sent for 
analysis (illustration 5.9) and the majority of patients have had this tissue tested for 
oestrogen and progesterone markers.  All have proven negative.  Although Shapsay 
(174) proposes a link with oestrogen, his group did not isolate oestrogen receptors in the 
tissue that they analysed.  Most series (172-176) describe an initial assessment of the 
airway stenosis under anaesthesia with management using some form of dilatation.   
 
Illustration 5.10 Complete stenosis of the glottis extending to the tracheostomy in a 
patient treated aggressively for idiopathic subglottic stenosis 
 
Other groups have undertaken endoscopic procedures using local mucosal flaps (8) 
whilst others have explored the use of Mitomycin-C (174) and steroid injections.  None 
of these have proven therapeutic benefits.  Care must, however, be taken because 
patients with idiopathic subglottic stenosis have a highly reactive airway and injudicious 
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attempts at endoscopic laser photo resection of the stenosis, pushing rigid 
bronchoscopes through, or stenting will almost invariably produce aggressive scar 
formation which can wholly close up the airway (illustration 5.10).  Similarly, long-
term tracheostomy is not a solution as the airway above the tracheostomy will scar and 
close down and cause aphonia.  The reason for the hyper-reactivity of the airway in 
these patients is unknown.  The disease does not affect or infiltrate the adjacent 
cartilaginous framework of the airway (177).  Embryologically, there does not appear to 
be any developmental significance to this anatomical site, although it is an area of 
intense immune activity.  Table 5.2 illustrates all the published case series with greater 
than 15 patients compared with our figures. 
 
Table 5.2  Review of the reported clinical series in the literature with greater than 
15 patients with idiopathic subglottic stenosis (ISS) 
 
      
 
Authors No. of 
patients 
No. of 
patients 
treated 
Period   
(years) 
Endoscopically 
treated 
patients 
No. of 
open-neck 
procedures 
No. of 
failed 
open-neck 
procedures 
Dedo and Catten  52 50 30 50 7 7 
Grillo et al   65 65 31 2 65 6 
Giudice et al 30 30 17 30 5 5 
Valdez and Shapshay 16 14 12 14 2 0 
Benjamin et al 15 15 15 12 1 4 
Sandhu et al 
(unpublished) 50 50 7 41 9 0 
 
 
The approach varies from crico-tracheal resection to repeated endoscopic procedures.  
Grillo (173) published a series of 73 patients which he had treated with crico-tracheal 
resection.  Only 65 of these patients turned out to have likely idiopathic subglottic 
stenosis.  He had 6 failures in this series of crico-tracheal resection.  Herb Dedo 
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published a series of 52 patients(175), 7 of whom were treated with crico-tracheal 
resection and all failed.  No other group has had a series as large as Grillo, nor have they 
been able to duplicate his success rate with crico-tracheal resection.  My approach to 
open surgery differs from the orthodoxy of crico-tracheal resection and anastomosis.  
The reason being that idiopathic subglottic stenosis is primarily a mucosal disease 
which overlies healthy perichondrium and cartilage (177).  In addition, no one has been 
able to duplicate the excellent cure rates reported by Grillo‟s group using crico-tracheal 
resection.  There is concern that crico-tracheal resection in a condition that 
predominantly affects females is likely to leave these patients with „male-type‟ voices 
after the surgery (178).  Moreover, crico-tracheal resection conceptually treats this 
condition as a benign neoplasm and in our series, the disease often extends up to the 
glottis (illustration 5.11) and it is difficult to conceive how a resection could be 
performed within millimetres of the vocal folds without leaving damage in this area.   
  
Illustration 5.11 Typical appearance of idiopathic subglottic stenosis extending up 
to vocal folds 
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5.IV  Treatment of Idiopathic Laryngotracheal Stenosis 
5.IV.a  Methods 
From the start of data collection in the beginning of 2004 to starting data analysis in the 
beginning of 2010, 50 patients had been diagnosed with idiopathic subglottic stenosis 
based on the criteria described above.  Only one was male.  All the patients were post 
puberty and the age range was from 26-82 years with a mean age of 52 years.  The 
length of lesion at presentation ranged from 0.75 cm to 5 cm with an average length of 
2.75 cm.  The lesion in all cases included the subglottis and first one or two tracheal 
rings with extension up to the glottis (illustration 5.11).  One case at presentation had 
complete stenosis extending from the glottis down to the tracheostomy, in total a length 
of 5 cm.  This patient will be discussed in detail later.   
The incidence of laryngo-pharyngeal reflux in adult males and females is very similar 
and this is therefore unlikely to be the principle aetiological factor. Even so, all patients 
were started on anti-reflux therapy at first diagnosis.  This comprised Omeprazole 20 
mg each morning before breakfast and Ranitidine 150 mg in the evening.  Gaviscon 
(Reckitt Benckiser, UK) was also prescribed to be taken after the evening meal.  Gastro-
oesophageal reflux management advice leaflets are offered routinely to all patients.  The 
patients are advised to continue with this therapy long-term.  Naturally, the majority of 
patients presented with dyspnoea and a smaller percentage had an associated cough.  
Most of the referred patients arrived with computer tomographic imaging of their 
airway.  However, where this had not been performed, it has not been our practice to 
arrange this.  This is because of the potential errors in estimating the size of the lesion 
that we have discussed previously.  The next step is generally to perform examination 
under anaesthesia at which time lesional anatomy is further assessed and endoscopic 
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airway surgery is performed.  An anatomical assessment consists of determining the 
cranio-caudal height of the lesion, its distance from the glottis and minimum airway 
cross-section.  These are determined using quantitive endoscopic techniques as 
previously described.  However, it is now my practice to stratify the cross-section using 
the Myer-Cotton grading system as the techniques of absolute measurement that I have 
deployed previously do not allow easy comparison with other groups‟ work.  All the 
patients in this series have been offered either repeated endoscopic procedures which 
are repeated on average every 7 months (range 4-12 months).  Only two patients have 
required no further treatment after the first endoscopic procedure.  All the patients have 
been offered an open reconstruction to provide a permanent solution to the airway 
problem.  However, to date only 10 have elected to go down this path.   
Surgical Technique 
Airway surgery and assessment is always performed using a technique of suspension 
laryngoscopy as described in the chapter on surgical techniques (3.I).  This gives an 
unencumbered no touch access to the laryngo-tracheal complex and allows for 2-handed 
minimally traumatic rigid instrumentation (illustration 5.12), microscope visualisation 
and line of site CO2 laser surgery.   
  
Illustration 5.12 View of subglottic stenosis using suspension laryngoscopy and the 
microscope 
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All patients receive intravenous induction of anaesthesia and supraglottic jet ventilation.  
A total intravenous technique is used for anaesthesia maintenance.  Most other groups 
(172-176) use a technique which includes the use of rigid ventilating bronchoscopes.  I 
find that this is unnecessary and as well as causing unnecessary trauma to tissues 
adjacent to the lesion, it also provides a less favourable view.  Our method of 
anaesthesia induction and maintenance is described in section 3.II.   
 
Illustration 5.13  Two cases of idiopathic subglottic before treatment (left) and after 
steroid injection, laser and balloon dilatation (right) 
 
Once the anatomy of the lesion has been assessed, it is our practice to inject 
Depamedrone (40 mg/ml) using a 27 gauge butterfly needle with the wings trimmed as 
shown in the illustration (illustration 4.18).  The butterfly is held in microsurgical 
laryngology forceps as shown and 3 ml of Methyl Prednisolone Acetate is injected.  The 
use of this steroid is unproven and its use is based purely on the fact that there is an 
inflammatory component to the lesion on histological analysis and the technique has 
been continued following personal communication with Professor Eliachar from the 
Cleveland Clinic, who had considerable experience with this disease.  Three or 4 radial 
incisions are made into the lesion using the Carbon Dioxide laser set at 8-10 watts 
(illustration 5.13).  This laser is deployed through a micro-manipulator attached to the 
operating microscope.  (It does not seem appropriate to use a KTP laser to treat 
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idiopathic subglottic stenosis because it causes deeper tissue penetration and more 
aggressive collateral tissue injury when compared with a CO2 laser.)  Following these 
radial cuts, the lesion is dilated using a pulmonary balloon dilatation system (Boston 
Scientific, Boston, USA) and the lesion is dilated to 15-16 mm.  A deep tissue biopsy is 
taken at this stage using microcup forceps and haemostasis is achieved using topical 
adrenaline applied with a neurosurgical pattie soaked in 1:1,000 adrenaline.   
My approach when performing open laryngotracheal surgery in these patients is to 
perform a laryngofissure with a posterior cricoid split.  Some, not all, of the lesion is 
excised off the perichondrium on the lateral walls.  Following the posterior cricoid split, 
a piece of costal cartilage is placed between the posterior cricoid split to separate the 
scar tissue and act as a temporary spacer.  This piece of cartilage is not expected to 
survive in adult patients.  Before closure of the laryngofissure, a closed silastic stent is 
fashioned as shown in the illustration (illustration 5.16) and then covered with a 
superficial skin graft with the dermis placed outwards.  This skin graft is held in place 
with a single monofilament suture of 4/0 ethilon.  The laryngeal anterior commissure is 
closed also with a 2/0 ethilon suture.  The subglottic airway is not completely closed, 
but is instead augmented anteriorly with an inferiorly pedicled sternohyoid muscle flap 
sutured in place with 3/0 vicryl.  A temporary tracheostomy needs to be fashioned 
below the reconstruction before the stent is stitched in place and the tracheostomy is left 
in place for 2 weeks.  At 2 weeks, the stent is removed endoscopically as well as the 
skin graft and the tracheostomy.  In all our patients, the area where the stenosis was 
excised is colonised with keratinocytes.  This is seen as an anterior and posterior 
longitudinal strip at the site of the rib graft and the anterior laryngotracheal split where 
the muscle was placed.  Keratinocytes also colonise some of the lateral walls where the 
stenosis was excised.  Eight of the 9 patients who have had this surgical approach have 
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had one further inspection under anaesthesia 4-6 weeks after decannulation, but none 
have required subsequent endoscopic procedures.  The 10th patient in the series was 
operated on in 2004 and the case is described below.   
A 36-year-old white Caucasian female had been referred from a teaching hospital in 
Scotland having had 12 endoscopic airway laser procedures to deal with an idiopathic 
subglottic stenosis.  She developed complete stenosis of her airway from the glottis 
down to the tracheostomy and had had no voice for 5 years.  She had requested surgery 
to restore her voice as she had not spoken to any of her children in 5 years.  The local 
surgical team’s recommendation was for a laryngectomy and surgical voice.  Having 
declined this option, she sought a referral to the Airway Reconstruction unit.   The 
appearance of the larynx at the time of first examination is shown in illustration 5.14.  
CT imaging revealed complete stenosis from the glottis to the tracheostomy 
(approximately 5cm) 
 
Illustration 5.14  View of glottis in patient with complete stenosis of the airway 
from the vocal cords to the tracheostomy 
 
Up until this time, I had performed no open surgical procedures on idiopathic 
subglottic stenosis.  As the patient was prepared to try any measures that might work 
rather than lose her larynx, a new technique was devised.  The airway was opened from 
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the level of the glottis to the tracheostomy using the CO2 laser delivered through a 
micromanipulator attached to the microscope.  
   
Illustration 5.15  Showing lasering (left) to open out airway, stenting (middle) and 
after removal of stent 
 
Following balloon dilatation, a size 12 soft silastic stent was stitched in place for one 
month (illustration 5.15).  The patient retained a tracheostomy and required 
nasogastric feeding only for the first few days.  Once the stent was removed, the voice 
gradually deteriorated and endoscopic examination demonstrated gradual closure of 
the airway above the tracheostomy.  An open laryngotracheal procedure was advised, 
to which the patient agreed.  A laryngotracheal fissure, as described above, was 
performed with a posterior cricoid split and posterior augmentation with a piece of 
costal cartilage and anterior augment with a pedicled sternohyoid flap.  The 
endoluminal stent in this case was a superficial skin covered Eliachar stent (illustration 
5.16) which was left in place for 2 weeks.  The stent was removed endoscopically and 
an adequate airway had been achieved.  The tracheostomy, however, was left in place 
for a further 10 weeks to be sure that there was going to be no re-stenosis of the airway.  
The patient has had a 6-year follow-up with no further endoscopic procedures.   
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Illustration 5.16  Costal cartilage fashioned to fit in a posterior cricoid split (left), Eliashar 
stent (middle) in place in the larynx covered with superficial skin graft. Larynx four years 
after reconstruction (right) 
 
Illustration 5.16(right) shows the appearance of her glottis at the last assessment.  She 
eats and drinks normally and although her voice is very rough in quality, it is usable 
and she retains a Scottish accent.  She does not describe dyspnoea and manages the 
normal activities of daily living. 
5.IV.b  Results 
The study of idiopathic subglottic stenosis is incomplete as further patients need to be 
recruited. However, the results of the open surgical approach are exceptional and it was 
felt that an early mention should be made in this thesis. At first diagnosis, before 
endoscopic tracheoplasty, some patients report an MRC dyspnoea score of IV or V. 
Some have even been ventilated because of type 2 respiratory failure before the 
diagnosis was made.  Following endoscopic surgery patients report normal airway 
swallowing and voice until recurrence. (typical flow volume loops 5.17).  
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Illustration 5.17  Typical flow volume loops before and after treatment of idiopathic 
subglottic stenosis 
 
All the open reconstructions report normal airway, voice and swallowing aside from 
two cases. The patient with complete laryngotracheal stenosis (described on previous 
page) has a very rough quality to her voice but it is functional. The other suboptimal 
result is in a relatively young patient (30-year-old female) has ended up with a weaker, 
breathier voice but excellent airway.  She is the last patient in the series to have been 
treated and has had 15 months follow-up.  The problem appears to be excessive 
separation of the posterior glottis leading to a persistent phonatory gap.  The voice has 
gradually improved with speech and language therapy guidance, but the problem 
appears to be incomplete resorption of the posterior rib graft augment 
5.IV.c  Discussion 
Idiopathic subglottic stenosis is a rare condition of unknown aetiology of which there 
have only been a few hundred cases described in the world literature.  The vast majority 
of the patients are female. My series is currently the third largest but has not as yet been 
published.  All the patients in my series are of European origin and the condition has not 
been described in the Oriental or South Asian literature.  Personal communication with 
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previous authors has revealed that some of the patients in these series are of Afro-
Caribbean descent.  Although all our patients have been offered open reconstructive 
procedures to definitively deal with this condition, the vast majority have elected to 
have once or twice yearly day case endoscopic procedures.  Only a small number of 
patients have been treated with the novel surgical approach, but the results are 
promising.  In the future, the plan is to use a smaller piece of cartilage in the posterior 
cricoid split.  In addition the team will also be performing pre and post surgical 
assessment along the lines of the proposed guidelines at the end of this thesis. 
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5.V  Sarcoidosis 
5.V.a  Introduction 
Cesar Boeck of Christiania, Denmark was the first to use the word “sarcoid” and 
describe the multi-system nature of the disease in 1899 (179, 180).  He mentioned the 
clinical similarity to a previous case described by Jonathan Hutchinson of London in 
1898 as Mortimer‟s Malady where a female patient, Mrs Mortimer, had generalised skin 
lesions and swelling of the bridge of the nose.  Sarcoidosis has a world-wide 
distribution and can affect any race, ethnicity, gender or age group.  Typically, it is 
found in patients aged 20-40 years and has a female to male ratio of 2:1, and has a 
predilection for black African Americans (180).  Otolaryngological involvement occurs 
in <3% of cases and can occur in isolation as the only initial presenting symptom or can 
represent progression of this systemic disease (181).  Laryngeal pathology is often 
overlooked and many authors have suggested that if actively sought, a high incidence 
would be found.  Laryngeal sarcoidosis thus has a variable incidence reported between 
1% and 5% (182-184).   
5.V.b  Pathogenesis 
The pathophysiology behind sarcoidosis remains obscure and numerous infectious, 
chemical or occupational agents have been postulated as inducing disease.  Abnormal 
auto-immune mechanisms are seen in sarcoidosis such as the inability to mount or 
maintain delayed type hypersensitivity reactions (185).  This forms the basis for a 
negative tuberculin test that is characteristically seen.  Current hypotheses propose 
sarcoidosis to occur in generally susceptible individuals through alterations in immune 
responses after exposure to various “triggering” agents.  In large case controlled trials, 
no single cause has been found.  Genetic associations have been investigated, 
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demonstrating HLA DRB1 allelles to be involved (186).  Although development of 
sarcoidosis is likely to be multifactoral, a genetic-environmental interplay appears to be 
important in disease initiation.  Histologically, granulomas are seen arranged in clusters 
or crops of tubercles typically at the same stage of development.  They consist of 
epithelioid cells, giant cells and various lymphocytes and plasma cells with no evidence 
of caseation or necrosis.  As disease remits, fibrosis occurs around and between 
granulomas.  Fibrous tissue then hyalises, forming a dense scar around the tubercle.  
Granulomas can completely resolve such that biopsy specimens do not show these 
characteristic features.  Multiple biopsies may be necessary for diagnosis, and even 
when carried out, may only yield features of non-specific inflammatory infiltrates.   
5.V.c  Diagnosis 
The diagnosis of sarcoidosis depends on the presence of typical clinical features and 
non-caseating granulomatous inflammation (illustration 5.18) on biopsy of an affected 
organ with the exclusion of other known causes of granulomas, including tuberculosis, 
leprosy, syphilis and fungal disease.   
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Illustration 5.18  HE stain (x200) of sarcoid granuloma with no caseation and 
peripheral rim of lymphocytes. Respiratory epithelium on right of specimen. 
 
The full blood count may be normal or reveal a normocytic anaemia of chronic disease 
with an elevated erythrocyte sedimentation rate.  There may be lymphopenia with a 
reduction of the CD4 to CD8 T cell ratio.  The serum angiotensin converting enzyme 
(ACE) level is typically elevated, but may be within the normal range.  Serum anti-
neutrophil cytoplasmic antibody (ANCA) is normal.  Biopsy of an affected organ is 
used to confirm granulomatous inflammation and for specific stains to exclude known 
infections causes including tuberculosis, leprosy, syphilis, fungi and other 
granulomatous diseases and vasculitis.  A chest X-ray may reveal hilar 
lymphadenopathy with or without pulmonary infiltrates or evidence of pulmonary 
fibrosis.  In suspected disease, if a chest X-ray is normal, then a CT scan should be 
requested.  Serum calcium may be elevated and a 24-hour urine collection should be 
obtained to exclude elevated urinary calcium excretion.  A Gallium scan may show 
enhanced uptake in the lacrimal and parotid glands due to granulomatous inflammation.  
ECG and echocardiogram are usually performed in order to exclude cardiac 
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involvement.  Anatomically, laryngeal sarcoid has a predilection for the supraglottic 
region, particularly the epiglottis, aryepiglottic folds and arytenoids (illustration 5.19).   
  
Illustration 5.19  Showing diffuse swelling of the surpaglottic larynx typical 
of sarcoidosis 
 
The macroscopic appearance of the supraglottis is diffusely thick, oedematous and 
characteristically pale or pink in colour.  These features are considered pathognomonic 
for this condition (182).  Although exophytic, polypoidal, nodular and granulating 
lesions have been described, these are less common (184).  Isolated involvement of the 
glottis is exceedingly rare (187).  This may be explained by the paucity of lymphatics 
draining the glottis and the sarcoidosis is a disease of the reticulo-endothelial system 
(188).  Decreased vocal cord mobility is a feature seen with diffuse laryngeal invasion.  
True vocal cord paralysis can also occur as a result of perineural invasion or multiple 
cranial nerve polyneuritis (182).  Laryngeal disease tends to progress slowly with a 
relapsing and remitting course.  The disease may ultimately “burn out” in later stages.  
Symptoms are recognised when granulomatous lesions are present; however, they may 
persist despite remission due to subsequent fibrosis.   
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5.V.d  Clinical Features 
The clinical features of laryngeal sarcoidosis have been well described.  These include 
dysphonia, dyspnoea, dysphagia and cough (189).  Stridor is a late symptom and an 
indicator of impending acute airway obstruction.  Pain is not a feature of laryngeal 
lesions as the mucosa remains intact and rarely ulcerates (185).  Other constitutional 
symptoms may be present, the most frequent being fever, weight loss and generalised 
malaise.  Alternatively, patients may be asymptomatic and are diagnosis made on 
clinical examination.   
5.V.e  Clinical Evaluation 
As 90% of cases of sarcoidosis have pulmonary involvement, patients are often referred 
to the otolaryngologist by a respiratory physician.  These patients therefore need to be 
managed in a multi-disciplinary setting.  The role of the otolaryngologist in this setting 
is to take a full history and perform a complete ear, nose and throat examination, 
including examination of the nose and upper aerodigestive tract with a flexible nasal 
endoscope.  The nose may demonstrate congestion or crusting; however, this alone is 
not diagnostic as one third of the population suffer with some degree of rhinitis.  The 
appearances of the larynx may be pathognomonic, but the diagnosis is still one of 
exclusion of other disease processes that may mimic sarcoidosis.  The otolaryngologist 
should also confirm that the investigations mentioned above have been performed and 
the results are collated.  If a CT scan of the chest has not recently been performed, then 
this can be requested to include the neck.  This may help with discrimination of soft 
tissue swelling and cartilaginous abnormalities in the larynx.  It may also pick up 
cervical lymphadenopathy that was not apparent on clinical examination.   
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Recently, positron emission tomography coupled with computer tomography (PET/CT) 
has been shown to have an increasing role as a non-invasive imaging tool specifically 
for extra-thoracic manifestations of sarcoidosis (190).  It has also been show to correlate 
well with active disease in biopsy proven pharyngo-laryngeal sarcoidosis.  The presence 
and degree of airway obstruction in these patients can be assessed with pulmonary 
function tests.  In upper airway obstruction, flow volume curves show characteristic 
truncation of peak flow rates.   
5.V.f  Treatment 
Optimum treatment techniques are still debated and various approaches exist, all 
intending to slow disease progression and/or remove it permanently.  The international 
consensus on sarcoidosis is that corticosteroids are indicated when critical organs are 
involved or if sarcoidosis is severe (191).  Although systemic corticosteroid therapy is 
initially effective, many patients require long-term low dose steroid treatment to 
maintain remission, which is not without complications.  If symptoms fail to respond or 
relapse when the Prednisolone is reduced to 10 mg daily, then an additional 
immunosuppressant is indicated.  Hydrochloroquine is given orally in daily doses of 20-
400 mg and has been shown to be effective in sarcoid skin lesions.  If a steroid sparing 
agent is required for systemic disease that does not involve the skin, then Methotrexate 
may be considered.  An initial dose of 2.5-5 mg of Methotrexate is increased at 1-2 
weekly intervals by 2.5 mg with repeated monitoring of blood count and liver function 
to a maximum of 15-20 mg once weekly.  If tolerated, this can continue long-term while 
gradually tapering the Prednisolone dosage.  Folic acid 5 mg on the day following 
Methotrexate will also be required.  In rare cases when corticosteroids alone or a 
combination with Methotrexate and/or Hydroxychloroquine fail, then there is a rationale 
for the use of strategies against human tumour necrosis factor alpha (TNFA) which is 
174 
 
known to be involved in granuloma formation.  However, there is very little evidence 
for or against the use in patients with predominantly upper respiratory tract sarcoidosis.  
In patients with significant airway compromise, unless specialist shared airway surgical 
and anaesthetic expertise is available, a tracheostomy may become mandatory (192).  
Laryngeal sarcoid has been treated previously with intra-lesional corticosteroids via 
direct or indirect laryngoscopy with moderate success (189, 192).  This technique does 
produce relief and reduction of systemic steroids in many patients, but recurrences are 
variable and individuals did require multiple injections to control disease.  However, a 
number of patients in these series still required oral steroids.  Various techniques of 
surgical debulking and excision of laryngeal sarcoid lesions have been described.  These 
include open procedures with laryngofissure (192) and laryngectomy (193) which have 
been used, but are understandably associated with significant morbidity and disability.  
More recently, minimally invasive direct laryngoscopy with carbon dioxide laser 
ablation has been shown to improve symptoms, create adequate airways and remove 
disease (194, 195) although this effect is often temporary (183, 196).  Other alternative 
treatments have included external beam radiotherapy (197, 198).  However, this does 
increase the risk of thyroid malignancies and has not often been utilised.   
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5.VI  Assessing a New Surgical Treatment for Laryngeal Sarcoidosis 
Following review of the literature, I did not feel that given the small number of cases of 
laryngeal sarcoidosis, that a prospective randomised trial comparing laser treatment of 
laryngeal disease versus steroid injection could be justified in patients who were acutely 
airway compromised.  Lesional steroid injection would be undertaken in these patients 
based on previous work on airway Wegener‟s granulomatosis (161).  However, the use 
of the laser to excise disease in itself had the potential to cause scarring and stenosis.  A 
new technique of laser usage had to be devised.  Although pedunculated lesions 
encroaching onto the airway could be excised “flush” with normal anatomy, 
circumferential injury in the laryngeal inlet had to be avoided.  It is not possible in each 
patient to determine the extent to which the supraglottic laryngeal swelling is due to 
scar tissue or active disease, there had to be a technique of reducing tissue bulk in this 
part of the larynx.  It was decided to reduce interstitial tissue bulk using the CO2 laser in 
a “pepper pot” fashion as described below. 
5.VI.a Methods 
Ethical considerations 
The following study is a report of the standard treatment for patients undergoing surgery 
for laryngeal sarcoid at our institution and therefore the Research Committee deemed 
ethical approval unnecessary.  The records of all patients with upper airway stenosis due 
to laryngeal sarcoid were prospectively collected on a database of adult patients with 
laryngotracheal stenosis from which this thesis is derived.  All the patients were jointly 
managed within a multi-disciplinary team and the diagnosis of sarcoidosis was based on 
internationally agreed clinical, radiological and histopathological criteria (191). 
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Laryngeal sarcoidosis accounted for 2.8% of the units workload at the time of this study 
(10 out of 353) which included all surgically treated adult airway cases presenting from 
2004 to 2008.  There were 9 women and 1 man, and the mean (SD) age at presentation 
was 37 (17) years with a range from 18-62 years.  All patients had dyspnoea on 
presentation.  In addition, two patients were stridulous on presentation and 2 were 
referred to our unit after having received an emergency tracheostomy elsewhere.  Six 
patients presented with isolated laryngeal sarcoid and the remaining 4 patients had 
multiple systems involvement.  Laryngeal subsite manifestation of disease was 
restricted to the supraglottis.  The most common sites (in descending order) were 
arytenoids, aryepiglottic folds, epiglottis and false vocal folds.  One patient had disease 
in the inter-arytenoid region.  There were no cases of macroscopic sarcoid affecting the 
glottis.   
All patients presented with dyspnoea and dysphonia.  Five patients presented with 
stridor, 7 with dysphagia and 2 with a chronic cough.  The table 5.3 lists further 
information about patient and disease characteristics in this series.   
Surgical technique 
Total intravenous anaesthesia was established as described in section 3.II.  The airway 
was secured during induction using a laryngeal mask and following suspension 
laryngoscopy (Lindholm pattern Laryngoscope, Storz, Germany) supraglottic jet 
ventilation was established.  Where patients did not sustain adequate oxygen saturation, 
a subglottic jetting catheter was placed during the surgery.  The laryngotracheal 
complex was visualised using laryngoscopy and a combination of microscope and 4 mm 
0° Karl Storz endoscope (Karl Storz, Tuttlingham, Germany) were used to visualise and 
treat the airway.   
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Laryngeal lesions were identified and a biopsy routinely performed.  Variable doses of 
between 40-120 mg of Methylprednisolone Acetate at a concentration of 40 mg/ml 
(Pharmacia Ltd, Kent, England) was administered according to lesion size.  A standard 
microlaryngoscopy injection needle or a modified 27 gauge butterfly was used to 
deliver multiple injections of steroid starting at the base of the lesion and withdrawing 
the needle to infiltrate as much of the bulk of the lesion as possible.  A good indicator of 
the end point of intra-lesional injection was complete blanching of the lesion.  
Immediately after complete infiltration of the lesion, laser photo reduction using the 
carbon dioxide laser was performed at a continuous setting of 8-10 watts.  Any 
pedunculated lesions encroaching on the airway were excised flush to the position of 
normal anatomical landmarks.  Tissue bulk was reduced by lasering spots through the 
mucosa to a depth of 4-5 mm separated by about 2 mm, thus creating a “pepper pot” 
effect (illustration 5.20). 
       
Illustration 5.20  Endoscopic views of laryngeal sarcoid. Preoperative (left) and three 
weeks post-surgery (right). Peroperative view (middle) demonstrating appearance after 
steroid injection and “pepper-pot” laser photoreduction. 
 
Data analysis 
Patient demographics and the nature and timing of treatments were obtained from 
patient records and the database.  Initial presenting symptoms and Medical Research 
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Council (MRC) dyspnoea scores were obtained pre-operatively, post-operatively and at 
last follow-up.  The MRC dyspnoea outcome assessment instrument has been shown to 
correlate well with the degree of luminal obstruction and has been validated for adult 
patients with laryngotracheal stenosis (150).  Sites of laryngeal involvement were 
recorded intra-operatively.  Qualitative assessment was via a prospective recorded 
endoscopic photograph database.  A timeline plot was used to illustrate the number and 
nature of treatment episodes that each patient received.  Data were presented either as 
mean values with standard deviations or binomial percentages where appropriate.  Data 
was analysed and displayed using SPSS software, version 16 for Windows (SPSS Inc, 
Chicago, Illinois).   
5.VI.b  Results 
Excluding patients with tracheostomy tubes, the median pre-operative and post-
operative MRC dyspnoea grade was 3 (range 2-4) and 1 (1-2) respectively.  Dyspnoea 
grading scores improved significantly post-operatively  (table 5.3 (p = <0.05 for the 
Wilcoxon signed- rank test), and patients with tracheostomy tubes were successfully 
decannulated 5-7 days after the initial operation.  The median number of endoscopic 
treatments was 2 (range 1-4). Illustration 5.21 demonstrates a detailed treatment line for 
all the patients.  The mean (SD) follow-up time was 24 (18) months with no mortalities 
and no surgical adverse effects reported during that time.  Prior to endoscopic surgery, 
all patients were treated with high dose corticosteroids (>40 mg daily of prednisolone).  
Post-operatively, 6 patients had a substantial dose reduction in their daily steroid 
requirements (to <7 mg daily of Prednisolone).  Three patients were able to discontinue 
their systemic corticosteroid therapy following endoscopic treatment (table 5.3) 
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Illustration 5.21  Showing timeline for individual patients. The preoperative and 
last follow-up MRC dyspnoea grade appears at the beginning and end, 
respectively, of each timeline. 
 
 
 
Table 5.3  Characteristics of patients treated for laryngeal sarcoidosis (199) 
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5.VI.c  Discussion 
The results of this study are consistent with the other research in this thesis on the 
management of inflammatory conditions of the laryngotracheal complex such as 
Wegener‟s granulomatosis and post-intubation laryngotracheal stenosis where intra-
lesional steroids and laser surgery administered in the active phase of the disease can 
prevent progression by altering its natural history (section 5.I and 4.VII).  This study has 
found that in those patients with laryngeal sarcoidosis, control of local disease with 
minimally invasive surgery allowed systemic treatment to be stopped or reduced with 
associated benefits in terms of reduced exposure to systemic steroids and steroid side 
effects.  This appears to be the largest study undertaken with respect to the management 
of laryngeal sarcoidosis by a single operator in a single setting using a single treatment 
philosophy over a short period during which data was systematically and prospectively 
collected.  This study demonstrates the effectiveness of minimally invasive laser 
surgery and furthermore suggests that laser treatment can be made even safer by the use 
of a mucosa sparing “pepper-pot” photo-reduction technique as shown in illustration 
5.20.  The main limitations of this study are the small sample size, which is an 
inescapable consequence of the rare disease entity that can only be addressed through a 
prospective multi-centre study.  This study also highlights that combining both intra-
lesional injection with steroids and laser ablation for debulking can successfully 
improve symptoms immediately with minimum morbidity.  This technique of “pepper-
pot” lasering reduces the bulk of underlying sarcoid tissue and allows rapid healing 
without compromising functional anatomy (illustration 5.20, right).  More importantly, 
this technique reduces the need for systemic steroid administration in most patients. 
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Chapter 6 
6.I  Screening for Laryngotracheal Stenosis 
It has already been shown in section 4.III that up to 4 out of 5 cases of post ICU 
laryngotracheal stenosis are missed. Flow volume loop studies (illustration 1.3) are a 
good screening tool for upper airway obstruction and also help identify its site and 
nature.  Access to these tests is easy within hospital departments or specialist clinics, 
but not in primary healthcare clinics.  An alternative form of community screening for 
upper airway obstruction is the Empey index.  Empey identified the relationship 
between peak expiratory flow rate (PEFR) and forced expiratory volume in 1 second 
(FEV1) (131).  The Empey index allows airway stenosis diagnosis through standard 
spirometry. A modification of the Empey Index is the ratio of FEV1 over PEFR x 100, 
which provides an expiratory disproportion index. The sensitivity and specificity of this 
ratio was formally validated using a database at Imperial College London of 10,048 
patients undergoing respiratory lung function testing.  The diagnosis in all of these 
patients was known and 200 of these patients had laryngotracheal stenosis.  The 
sensitivity was calculated at 95.2% and the specificity at 94.6% (illustration 6.1).  If the 
expiratory disproportion index (EDI) is greater than 50, then a diagnosis of 
laryngotracheal stenosis can be excluded.  If the index is less than 50, then a patient 
should be referred for flow volume loop testing. This makes the EDI a very suitable 
screening tool. 
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Illustration 6.1 Graph to show sensitivity and specificity of the expiratory disproportion 
index (EDI). Area under the curve is 0.98. (FEV1= forced expiratory volume in one second, 
FVC=forced vital capacity, PEFR=peak expiratory flow rate) 
 
 
A screening test would have to be applied to an ICU patient at the time of discharge 
from hospital and again at 3 months. This would identify patients with a compromised 
airway before they leave hospital and also those patients who have a circumferential 
airway injury that granulates and narrows later, leaving a window to treat 
endoscopically before significant scarring and contracture takes place (section 4.VII).  
The UK National Screening Committee (NSC) define screening as: 
“Screening is a process of identifying apparently healthy people who may be at 
increased risk of a disease or condition. They can then be offered information, further 
tests and appropriate treatment to reduce their risk and/or any complications arising 
from the disease or condition” 
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Wilson and Jungner criteria for screening (200) 
 Knowledge of disease:  
o The condition should be important. 
o There must be a recognisable latent or early symptomatic stage. 
o Natural course of condition, including development from latent to declared disease, 
should be adequately understood. 
 Knowledge of test:  
o Suitable test or examination. 
o Test acceptable to population. 
o Case finding should be continuous (not just a "once and for all" project). 
 Treatment for disease:  
o Accepted treatment for patients with recognised disease. 
o Facilities for diagnosis and treatment available. 
o Agreed policy concerning whom to treat as patients. 
 Cost considerations:  
o Costs of case finding (including diagnosis and treatment of patients diagnosed) 
economically balanced in relation to possible expenditures on medical care as a whole. 
 
Post-ICU laryngotracheal stenosis, as a condition, meets most of these criteria, except 
for health economics. Only small numbers of patients develop this condition (130), but 
the cost of diagnosis would also be small. Individual hospitals could set up screening, 
however, ICU patients often live at some distance from the hospital in which they were 
ventilated and it is likely that attendance at follow up clinics (at 3 months) would be 
poor. Primary health care practitioners could be recruited to review these patients at 3 
months with coordination and data collection from a hospital department. These are 
issues that need to be explored further in future projects. 
 
 
 
 
 
 
184 
 
6.II  Proposed Assessment of Patients with Laryngotracheal Airway 
Compromise 
 
Illustration 6.2  This thesis has researched the anatomy and physiology of airway 
stenosis, however, future research also needs to be directed towards validating 
symptom assessment tools and quality of life. 
 
This thesis has looked, in depth, at the anatomy and to some degree the physiology of 
laryngotracheal stenosis (illustration 6.2). It is possible to accurately calculate the cross 
sectional area of the airway at the site of a stenosis (section 4.VI) but the most important 
outcome is the improvement in the patient‟s symptoms and also the impact on his or her 
quality of life. For the purpose of documenting the grade of a stenosis, the Myer-Cotton 
system will continue to be used.  
A simple system for documenting the functional outcome of adult laryngotracheal 
stenosis is proposed, consisting of four domains of airway (A), providing a description 
of the status of the airway, dyspnoea (D) which is an adaptation of the Medical 
Research Council (MRC) dyspnoea grading system,
 
 voice (V) and swallowing (S). The 
last three components are scored by the patient while airway status is documented by 
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the clinician. All parts of the system have a 1–5 ordinal scale. The airway (A) domain is 
reported by the surgeon and is as follows: 
Airway status (A) 
 1. No airway prosthesis 
 2. Intraluminal airway prosthesis (stent) 
 3. Tracheostomy or T-tube dependent, patient voices 
 4. Tracheostomy-dependent, patient does not voice 
 5. Death as a result of a direct complication of airway disease 
 
The dyspnoea (D), voice(V) and swallowing(S) domains are scored by the patient 
before and after treatment and are shown in illustration 6.3. Outcomes are documented 
as subscripts, for example A1-D2-V1-S1 and should not be combined to form a single 
number. This information can be tabulated or plotted to provide a visual temporal 
treatment map, charting patient progress through treatment. It can also yield time-
dependent variables, e.g. time to the attainment of a prosthesis-free (A1) or 
tracheostomy-free (A1 or A2) airway from the outset of therapy, for actuarial analysis. 
The proposed system provides a simple patient-centred method of assessing the 
outcome of patients with laryngotracheal stenosis throughout treatment through the use 
of simple-to-use ordinal scales. The MRC scale which forms the „D‟ component of the 
system has been validated for this purpose and is already widely used for evaluating 
dyspnoea (150, 201). The one difficulty with this MRC dyspnoea scale is its application 
to patients who have tracheostomies. The „A‟, „V‟ and „S‟ components have been 
derived through studying other voice and swallowing scales and in consultation with 
laryngologists and speech and language therapists and still require validation. They are 
based on the experience of evaluating the range of functional impairments that were 
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observed in 210 patients with laryngotracheal stenosis who were treated over the first 
3 years (level IV evidence) of this study. 
 
Illustration 6.3 The proposed symptom scoring system for the Airway Reconstruction 
Unit. The Dyspnoea component (top) is based on the Medical Research Council dyspnoea 
scale and has already been validated for adult airway stenosis (150, 201). 
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For a more detailed assessment of airway, voice and swallowing symptoms and 
morbidity  the Clinical COPD Questionnaire (CCQ) (202), the Voice Handicap Index-
10 (VHI-10) (203) and the Eating Assessment Tool (EAT-10) (204) can be used. These 
are all validated, 10-item, patient-administered, symptom severity instruments. The 
Short Form 36 health survey questionnaire (SF-36) can be used to assess changes in 
patient quality of life in response to airway treatment (205). It is proposed to administer 
the SF-36 at least six months after the conclusion of airway therapy. It is hoped that this 
proposed (ADVS scoring) system could lead to a more uniform reporting of airway 
reconstruction outcomes for easier comparison and combination of treatment results for 
audit, research and meta-analysis purposes. Table 6.1 lists assessment and outcome 
measures for all future patients referred to the Airway Reconstruction Unit. 
 
Table 6.1 Proposed outcome assessment in airway stenosis in the future 
Level of Assessment Outcome Measures 
Anatomy  Myer-Cotton scale for cross-section narrowing 
 Cranio-caudal extent (vertical height) of the lesion 
 Distance from glottis 
Flow Physiology  Spirometry 
 Flow-volume loop 
Exercise Physiology  Incremental shuttle walk test 
 Cardiopulmonary exercise testing (CPET) 
Airway Status  A domain of ADVS 
Symptoms – Dyspnoea and 
effort intolerance 
 D domain of ADVS 
 Clinical COPD Questionnaire (CCQ) 
Symptoms – Voice  V domain of ADVS 
 VHI-10 
Symptoms – Swallowing  S domain of ADVS 
 EAT-10 Instrument 
Quality of Life  Short Form 36 Health Survey Questionnaire (SF-36) 
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Chapter 7 
The Future of Laryngotracheal Stenosis Management 
This thesis has shown that it is safe to paralyse and ventilate a patient even with severe 
laryngotracheal stenosis. These safe anaesthetic techniques have made the exploration 
of adult benign laryngotracheal stenosis by minimally invasive endoscopic surgery 
possible. The research in this thesis has: 
- Shown that 72% of new cases of post-ventilation airway stenosis can be 
managed endoscopically, without the need for open surgical procedures and 
tracheostomies.   
- Demonstrated successful surgical approaches to the management of the airway 
in hitherto difficult to manage inflammatory conditions such as Wegener‟s 
granulomatosis, idiopathic subglottic stenosis and sarcoidosis.  
- Pioneered a new approach for managing patients with long length tracheal 
stenosis. 
- Evaluated the possible incidence of this condition and promoted a better 
understanding of the aetiologies and prevention. 
Over the course of this research, following the presentation of some of its findings at 
national anaesthetic, intensive care, ENT and speech science meetings, there have been 
changes in medical practice. Colleagues now make balanced decisions in respect of 
sizing of ventilation tubes rather than „largest is best‟ and intensivists are moving 
towards earlier tracheostomies on ICUs. There appears to be a better understanding of 
the need for regular monitoring of ventilation tube cuff pressures and future designs of 
tubes will not allow the upper limit of cuff pressure to be exceeded (206).  
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This thesis has explored the limits of endoscopic techniques for managing 
laryngotracheal stenosis. However, any piece of research throws up more questions and 
ideas for future research. 
One area of active research and development is in the field of tracheobronchial stents. 
Stents would be the simplest solution to the immediate management of airway 
compromise. The ideal stent would be easy to insert and remove, not migrate, cause no 
airway injury and experience no bio-fouling or risk of obstruction.  Unfortunately there 
is no such stent. The next generation of stents will be reabsorbable (illustration 7.1), or 
bioengineered in other ways, so that they do not need to be removed. In addition the 
functional life of the stent could be pre-determined. One concern is that they could 
degrade non-uniformly, fracture and compromise the airway. 
                                     
Illustration 7.1 Prototype of a biodegradable airway stent                                                
(Qualimed, Hamburg, Germany) 
 
The repair of long lengths of airway defects remains a major problem for clinicians.  Up 
to 6 cm of trachea can be resected (7) in the adult with primary anastomosis.   The 
repair of tracheas beyond this length or where there has been failed previous resective 
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surgery has proven difficult.  Tissue engineering and tracheal allotransplantation are two 
techniques that are being explored and hold promise for the future.  The first clinical 
transplantation of a tissue engineered airway (207) was reported in 2008.  The technique 
used a decellularised donor tracheal scaffold which was recolonised with the recipients 
own cells in a novel bioreactor system.  The technique used mesenchymal stem cell 
derived chondrocytes and the epithelium of the trachea was replaced by culturing 
samples of the patients own respiratory epithelium in the laboratory.  An area of 
damaged trachea and adjacent left main bronchus was replaced in a 30-year-old woman 
who had sustained damage to her airway from a tuberculous infection.  The transplant 
was successful and the patient required no immunsuppressive therapy.  The downside of 
this technique is that the graft requires restoration of the blood supply from adjacent 
tissues.  There is concern that replacing longer lengths of airway runs the risk of some 
degree of avascular necrosis, even though the metabolic demands of chondrocytes are 
very low.   
Another technique that has been reported (208) uses tracheal allotransplanatation 
without the need for long-term immunsuppressive therapy.  In this technique, a donor‟s 
trachea was wrapped in the subcutaneous tissue of the recipients forearm in an 
orientation to allow revascularisation.  Immunosuppressives were initially started and 
continued until 229 days after completion of airway surgery.  During this time, the 
posterior membranous sheath of the trachea necrosed and was replaced with buccal 
mucosa from the recipient.  At 4 months, the tracheal allograft was found to be fully 
mucosal lined and with intact cartilaginous rings. This revascularised allograft was 
dissected with the radial artery and two radial veins and transported as a free flap to the 
neck where it was used for reconstruction. The allograft was used to repair a 4.5 cm 
defect in the trachea of a 55-year-old woman. The procedure was reported in January 
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2010 and there has been no evidence of rejection, despite stopping immunsuppressants.  
The donor trachea histologically had been surrounded by recipient blood vessels and the 
mucosal epithelial lining originated from the recipient.   
The alternative approach to the two techniques mentioned above is direct organ 
(laryngeal) transplant with immunosuppresssants.  The first such procedure was 
performed in Cleveland, Ohio in 1998 (209).  However, the patient still retains a 
tracheostomy tube.  A more recent composite tissue transplant, performed in California 
(210) in October 2010, replaced the larynx, thyroid gland and an adjacent length of 
trachea.  This transplant included implantation of the posterior cricoarytenoid muscles 
with a division of the phrenic nerve (211). It is hoped that abductor motor function to 
the larynx will be restored to allow decannulation of the patient. A group at the San 
Vicente de Paul University Hospital in Medellin, Colombia, led by Dr Luis Fernando 
Tintinago, have claimed several laryngeal and laryngotracheal transplants since the first 
procedure by the Cleveland Clinic. Unfortunately there are no references in the medical 
literature of either the short term or long term results in these patients. 
Advances in biotechnology may provide the solution to difficult problems such as long 
length tracheal replacement and tracheomalacia. Biocompatible and biointegratable 
scaffolds that mimic the mechanical properties of tracheal cartilage could be used to 
provide shape to muscle flaps for use as tracheal replacements. Biointegratable stents 
could be a simple solution to airway stenosis. However, the research into these 
biomaterials is still in its infancy. 
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